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Summary 
Human immunodeficiency viruses type 1 and 2 (HIV-1 and HIV-2, respectively) are the 
causative agent of acquired immunodeficiency syndrome (AIDS). Most of the available clinically 
approved antiretroviral drugs directed against HIV inhibit the viral reverse transcriptase (RT), a 
multifunctional enzyme with RNA- and DNA-dependent DNA polymerase activity, as well as 
ribonuclease H, strand-transfer, and strand displacement activities. Nucleoside RT inhibitors 
(NRTIs) constitute the backbone of current therapies against both types of HIV, although the 
acquisition of NRTI resistance is mediated by the development of different mutational pathways. In 
HIV-2, resistance to all approved nucleoside analogues is conferred by the combination of RT 
substitutions K65R, Q151M and M184V. Interestingly, in highly divergent HIV-1 RTs, K65R alone 
confers >8-fold increased accuracy of DNA synthesis. In this Thesis, we have determined the 
intrinsic fidelity of DNA synthesis of wild-type (WT) HIV-2 group A (strain ROD) RT and mutants 
K65R and K65R/Q151M/M184V. Our results show that in HIV-2ROD RT those changes have a 
relatively small impact on nucleotide selectivity. Furthermore, we found that there were less than 2-
fold differences in error rates obtained with forward mutation assays using mutant and WT HIV-
2ROD RTs. A different conformation of the β3-β4 hairpin loop in HIV-1 and HIV-2 RTs could 
probably explain the different effects of K65R. 
In addition to its importance in natural infection, RTs are also widely used in biotechnology for 
their capacity to synthesize complementary DNA using RNA as templates. Intrinsic fidelity of RT’s 
DNA-dependent DNA synthesis has been extensively studied. In M13mp2 lacZα forward mutation 
assays, WT HIV-1 RTs of group M/subtype B showed >10-fold higher error rates than murine 
leukemia virus (MLV) and avian myeloblastosis virus (AMV) RTs. This Thesis aimed to determine 
error rates for RNA-dependent DNA synthesis catalyzed by several RTs, including WT HIV-1BH10, 
HIV-1ESP49, AMV and MLV RTs, and the high-fidelity mutants of HIV-1ESP49 RT K65R and 
K65R/V75I. Our results show that these retroviral RTs have less than 2-fold differences in fidelity, 
with error rates in the range of 2.5 × 10−5 and 3.5 × 10−5. These results were consistent with the 
existence of a transcriptional inaccuracy threshold, generated by the RNA polymerase while 
synthesizing the RNA template used in the assay. A modest but consistent reduction of the 
inaccuracy threshold was achieved by lowering the pH and Mg2+ concentration of the transcription 
reaction, needed to synthesize the RNA template. Despite assay limitations, we concluded that HIV-
1BH10 and HIV-1ESP49 RTs are less accurate when copying DNA templates than RNA templates. 
Analysis of the RNA-dependent mutational spectra revealed a higher tendency to introduce large 
deletions at the initiation of reverse transcription by all HIV-1 RTs except the double-mutant 
K65R/V75I. Data provided by deep sequencing experiments also showed similar differences in 
accuracy between HIV-1BH10 and K65R/V75IESP49 RTs.  
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Resumen 
El síndrome de la inmunodeficiencia adquirida (SIDA) está causado por el virus de la  
inmunodeficiencia humana de tipo 1 y 2 (VIH-1 y VIH-2, respectivamente). La mayoría de los 
fármacos antirretrovirales aprobados clínicamente para su uso contra la infección por el VIH actúan 
sobre la retrotranscriptasa (RT) viral. La RT es una enzima multifuncional con actividad ADN 
polimerasa dependiente de moldes ARN y ADN, así como con actividad ribonucleasa H. Los 
inhibidores de la RT análogos a nucleósido constituyen el eje central de las terapias actuales contra 
ambos tipos de VIH. En la RT del VIH-2, la combinación de cambios de aminoácido K65R, Q151M 
y M184V confiere resistencia a todos los análogos a nucleósido aprobados. Cabe destacar que en 
RTs de VIH-1 muy divergentes, la mutación K65R confiere por sí misma >8 veces mayor fidelidad 
en la síntesis de ADN. En esta Tesis, hemos determinado la fidelidad intrínseca para la síntesis de 
ADN dependiente de moldes de ADN de la RT de tipo salvaje (WT) del VIH-2, grupo A, cepa ROD 
y de las RTs mutantes K65R y K65R/Q151M/M184V. Nuestros resultados mostraron que estos 
cambios tienen un efecto relativamente pequeño (menos de 2 veces) en la selectividad de nucleótido 
de la RT del VIH-2ROD. Una conformación diferente de la horquilla β3-β4 en las RTs del VIH-1 y 
VIH-2 probablemente podría explicar los diferentes efectos de K65R. 
Además de su importancia en la infección natural, las RTs también se utilizan ampliamente en 
biotecnología por su capacidad de sintetizar ADN complementario utilizando ARN como molde. Se 
ha estudiado ampliamente la fidelidad intrínseca de la síntesis de ADN dependiente de ADN. En 
ensayos genéticos basados en la expresión del gen lacZα del fago M13mp2, las RTs WT del VIH-
1, grupo M, subtipo B mostraron tasas de error >10 veces mayores que el virus de la leucemia de 
ratón (MLV) y el virus de la mieloblastosis de aves (AMV). En esta Tesis se han determinado las 
tasas de error de síntesis de ADN dependiente de ARN para varias RTs, incluyendo las de los virus 
WT del VIH-1BH10, VIH-1ESP49, AMV y MLV, y las RTs de alta fidelidad del VIH-1ESP49 con los 
cambios K65R y K65R/V75I. Nuestros resultados muestran diferencias de menos de 2 veces en la 
fidelidad de estas RTs, con valores de tasas de error entre 2.5×10-5 y 3.5×10-5. Estos resultados 
fueron consistentes con la existencia de un umbral de error de la transcripción, generado por la ARN 
polimerasa al sintetizar el ARN utilizado como molde en el ensayo. Se logró una reducción modesta 
pero consistente del umbral de error al disminuir el pH y la concentración de Mg2+ de la reacción de 
transcripción. A pesar de las limitaciones del ensayo, concluimos que las RTs del VIH-1BH10 y VIH-
1ESP49 son menos precisas cuando se copian moldes de ADN que de ARN. El análisis de los espectros 
de mutación dependientes de ARN reveló una mayor tendencia a introducir deleciones largas al 
inicio de la retrotranscripción en todas las RTs del VIH-1, excepto la del doble mutante K65R/V75I. 
Los datos proporcionados por secuenciación masiva muestran también diferencias similares en la 
fidelidad entre las RTs del VIH-1BH10 y del doble mutante K65R/V75IESP49. 
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1.1. Human immunodeficiency virus  
Reverse-transcribing viruses are characterized by the presence of a monophyletic hallmark 
enzyme named reverse transcriptase (RT). In 2017, the International Committee on Taxonomy of 
Viruses (ICTV) regrouped most of these viruses into the order Ortervirales (Orter is an inversion 
of “retro,” which derived from reverse transcription). Orterviruses share several features, such as (i) 
a homologous aspartate protease domain in their polymerase polyprotein, (ii) the use of host tRNA 
molecules as primers for genome replication, and (iii) the two principal protein components of the 
virions (capsid and nucleocapsid) (reviewed in Krupovic et al., 2018). Within the Ortervirales order, 
human immunodeficiency viruses (HIV) belong to the Retroviridae family, which naturally infects 
a variety of animals including non-human primates. Taxonomically, HIV is classified in the 
Orthoretrovirinae subfamily and the Lentivirus genus, in which is considered the type species 
(https://talk.ictvonline.org/taxonomy/).  
HIV is classified into two different types, HIV-1 and HIV-2. HIV-1 was firstly described in 
1983 in the Luc Montagnier’s laboratory of the Institute Pasteur, and was initially named 
lymphadenopathy-associated virus (LAV) (Barré-Sinoussi et al., 1983). HIV-1 was also referred to 
as human T-lymphotropic virus III (HTLV-III) (Gallo et al., 1984; Levy et al., 1984; Popovic et al., 
1984). HIV-2 was later described in 1986 at the Institute Pasteur (Clavel et al., 1986). Both viruses 
are considered the etiological agents of the acquired immunodeficiency syndrome (AIDS), but they 
differ in their virological and clinical manifestations. 
Like HIV-1, HIV-2 is transmitted perinatally, through several sexual practices, by contact with 
infected blood products and with contaminated syringes during injectable drug use. However, HIV-
2 is generally less pathogenic and infectious, showing lower rates of sexual and vertical 
transmission, longer asymptomatic phases (ten years or more) and a slower progression to AIDS in 
comparison with HIV-1. In addition, long-term non-progressors are more frequent in people living 
with HIV-2 than in those infected with HIV-1 (86-95% versus 5-15%, respectively). These patients 
maintain high CD4+ T cell counts over many years in the absence of antiretroviral therapy, despite 
a possible low but detectable viremia. Although HIV-2 infection courses with less morbidity and 
mortality, it has fewer and less effective treatment options than HIV-1 infections, yielding a much 
poorer immunological recovery after starting treatment (reviewed in Menéndez-Arias and Álvarez, 
2014; Saleh et al., 2017).  
HIV originated from distinct zoonotic transmissions of simian immunodeficiency viruses (SIV) 
from primate to human. HIV-1 came from at least four independent events that leaded to the 
emergence of groups M (main), O (outlier), N (non-M, non-O) and P (putative) (Figure 1). Viruses 
belonging to groups M and N originated from SIV strains found in chimpanzees (SIVcpz, Pan 
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troglodytes troglodytes), while those SIV strains originating groups O and P were found in gorillas 
(SIVgor, Gorilla gorilla gorilla), in central Africa (D’arc et al., 2015). Likewise, HIV-1 group M 
can be subdivided into 11 subtypes from A to K. On the other hand, HIV-2 has independently crossed 
into humans at least nine times (groups A to I) from SIV strains of sooty mangabey monkeys 
(SIVsmm, Cercocebus atys atys) in West Africa. No subtypes have been formally described but 
some preliminary data suggest that HIV-2 group A may be divided in two different subtypes with 
distinct geographical origins (reviewed in Ndung’u and Weiss, 2012; Visseaux et al., 2016). HIV-1 
presents multiple circulating recombinant forms, while HIV-2 only has two recombinant forms (one 
circulating referred to as CRF01_AB, and one unique) (Visseaux et al., 2016). 
 
Figure 1. Phylogenetic tree analysis of the pol gene of HIV reference strains. Sequences are identified by 
their GenBank accession codes, from where they were retrieved. Phylogenetic analyses were carried out by 
using the Geneious 6.1.8. software (https://www.geneious.com), and assuming the sequence alignment 
provided by the ClustalW algorithm (Thompson et al., 1994). Evolutionary relationships were inferred using 
the neighbor-joining method, constructing the tree to scale (represented in the line below), with branch lengths 
in the same units as those of the evolutionary distances. The Tamura-Nei method (Tamura and Nei, 1993) was 
used to compute evolutionary distances, whose units indicate the number of base substitutions per site. Strains 
of HIV classified in diverse subtypes and groups are indicated for HIV-1 (green) and HIV-2 (fuchsia). Strains 
of SIV (simian immunodeficiency virus) that infect chimpanzees (cpz), gorillas (gor), sooty mangabeys 
(smm), African green monkeys (agm), macaques (mac) and pigtail macaques (mne) are represented in blue. 
Well-characterized reference strains are colored in red.    
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Despite the high diversity, pandemic HIV infection is mainly caused by HIV-1 group M viruses 
and to a lesser extent by HIV-1 group O, together with HIV-2 groups A and B viruses. The original 
outbreak of HIV-1 occurred in Kinshasa around 1920 (Faria et al., 2014). Since the onset of the 
AIDS epidemic, HIV has infected around 76.6 million individuals and has claimed the lives of 35.2 
million people (http://www.unaids.org/en). Nowadays, around 36.7 million people are living with 
HIV, of which between one and two million are HIV-2 infections.  
 
1.2. HIV virion  
The cell-free form of the virus is surrounded by a lipid bilayer derived from the plasma 
membrane of the infected cell, acquired during virion budding (Figure 2A). The viral envelope 
contains trimeric glycoproteins (Env) composed of transmembrane subunits (TM, gp41), non-
covalently linked to surface subunits (SU, gp120). Associated with the inner leaflet of the envelope 
through lipid contacts, the matrix protein (MA, p17) organizes in a matrix layer. The core of the 
virion is made of capsid proteins (CA, p24) forming a conical shell and its content. The capsid cone 
is composed of roughly two hundred and fifty CA hexamers, and twelve CA pentamers 
asymmetrically distributed (seven at the wide end and five at the narrow end) (Ganser-Pornillos et 
al., 2012). This capsid contains the viral genome that is composed of two molecules of positive-
sense single-stranded unspliced RNA ((+)ssRNA). The genomic RNA (gRNA) is stabilized by 
interactions with the nucleocapsid protein (NC, p7). Inside the virion, there are also three essential 
enzymes for HIV replication: (i) the reverse transcriptase (RT, p66/p51), responsible for 
synthesizing a double-stranded DNA (dsDNA) from the viral (+)ssRNA; (ii) the integrase (IN, p32) 
that catalyzes the insertion of the viral dsDNA into the host cell genome; and (iii) the protease (PR, 
p11), which carries out the proteolytic processing of precursor polyproteins, allowing the maturation 
of the virion (for reviews see Adamson and Freed, 2007; Ganser-Pornillos et al., 2012; Freed, 2015). 
The gRNA contains a 5’ cap and a 3’-polyadenylated tail, resembling a messenger RNA 
(mRNA). Elements structurally important for HIV replication are located within the 5’ termini. After 
reverse transcription, proviral DNA is flanked in both extremes by long terminal repeats (LTRs) 
(Figure 2B), including regions U3 (unique 3’)-R (repeat)-U5 (unique 5’) (Menéndez-Arias et al., 
2017). The HIV genome (around 9.7 kb) contains nine different open reading frames. Three major 
genes (gag, pol and env) code for the structural and enzymatic proteins described above. Two genes 
code for the regulatory proteins Tat (transactivator protein) and Rev (RNA splicing-regulator), 
essential for virus replication (Romani and Engelbrecht, 2009); whereas four additional genes code 
for accessory proteins known as Vif (viral infectivity factor), Nef (negative regulating factor), Vpr 
(viral protein R); and Vpu/Vpx (viral protein unique/X). Vpu is found exclusively in HIV-1 and Vpx 
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is present in HIV-2, although they are not functional homologues (Faust et al., 2017). Accessory 
proteins were dispensable in studies in vitro, although they are considered increasingly important 
for efficient infection in vivo (Seelamgari et al., 2004; Anderson and Hope, 2004; Richter et al., 
2009). Vif, Vpr and Vpx are packaged into the virion (Yu et al., 1988; Cohen et al., 1990; Müller et 
al., 2000; Kao et al., 2003; González et al., 2017). Several cellular proteins (e.g., actin, cyclophilin 
A and multiple RNA-binding proteins) are also incorporated into the nascent virion, but their precise 
functions (if any) are unclear in most cases (reviewed in Briggs and Kräusslich, 2011; Telesnitsky 
and Wolin, 2016).  
 
Figure 2. Structure and genome organization of HIV. (A) Schematic representation of the viral particle. 
(B) HIV-1 and HIV-2 genome organization, adapted from the HIV sequence compendium 2018 (Foley et al., 
2018). Long-terminal repeats (LTRs) flanking the HIV genome, and open reading frames for major genes 
(gag, pol, env), regulatory genes (tat, rev), and accessory genes (nef, vif, vpu, vpr/vpx) are shown as rectangles, 
distributed in three lines following the corresponding frame (indicated at right). Numbering nucleotide 
positions are indicated above. Below, polyprotein products obtained from the three major genes. Arrows show 
the site of cleavage mediated by HIV PR (in the case of Gag and Gag-Pol precursors) or by the cellular furin 
(in the case of precursor gp160). The order of proteolytic processing is indicated for Gag. A myristic acid 
molecule is attached to the N-termini of Gag and Gag-Pol polyproteins.  
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1.3. Cycle of HIV infection  
HIV-1 is adapted to replicate in human cells, in particular CD4+ T cells such as helper T-
lymphocytes, macrophages and microglial cells. The replication cycle can be divided into early and 
late phases. The early phase encompasses the events that occur from virus binding to the host cell 
surface until the integration of the HIV-1 genome into that of the host cell. Viral infection initiates 
with the high-affinity binding of gp120 to the cellular surface receptor CD4 (Figure 3). This 
interaction produces a conformational change that allows the virus to interact with a co-receptor, 
such as CCR5 or CXCR4 (reviewed in Fassati, 2012). The initial attachment of the virus triggers 
rearrangements of gp41 protein, leading to the fusion of the viral envelope with the cell membrane, 
and delivering the viral core into the cytoplasm. The released viral core is transported towards the 
nucleus by cellular motor proteins, likely using microtubule and actin network for trafficking 
(reviewed in Suzuki and Craigie, 2007). 
The dissociation of CA from the conical shell is referred to as uncoating, which may happen 
near the plasma membrane or close to the nuclear pore. Controversy relates to the high percentage 
of nonfunctional particles that hampers the correlation between phenotype and progression of the 
infection (reviewed in Ambrose and Aiken, 2014). Recent ground-breaking studies suggested that 
long-lived/gradually uncoating cores are more likely to enter the nucleus and establish infection than 
the cores undergoing early/abrupt uncoating in the cytoplasm (Mamede et al., 2017; Francis and 
Melikyan, 2018a; reviewed in Francis and Melikyan, 2018b). Thus, viral RNA would be reverse 
transcribed within the protected environment of the capsid, preventing the trigger of the innate 
immune sensing, while recruiting nucleotides for reverse transcription through a strongly 
electropositive pore found at the center of CA hexamers (Jacques et al., 2016). Indeed, reverse 
transcription itself could partly trigger the uncoating, destabilizing the core due to the pressure 
exerted by the size and rigidity of the nascent RNA/DNA hybrid or dsDNA genome (Hulme et al., 
2011; Rankovic et al., 2017). After the stripping of most (if not all) CA monomers from the core, 
the viral dsDNA remains associated with proteins, forming the pre-integration complex (PIC).  
HIV-1 PIC may contain Vpr, MA, IN, RT, NC and triple-stranded cDNA flap (generated after 
reverse transcription), as well as cellular cofactors such as the lens epithelium-derived growth factor 
(LEDGF/p75) or importin α, among others. Several cellular proteins regulate the uncoating (e.g., 
CypA and CPSF6) and help the PIC to break into the nucleus (e.g., Tnpo3, Nup358, and Nup153) 
(reviewed in Fassati, 2012; Suzuki and Craigie, 2007; Zhan et al., 2010). Once in the nucleus, HIV-
1 PIC is directed towards chromatin via the interaction of the viral IN with LEDGF/p75 that is a 
host transcription factor, thereby stimulating targeted integration into the host genome (Cherepanov 
et al., 2003). After integration, the HIV-1 provirus is packaged into nucleosomes. A multifactorial 
context determines whether HIV transcription will be silenced (leading to latency) or become active 
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(resulting in a productive infection). This context refers to the chromatin landscape, nucleosome 
positioning and post-transcriptional modifications (reviewed in Cary et al., 2016; Ne et al., 2018). 
 
Figure 3. Schematic representation of the HIV infection cycle. Early phase starts with the attachment of 
the virus to the plasma membrane of the host cell, followed by fusion and entry. If uncoating occurs abruptly 
or gradually is not known. After reverse transcription, the PIC enters the nucleus by the nuclear pores, and the 
proviral DNA integrates into the host genome mediated by the viral IN. Transcription of the proviral DNA 
marks the beginning of the late phase, which includes expression of viral genes, assembly of viral particles, 
and their release and maturation into infectious viruses.   
 
The late phase comprises events from gene expression to the release and maturation of new 
virions. HIV-1 transcription is controlled by a promoter located at the 5’ LTR, and it initiates at one 
of the three consecutive guanosine residues found in the junction U3-R, by recruiting critical cellular 
factors (reviewed in Ne et al., 2018). However, at this stage, predominantly short incomplete viral 
transcripts are produced by human RNA polymerase (RNAP) II. Expression of viral Tat overcomes 
this block by recruiting a super elongation complex that phosphorylates the RNAP II on its carboxyl 
terminal, improving its processivity. This activation yields fully spliced RNAs that result in 
translation of only three viral proteins: Tat, Rev and Nef. Rev is then reimported through its nuclear 
localization signal, where it directs the export of intron-containing RNAs. Singly spliced messengers 
are translated into the remaining viral accessory proteins and the Env polyprotein; while unspliced 
RNAs provide Gag and Gag-Pol polyproteins, as well as gRNA molecules (Figure 3) (reviewed in 
Faust et al., 2017; Hidalgo and Swanson, 2017).  
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After translation in the cytosol, Gag seems to specifically bind a gRNA dimer, multimerize and 
reach the plasma membrane by a still-undefined pathway (reviewed in Freed, 2015; Dubois et al., 
2018). Assembly disposes radially with the sequential Gag (or Gag-Pol) domains arranged with the 
N-terminus on the plasma membrane and the C-terminus pointing toward the center of the virion. 
This association is facilitated by the myristic acid moiety of MA (Figure 2B), and likely prompts 
the formation of lipid microdomains or rafts, where retrovirus assembly appears to be initiated. MA 
also seems to be responsible for the incorporation of mature Env glycoproteins, previously processed 
by the cellular protease furin. The principal sites of Gag-Gag interaction are found in the N- and C-
termini of CA, as well as in the SP1 linker. Lastly, NC recruits the gRNA dimer, whereas the p6 
domain adapts the host endosomal sorting complex required for transport (ESCRT) machinery, 
which catalyzes the membrane fission step to complete the release of new virions from the host cell 
surface (Figure 3) (reviewed in Ganser-Pornillos et al., 2012).  
Virus particles bud in a noninfectious or immature form. Gag-Pol polyprotein, which arises from 
a ribosomal frameshift occurring with a frequency of around 5% during Gag translation, contains 
the viral PR. After dimerization, functional PR is liberated by autoproteolysis during or immediately 
after budding. Processing is likely initiated by the PR at the rim of the incompletely closed Gag shell 
and then proceeds as a “wave” into the interior of the lattice. Proteolysis proceeds at a specific rate 
and order (Figure 2B), resulting in the formation of structural and functional proteins: MA, that 
remains attached to the envelope; CA, that rearranges to form the conical shell; NC, which possesses 
nucleic acid chaperone activity and condenses with the RNA into a compact ribonucleoprotein, with 
a more stable RNA; p6, PR, RT and IN. These structural rearrangements lead to the formation of 
mature infectious virions (reviewed in Ganser-Pornillos et al., 2012).  
Accessory proteins do not have enzymatic activity but interact with cellular restriction factors, 
facilitating viral replication (for a review see Faust et al., 2017). Vif counteracts the antiviral effects 
of host APOBEC3G by inducing its ubiquitinitation and subsequent degradation in cellular 
proteasomes. In the absence of Vif, APOBEC3G is packaged into virions and induces lethal 
mutagenesis via hypermutation of the viral genome by deaminating cytidine residues (reviewed in 
Okada and Iwatani, 2016). Vpu is unique to HIV-1 and acts on BST-2/Tetherin, which blocks virus 
release by anchoring virions to the plasma membrane. Vpu can inhibit the recycling of internalized 
BST-2 to the plasma membrane, or induce its ubiquitination. In HIV-2, the function of Vpu is exerted 
by the Env glycoprotein (reviewed in Strebel, 2013). In contrast, Vpx is found only in HIV-2 and 
targets SAMHD1 for proteasomal degradation, avoiding the depletion of cellular deoxynucleoside 
triphosphate (dNTP) pools to a level similar to non-dividing cells and resting T cells (Lim et al., 
2012; Laguette et al., 2012). HIV-1 does not present a similar anti-SAMHD1 activity, but replication 
is not avoided due to a higher binding affinity of HIV-1 RT to dNTPs relative to other lentiviruses. 
Vpr has many reported functions, including LTR transactivation, nuclear import of the PIC, cellular 
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apoptosis, cell cycle arrest, and activation of the DNA damage response. Finally, Nef promotes HIV-
1 infectivity, likely mediated by the downregulation of the integral membrane protein SERINC5. 
 
1.4. HIV RT 
1.4.1. Structure  
HIV-1 RT is an asymmetric heterodimer composed of two related subunits of different lengths, 
p66 and p51 (di Marzo Veronese et al., 1986), which share a common amino terminus. Many crystal 
structures of the enzyme have been obtained under different conditions (e.g., apoenzyme alone, 
complexed with a variety of nucleic acids, with or without antiretroviral drugs) (for a review, see 
Menéndez-Arias et al., 2017). Analysis of X-ray crystallographic data revealed important structural 
features in the HIV-1 RT. The large subunit p66 (560 amino acids) is composed of two spatially 
distinct domains, DNA polymerase and ribonuclease H (RNase H). The DNA polymerase domain 
includes three subdomains called fingers (residues 1–85 and 118–155), palm (86–117 and 156–236), 
and thumb (237–318) (Figure 4A) (Kohlstaedt et al., 1992; Jacobo-Molina et al., 1993). A region 
known as connection (residues 319–426) links the DNA polymerase domain with the RNase H 
domain, which extends between residues 427 and 560 (Jacobo-Molina et al., 1993).  
 
Figure 4. HIV-1 RT structure and active sites. (A) Crystallographic structure of HIV-1 RT bound to dsDNA 
and an incoming dNTP (PDB file 1RTD). Subunits p66 (blue) and p51 (green) are represented with ribbons, 
using different shades for each subdomain. Connection and thumb subdomains of p51 are inverted relative to 
those of p66. Template (grey), primer (orange) and the incoming dNTP (fuchsia) are represented with spheres. 
(B) Nucleotide binding site in the DNA polymerase domain showing the location of catalytic residues Asp110, 
Asp185 and Asp186 (red spheres), and the side-chains of Lys65, Arg72, Tyr115, and Gln151 (blue sticks). 
The incoming nucleotide is represented with yellow sticks. (C) RNase H active site showing the location of 
Asp443, Glu478, Asp498, and Asp549 (red spheres), and the coordinating metal ions (dot yellow surfaces). 
Figures 4B and 4C were adapted from Menéndez-Arias et al. (2017). 
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Meanwhile, the smaller subunit p51 (440 amino acids) is identical to the N-terminal portion of 
p66, lacks the RNase H domain, and folds into the same p66 polymerase subdomains. However, the 
spatial organization of the subdomains relative to each other is different in p66 and p51. Thus, p51 
is more tightly packed, with the connection rotated to cover the palm and displacing the thumb 
(Figure 4A). As a result, p51 is catalytically inactive, while p66 contains the active sites for the 
enzymatic activities of RT (LeGrice et al., 1991; Hostomsky et al., 1992). For the most part, p51 
has a structural role anchoring the proper folding of p66, and playing a pivotal role in stabilizing the 
heterodimer. This subunit also participates in binding the tRNA primer (Zakharova et al, 1995; 
Dufour et al., 1998) and has an impact on the RT’s RNase H activity (Chung et al., 2013). 
The nucleic acid binding cleft is formed by the fingers, palm and thumb subdomains of p66, 
which provide lateral and apical interactions with the nucleic acid substrate. In addition, the ‘floor’ 
of the cleft is shaped by the connection subdomains of both subunits and the thumb subdomain of 
p51 (Jacobo-Molina et al., 1993). The RNase H domain plays only a minor role in the template-
primer binding. HIV-1 RT binds the nucleic acid substrate in a conformation that places the substrate 
in direct contact simultaneously with both the DNA polymerase and RNase H active sites. The 
distance between the two active sites is about 60 Å, equivalent to 17 nucleotides of a DNA/DNA 
complex or 18 nucleotides of a RNA/DNA hybrid (reviewed in Esposito et al., 2012).   
The active site of the polymerase domain presents three highly conserved aspartate residues at 
positions 110, 185 and 186, located within the palm subdomain of p66 (Figure 4B). Asp185 and 
Asp186, together with Tyr183 and Met184, are part of the YXDD motif, highly conserved in 
retroviral RTs. The carboxylate moieties of the conserved aspartates bind two divalent ion cofactors 
(likely Mg2+) that are essential for catalysis (Larder et al., 1987; Lowe et al., 1991). The catalytic 
metals in coordination with both the 3’-OH of the primer terminus, and the non-bridging oxygen of 
the α-phosphate of the incoming dNTP appear to be critical to maintain the appropriate distance for 
the nucleophilic attack (Huang et al., 1998; Mendieta et al., 2008).  
The incoming dNTP is tightly coordinated by the side-chains of Arg72 and Lys65 in the fingers 
subdomain of p66, which bind the β- and γ-phosphates, respectively (Figure 4B). Other important 
residues that delineate the dNTP binding pocket are Ala113, Ala114, Tyr115 and Phe116. Residue 
Tyr115 contributes to the binding of the deoxyribose ring of the incoming dNTP and discriminates 
between deoxy and ribonucleoside triphosphates due to the presence of the 2’-OH in their ribose 
ring (Cases-González et al., 2000). Another remarkable interaction in the dNTP binding site is that 
of Gln151 with the 3’-OH of the incoming dNTP (reviewed in Sarafianos et al., 2009).  
On the other hand, the RNase H domain folds into five β-stranded sheets and four α helices. The 
active site is surrounded by a cluster of four conserved acidic residues: Asp443, Glu478, Asp498 
and Asp549 (motif DDE), which bind two divalent Mg2+ cations (Figure 4C). The two metal ions 
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are asymmetrically coordinated in the active site and have distinct roles: ion A activates the 
nucleophilic water molecule, and ion B (possibly in conjunction with metal ion A) stabilizes the 
transition state intermediate. Mutations in any of the Asp443, Glu478, and Asp498 residues abolish 
the enzyme activity (Mizrahi et al., 1990, 1994).  
Unlike in the case of HIV-1 RT, there is only one crystal structure available for HIV-2 RT (PDB 
1MU2) (Ren et al., 2002), corresponding with the unliganded form of the enzyme. Both polymerases 
share around 60% identity and show a similar organization into domain/subdomains, although HIV-
2 RT heterodimers are more stable than those of HIV-1 (Divita et al., 1995). The large subunit of 
HIV-2 RT (p68) is 559 residues long, whereas the size of the smaller subunit p54 is uncertain. 
Biochemical evidence suggests that cleavage leading to the formation of p54 occurs after Met484, 
and not at the equivalent site of HIV-1 RT (i.e., between Phe440 and Tyr441) (Fan et al., 1995). 
This difference is likely due to the distinct specificities of the two HIV proteases. In the crystal 
structure, the smaller subunit contains only 427 residues, attributed to degradation of p68 subunit by 
bacterial proteases (Bird et al., 2003).  
The most significant structural differences between HIV-2 and HIV-1 RTs are located in the 
non-nucleoside RT inhibitors (NNRTI)-binding pocket, near the DNA polymerase active site. The 
presence of Ile181 and Leu188 in HIV-2 RT, instead of Tyr as in HIV-1 RT, together with the lack 
of the aromatic side chains at these positions, abolish the effects of ring stacking interactions 
between the RT and many NNRTIs. These differences contribute to HIV-2 RT resistance to many 
NNRTIs (reviewed in Herschhorn and Hizi, 2010). In the absence of crystals of ternary complexes 
including HIV-2 RT, a template-primer and the incoming dNTP, any functional or mechanistic 
interpretation of the role of different residues relies on information available for HIV-1 RT. 
 
1.4.2. RT activities  
1.4.2.1. DNA polymerization 
The RT is able to synthesize DNA using both RNA and DNA molecules, as templates and 
primers. In general, RTs may be able to incorporate a few hundred nucleotides in one round of DNA 
synthesis. Processivity and fidelity, among other features of the RT’s DNA polymerization activity, 
have been widely optimized and exploited for their use in biotechnology, as discussed below. 
Despite the lack of proofreading 3’-5’ exonuclease activity, HIV RTs are able to carry out the 
reversal of dNTP incorporation (i.e., pyrophosphorolysis), using pyrophosphate (PPi) or an NTP as 
the acceptor substrate (reviewed in Esposito et al., 2012). This capacity is particularly important for 
resistance mechanisms involving the removal of azidothymidine (AZT) and other nucleoside 
analogues (Arion et al., 1998; Meyer et al., 1999; reviewed in Menéndez-Arias, 2008).  
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Additionally, RTs can perform strand DNA displacement coupled to DNA polymerization. This 
property has been attributed to specific residues of the fingers subdomain (e.g., Phe61 in HIV-1 RT) 
(Fisher et al., 2003). Moreover, RTs can add non-templated nucleotides at the 3’-end of nascent 
DNA strands in reactions carried out in vitro (Patel and Preston, 1994; Golinelli and Hughes, 2002).  
 
1.4.2.2. RNase H 
The RNase H activity present in RTs hydrolyzes phosphodiester bonds in RNA strands when 
being part of RNA/DNA heteroduplexes, rendering RNAs with free 3’-OH and 5’ phosphate ends. 
The RNase H activity is mediated by a nucleophilic attack of a water molecule on the scissile 
phosphate, breaking the bond between two adjacent ribonucleosides in the RNA strand. The RNase 
H specificity depends on the particular RNA minor groove width and its interaction with the “primer 
grip” (residues 227−235 of p66), a region that contacts the template-primer. The RNA/DNA hybrid 
has a minor groove width of ∼9-10 Å, while non-hydrolysable polypurine tracks (PTTs) show a 
width of 7 Å probably due to the presence of A-tracts (reviewed in Schultz and Champoux, 2008; 
Esposito et al., 2012; Menéndez-Arias et al., 2017).  
Three distinct types of cleavages have been reported based on the position of DNA polymerase 
and RNase H domains of the RT in relation to the RNA/DNA complexes (Figure 5).  
 DNA 3’ end-directed cleavage: this hydrolysis is polymerase-dependent and occurs when the 
3’ end of the growing DNA strand locates at the polymerase active site, annealed to a longer 
RNA. The catalysis results in the cleavage of RNA 15–20 nucleotides away from the DNA end.  
 RNA 5’ end-directed cleavage: the polymerase domain binds internally to a DNA strand 
annealed with the 5’ end of a recessed RNA, cleaving it at 13−19 bases away. The 5’ end is not 
recognized at a nick, but a gap of two or more bases upstream is sufficient for such recognition.  
 Internal cleavage: in this type of cleavage, the nucleic acid strand-ends do not influence RT 
positioning. The hydrolysis occurs internally on a RNA/DNA hybrid.  
 
Figure 5. HIV RT binding modes to RNA/DNA hybrids and effects on RNase H cleavage. Polymerase-
dependent or -independent binding produce different cleavage patterns, which result from different 
orientations of the RT relative to the template-primer. Adapted from Menéndez-Arias et al. (2017). 
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Nucleotide sequence in the vicinity of the cleavage site is a main determinant of RNase H 
specificity (Schultz et al., 2009; Kielpinski et al., 2017). The RNase H activity of HIV-2 RT is about 
ten times lower than that of HIV-1 RT, due to the presence of Gln294 in p54, instead of proline as 
occurs in the HIV-1 RT p51 subunit (Sevilya et al., 2001, 2003; Herzig and Hizi, 2015). RNase H 
activity plays an important role in strand transfer events by generating the single-stranded DNA 
(ssDNA) region that anneals to the acceptor molecule (Luczkowiak et al., 2018). This capacity of 
HIV RT to switch templates is based on sequence complementarity at the 3’-end of both donor and 
acceptor strands, and is facilitated by the presence of specific sequences in the viral genome (e.g., 
repeated sequences, and pausing sites). Strand transfer is assisted by the chaperone activity of the 
viral NC protein that enhances minus-strand transfer (Darlix et al., 2011). Reverse transcription 
involves at least two strand transfer events, although additional ones were suggested to occur at 
broken as well as intact templates (reviewed in Herschhorn and Hizi, 2010).  
 
1.4.3. Fidelity of RTs  
Genetic variation remains one of the major obstacles to the eradication of HIV, helping the virus 
to escape host immune responses, and to develop resistance to antiretroviral drugs (Megens and 
Laethem, 2013). Diversity emerges from high rates of replication, mutation and recombination, 
among others (Smyth et al., 2012). Mutations may be introduced into the viral genome by different 
enzymes throughout the replicative cycle: (i) RT during RNA- and DNA-dependent DNA synthesis, 
(ii) replicative host DNA polymerases (e.g., α, δ, γ, ε) involved in proviral DNA amplification, and 
(iii) the cellular transcriptional machinery (RNAP II) (reviewed in Menéndez-Arias, 2013a). The 
effect of host cell DNA polymerases on the viral mutation rate is expected to be minimal due to their 
high fidelity (estimated in 10−9 to 10−12 mutations/base pair/cycle) (reviewed in Svarovskaia et al., 
2003). However, the contribution of RNA-dependent relative to DNA-dependent DNA synthesis by 
RTs is unknown, as well as that of human RNAP II during the synthesis of viral RNAs.  
In addition to their role in viral infection, RTs play a fundamental role in supporting the 
biotechnological advances introduced in the late 1990s, such as cDNA microarrays and next-
generation sequencing (NGS) technologies, due to their ability to synthesize DNA using RNA 
templates. For these purposes, wild-type (WT) and engineered RT variants of avian myeloblastosis 
virus (AMV), murine leukemia virus (MLV), HIV-1, and Geobacillus stearothermophilus group II 
introns have been developed into more efficient tools to study gene expression by increasing their 
catalytic efficiency, processivity, thermostability or fidelity of DNA synthesis (Arezi and Hogrefe, 
2009; Baranauskas et al., 2012; Matamoros et al., 2013; Mohr et al., 2013). Improvements in the 
intrinsic fidelity of RTs may have a positive impact on the reliability of whole transcriptome shotgun 
sequencing (i.e., RNA-seq) data (Ozsolak and Milos, 2011). 
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1.4.3.1. Experimental methods to estimate the accuracy of RTs in vitro 
1.4.3.1.1. Biochemical assays 
The fidelity of purified RTs has been analyzed in vitro by using gel-based assays. The fixation 
of a base substitution involves the incorporation of an incorrect nucleotide, followed by the 
extension of the mismatched primer. These events can be qualitatively detected by dNTP exclusion 
assays, and quantitatively analyzed by enzymological tests involving the determination of enzyme 
kinetics for the incorporation of correct and incorrect nucleotides.  
The dNTP exclusion assays (also refer to as “minus”-sequencing gel assays) provide a rough 
estimate of fidelity based on the observed primer extension efficiencies (Sanger and Coulson, 1975; 
Preston et al., 1988). Three dNTPs, each one at a relatively high concentration, are used to assess 
misincorporation opposite multiple template sites. Faithful enzymes are expected to stop synthesis 
in the position where the absent dNTP should be incorporated. Thus, full-extension bands require 
insertion of incorrect nucleotides beyond this position. The analysis of the pattern of bands generated 
by each RT gives an idea of its fidelity.  
In nucleotide misinsertion assays, a binary complex RT/template-primer is formed (Preston et 
al., 1988), and the ability to extend the 3’ end of the primer is determined in the presence of 
increasing concentrations of correct or incorrect nucleotides at different times. The extended primer 
is measured by quantitative gel electrophoresis; and then kinetic parameters showing the efficiency 
of nucleotide incorporation are obtained by fitting the resulting data to the Michaelis-Menten 
equation. The turnover number (kcat) and the Michaelis constant for dNTP (Km) can be determined 
under steady-state conditions. However, these parameters are not appropriate to obtain mechanistic 
insight into the DNA polymerization reaction, since their values are strongly influenced by the slow 
rate of dissociation of the enzyme from the template-primer (koff) (Kati et al., 1992).  
Relevant parameters in these assays are obtained under rapid transient kinetics methods, that 
allow the measurement of the equilibrium dissociation constant (Kd) for the interaction of dNTP 
with the binary complex RT/template-primer, as well as the nucleotide incorporation rate (kpol) 
(Figure 6). These kinetics are determined under pre-steady-state conditions, after time intervals 
ranging from 3 ms to several seconds (reviewed in Menéndez-Arias, 2002, 2009). The catalytic 
efficiency of the reaction can be determined by the ratio kpol/Kd (or kcat/Km). Thus, misinsertion 
efficiencies (fins) are defined as the catalytic efficiency of incorporation of each incorrect nucleotide 
relative to the correct one on a specific template-primer, and reflect the nucleotide selectivity of the 
enzyme (reviewed in Echols and Goodman, 1991; Johnson, 1993): 
𝑓ins =  
(𝑘pol/𝐾d) incorrect nucleotide
(𝑘pol/𝐾d) correct nucleotide 
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Figure 6. Determination of pre-steady-state kinetic constants through one-nucleotide incorporation 
assays under heteropolymeric template-primers. The proportion of extended primer at position +1 is 
quantified by densitometry at different times and dNTP concentrations. Results are fitted to a first order 
equation (below the center panel), where A is the amplitude, t is the reaction time, kobs is the apparent kinetic 
constant of formation of the phosphodiester bond, and kss is the kinetic constant of the steady-state linear 
phase. The dependence of kobs on the dNTP concentration is described by the hyperbolic equation of Michaelis-
Menten, where Kd and kpol are the catalytic and affinity constants for the dNTP incorporation, respectively. 
Adapted from Barrioluengo (2013).  
 
The rate of polymerization (kpol or kcat) is expected to be higher for the correct nucleotide than 
for the incorrect ones. In contrast, incorrect nucleotides bind the RT/template-primer complex with 
less affinity, and show a higher Kd or Km value. Therefore, higher fidelity implies lower misinsertion 
efficiency. The method is also adequate to compare the incorporation of dNTPs versus rNTPs, 
dNTPs versus ddNTPs, or natural versus nucleotide analogues (reviewed in Menéndez-Arias, 2002).  
Mispair extension assays involve the determination of kinetic constants (kpol and Kd) for the 
incorporation of a correct nucleotide, using template-primer complexes with either matched or 
mismatched 3' primer termini. The efficient extension of mismatched complexes has been 
recognized as a major determinant of the low accuracy of retroviral RTs (Perrino et al., 1989; Yu 
and Goodman, 1992). In these assays, mispair extension ratios (fext) can be obtained as follows:   
𝑓ext =  
(𝑘pol/𝐾d) mismatched primer
(𝑘pol/𝐾d) matched primer 
 
Biochemical assays allow a proper comparison of the mechanistic insights into the DNA 
synthesis activity of multiple RTs. However, these assays have several limitations. First, reaction 
conditions such as pH, dNTP concentrations, the nature and concentration of the divalent cation 
(e.g., Mg+2, Mn2+), and the sequence of the template-primer can all significantly impact the observed 
selectivity rate (Brosius et al., 1983; Beckman et al., 1985; Eckert and Kunkel, 1990, 1993a, 1993b; 
Bebenek et al., 1992; Bakhanashvili and Hizi, 1992a, 1992b, 1993; Achuthan et al., 2014). Second, 
the stability and structure of the template-primer complex and its ratio to the RT may impact the 
observed results. Third, gel-based experiments are restricted to the analysis of a small number of 
incorporation sites, with only one or a few target nucleotides, which may not represent the overall 
error rate (reviewed in Svarovskaia et al., 2003).  
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1.4.3.1.2. Genetic assays  
Many genetic assays have been used to estimate the fidelity of numerous polymerases by 
measuring mutant frequencies in a reporter gene. These assays can be classified into two major 
groups, including those designed to detect the inactivation of a reporter gene (forward mutation 
assays) or the reversion of an inactivating mutation (codon reversion assays). The reporter genes 
should be easily selected or phenotypically identifiable (e.g., lacZ gene or its truncated peptide 
lacZα).   
Codon reversion assays were initially used to determine base substitution rates of DNA 
polymerases (Weymouth and Loeb, 1978). In these assays, the bacteriophage ssDNA that was used 
as template for DNA synthesis contained an in-frame termination codon in essential phage genes. 
Typically, it is an amber (TAG) mutant in the phage ФX174 DNA (Preston et al., 1988; Weber and 
Grosse, 1989), an ochre (TAA) mutant in phage T4 DNA (Orias and Gartner, 1966; Soll and Berg, 
1969; Ohta et al., 2002), or an opal (TGA) mutant at position 89 of the lacZ gene in phage M13mp2 
DNA (Roberts et al., 1988; Kunkel and Soni, 1988). The reversion of nonsense codons to a coding 
triplet can be visualized as a revertant plaque upon transformation of host cell bacteria with copied 
DNA or as a dark blue M13 plaque using the appropriate conditions (Preston et al., 1988; Roberts 
et al., 1989). However, these methods only focus on one or a few sites, and estimates are restricted 
to specific base substitution errors (mostly, G-to-A). Because retroviral mutation rates are highly 
sequence-dependent, the target nucleotides chosen in a reversion assay probably do not reflect the 
overall mutation rate.  
In contrast, forward mutation assays score for nucleotide changes at many different sites and in 
a wide variety of sequence contexts, thereby providing information not only on base substitutions, 
but also on frameshifts. Besides, these assays may help the identification of relevant hotspots. 
Several reporter genes used in forward mutation assays are HIV-1 env gene variable region 1 (V1) 
(cloned in M13) (Ji and Loeb, 1994), and the truncated lacZα gene (cloned in vectors pBluescript 
or Litmus 29, and in phage M13mp2) (Ji and Loeb, 1992; Bebenek and Kunkel, 1995; Boyer and 
Hughes, 2000).  
Using this method, some mutations in the reporter gene remain undetectable by not producing a 
noticeable phenotypic change. Detailed information based on experimental data of mutational target 
sites that reliably result in a detectable mutant phenotype is available for lacZα gene, but not for the 
complete lacZ gene or other reporters (Svarovskaia et al., 2003). Then, lacZα-based forward 
mutation assays do not depend on assumptions of which mutations lead to a detectable phenotypic 
change, being the most widely used to measure the fidelity of purified RTs (Table 1). In these assays, 
a gapped DNA from phage M13mp2 (dsDNA lacking the lacZα gene in one of the two strands) is 
used as substrate of DNA synthesis reactions catalyzed by the RT. Errors produced by the enzyme 
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while copying the gapped region may generate β-galactosidase enzymes with lower activity, and are 
detected as colorless or light blue plaques after transformation in appropriate bacterial strains, in the 
presence of 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal) and isopropyl β-D-1-
thiogalactopyranoside (IPTG) (Roberts et al., 1988).  
Table 1. Estimated error rates of retroviral RTs in comparison with wild-type HIV-1 RT 
(group M subtype B) determined with M13mp2-based forward mutation assays using lacZα 
as reporter gene 
RT 
Mutation 
rate 
Accuracy a 
(fold change) 
HIV-1 RT References 
HIV-1 group O 5.5×10−5 2.5 BH10 (p66/p51) Álvarez et al., 2009 
SIVagm 2.9×10−5 1.8 HXB2 (p66/p51) Stuke et al., 1997 
SIVmne 1.6×10−5 9.7 BH10 (p66/p51)b Diamond et al., 2003 
FIV 6.2×10−5  2.8 BH10 (p66/p51)b Operario et al., 2005 
MLV 3.3×10−5 14.3 (p66/p61)c Roberts et al., 1988, 1989 
 1.2×10−5 11.7 BH10 (p66/p51) Barrioluengo et al., 2012 
XMRV 1.2×10−5 11.7 BH10 (p66/p51) Barrioluengo et al., 2012 
FeLV 5.8×10−6 29 BH10 (p66/p51)b Operario et al., 2005 
AMV 5.9×10−5 9.5 (p66/p61)c Roberts et al., 1988, 1989 
PFV 1.7×10−4 0.4 BH10 (p66/p51) Boyer et al., 2007 
SIV, simian immunodeficiency virus (agm, African green monkey; mne, pigtail macaque); FIV, feline 
immunodeficiency virus; MLV, murine leukemia virus; XMRV, xenotropic murine leukemia virus-related 
virus, FeLV, feline leukemia virus; AMV, avian myeloblastosis virus; PFV, prototype primate foamy virus. 
a Increase relative to the WT HIV-1 (group M subtype B) RT of each experiment. The error rates for enzymes 
of subtype B were in the range of 0.6-6.7×10-4 (reviewed in Menéndez-Arias, 2009). b Data for HIV-1 RT 
were not provided in the referenced papers. For comparative purposes, mutation rates for HIV-1 RT obtained 
in the same lab were taken from Weiss et al., 2004. c Purified from HIV-1 group M subtype B virions 
(unreported strain) (Roberts et al., 1988).  
 
1.4.3.1.3. Deep sequencing assays  
Deep sequencing technologies are commonly used for extensive sampling of viral populations 
and cellular transcriptomes (Capobianchi et al., 2013; Brancaccio et al., 2018; Gallego et al., 2018; 
Pennington et al., 2018). However, protocols can be adapted for the analysis of RT’s fidelity while 
synthesizing cDNA in reactions carried out in vitro (Gordon et al., 2015; de Paz et al., 2018; Hebert 
et al., 2018). These outbreaking methodologies yield thousands of nucleotides, which may facilitate 
the calculation of error rates of high-fidelity enzymes. The main advantage of this approach is that 
all types of errors can be detected regardless of whether they give rise to a phenotypic change or not, 
and the analysis can be performed in hundreds of sites with a wide range of sequence contexts. 
However, deep sequencing also presents several restrictions that bias the sampling. Among them, 
errors introduced during the polymerase-chain reaction (PCR) steps and throughout the sequencing 
protocol are probably the most important ones in inflating the heterogeneity of the sample. In 
addition, differential amplification can skew allele/mutations frequency, and PCR-mediated 
recombination can disrupt linkage (Jabara et al., 2011).  
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Many different protocols have been designed to address these issues. Barcoding of nucleic acid 
molecules before sequencing has become one of the most recurrent solutions, since it could facilitate 
the discrimination of sequencing errors from genuine mutations, by creating a consensus between 
all reads with the same barcode. Barcodes were applied in different steps of reverse transcription 
and sequencing processes, each one allowing the discrimination or elucidation of a specific source 
of errors (Figure 7). First, transcription errors can be elucidated by attaching the barcode at the 5’ 
end of the RNA molecules used as template, as in the Replicated sequencing (Rep-Seq) protocol 
(Gout et al., 2013).  
 
Figure 7. Summary of several next-generation sequencing technologies adapted to study polymerase 
fidelity by using barcodes before sequencing. Replicated sequencing (Rep-Seq) (Gout et al. 2013) identifies 
transcription errors (red stars) by attaching individual barcoded mRNAs to beads and reverse transcribing 
them multiple times. Mutational changes in common to all cDNAs containing the same barcode represent 
transcription errors. Additional errors are shown as stars of different colors: blue, for those made during reverse 
transcription; green, for errors made during the synthesis of the second strand (i.e., completion of dsDNA 
using the cDNA obtained in the reverse transcription as template); purple and pink, for amplification and 
sequencing errors. This criteria is maintained in the whole picture. Primer IDs (Jabara et al., 2011) barcode 
each cDNA molecule, revealing the combination of transcription and reverse transcription errors. High-
resolution RNA sequencing (HiRes-Seq) (Imashimizu et al., 2013) include barcodes in the PCR primers, 
discarding amplification and sequencing errors. RNAP, RNA polymerase.  
 
Second, the barcodes can be introduced in the primer used for reverse transcription (also known 
as Primer IDs) (Jabara et al., 2011; Zhou et al., 2015), discriminating the PCR and sequencing errors, 
and obtaining a combined error rate between transcription and RT-mediated RNA-dependent DNA 
synthesis. Moreover, amplicons or cDNA molecules can be tagged at their termini by ligation of 
adaptors harboring random nucleotide sequences (Kinde et al., 2011; Schmitt et al., 2012; Kennedy 
et al., 2014). Finally, in the first PCR, including the barcode in the primers used for amplification 
may enable to discount PCR and sequencing errors during analysis of the high-resolution RNA- 
sequencing method (HiRes-Seq) (Imashimizu et al., 2013).  
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Of all these methods, the most convenient to measure the fidelity of RTs is that of PrimerIDs, 
that allows to tag each cDNA molecule giving them a unique identity. However, the diversity of 
techniques arises from the complexity of the pipelines used for producing libraries and analyzing 
results by bioinformatics. A standardize and consistent measurement of RT’s fidelity by next-
generation sequencing platforms is still missing. 
 
1.4.3.2. DNA-dependent DNA synthesis fidelity of WT and multidrug-resistant HIV-2 RTs  
Fidelity of WT and mutant HIV-1 RTs has been extensively studied (for a review see Menéndez-
Arias, 2002, 2009, 2013a; Svarovskaia et al., 2003). However, attempts to correlate mutation 
frequencies in HIV-1 and HIV-2 with the attenuated progression to AIDS have been inconclusive 
(Lemey et al., 2007; MacNeil et al., 2007; Skar et al., 2010). Several factors including dNTP pools, 
viral and cellular proteins and the cell types used in the assays may have an important effect on the 
viral mutation rate. Next-generation sequencing analysis of amplicons obtained from infected cells 
showed that HIV-2 had lower mutation rates than HIV-1, although the observed differences were 
due to the high frequency of G-to-A transitions found in HIV-1 (Rawson et al., 2015). The higher 
susceptibility of this virus to APOBEC3-mediated hypermutation could explain these results 
(Ribeiro et al., 2005). Nucleotide incorporation assays carried out with heteropolymeric template-
primers under steady-state conditions revealed only subtle differences in misinsertion and mispair 
extension fidelity between the prototypic HIV-1BH10 and HIV-2ROD RTs (Bakhanashvili and Hizi, 
1993). However, proper assessments of the intrinsic fidelity of the HIV-2 RT, including estimates 
of base substitution and frameshift error rates relative to other RTs have not been reported.  
HIV-2 shows natural resistance to a number of antiretroviral drugs designed to suppress HIV-1 
propagation. Thus, NNRTIs (Figure 8A), the fusion inhibitor enfuvirtide and several protease 
inhibitors are ineffective against HIV-2, while the clinical efficacy of maraviroc is uncertain 
(reviewed in Menéndez-Arias and Álvarez, 2014). Unlike HIV-1, HIV-2 does not develop resistance 
to nucleoside RT inhibitors (NRTIs) (Figure 8B) through the excision pathway (involving amino 
acid substitutions M41L, D67N, K70R, L210W, T215F/Y and K219E/Q in the viral HIV-1 RT 
(reviewed in Menéndez-Arias, 2013b)), but relies exclusively on nucleotide discrimination (Boyer 
et al., 2012).  
Clinical and epidemiological studies have shown that HIV-2 has lower genetic barriers than 
HIV-1 to the development of multidrug resistance (Gottlieb et al., 2009). NRTIs (usually 
tenofovir/emtricitabine) constitute the backbone of commonly prescribed therapies against HIV-2 
(Menéndez-Arias and Álvarez, 2014; Günthard et al., 2016). RT substitutions K65R and Q151M 
are frequently identified in virus obtained from treated HIV-2-infected patients (Ntemgwa et al., 
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2009), and the presence of both changes together with M184V confers classwide NRTI resistance 
(Smith et al., 2009). An estimated prevalence of 9% has been reported for the combination of K65R, 
Q151M and M184V in a European cohort of HIV-2-infected patients treated with antiretroviral 
drugs (Deuzing et al., 2015). 
 
Figure 8. Chemical structures of antiretroviral drugs active against HIV-1 RT. (A) Chemical structures 
of nucleoside analogues RT inhibitors (NRTIs). Tenofovir alafenamide, emtricitabine, abacavir, lamivudine 
and zidovudine are approved drugs commonly used to treat HIV-infected patients. Tenofovir alafenamide is 
a prodrug currently preferred over tenofovir disoproxil fumarate due to its reduced renal and bone toxicity 
(Ray et al., 2016). EFdA is a nucleoside analogue in preclinical development. Atoms modified during the 
conversion of the analogues to metabolically relevant derivatives are indicated in red. (B) Chemical structures 
of nonnucleoside RT inhibitors. Adapted from Menéndez-Arias et al. (2017). 
 
Phenotypic studies using recombinant HIV-2 have shown that Q151M alone confers high-level 
resistance to zidovudine (AZT), and moderate- to low-level resistance to stavudine, abacavir, 
didanosine and emtricitabine. However, it has a small impact on the viral susceptibility to 
lamivudine and tenofovir (Damond et al., 2005; Smith et al, 2009; Deuzing et al., 2015). M184V 
confers high-level resistance to approved cytidine analogues (i.e., lamivudine and emtricitabine) 
(Smith et al., 2009), while K65R confers low-level resistance to didanosine and moderate to high-
level resistance to cytidine analogues in HIV-2 strains (Damond et al., 2005; Smith et al., 2009). As 
previously shown in HIV-1 (Menéndez-Arias, 2013b), K65R arises in HIV-2-infected patients 
exposed to tenofovir and other NRTIs (Ntemgwa et al., 2009; Peterson et al., 2011). In addition, 
K65R can be selected in vitro after HIV-2 exposure to increasing doses of tenofovir (Andreatta et 
al., 2013), and produces a 2- to 7-fold decrease in viral susceptibility to the drug (Andreatta et al., 
2013; Deuzing et al., 2015).  
Lys65, Gln151 and Met184 locate at the dNTP binding site of the RT (Huang et al., 1998) 
(Figure 4B). By themselves, amino acid substitutions K65R, Q151M or M184V in HIV-1 RT confer 
reduced catalytic efficiency of nucleotide analogue incorporation (reviewed in Menéndez-Arias, 
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2013b). Consistently with those findings, mutant HIV-1 with RT substitutions K65R or M184V 
show delayed replication kinetics in comparison with the WT virus (Back et al., 1996; Cong et al., 
2007). In the case of M184V, the fitness defect is more pronounced at low dNTP concentrations and 
is expected to be more relevant for viruses replicating in non-dividing cells (e.g., macrophages) 
(Keulen et al., 1997). HIV-1 RTs with Arg65 instead of Lys showed decreased nucleotide 
incorporation rates (kpol) in pre-steady-state kinetic assays (Deval et al., 2004, 2005; Barrioluengo 
et al., 2011). Other studies have shown that K65R produces a > 8-fold increase in the intrinsic 
fidelity of the HIV-1 RT, an effect that has been demonstrated with RTs of highly divergent HIV-1 
group M (subtype B) and group O strains (Shah et al., 2000; Barrioluengo et al., 2011). In agreement 
with enzymatic data, K65R produced a 3.3-fold mutant frequency reduction in single round of 
replication assays, using an HIV-1NL43 vector containing the lacZ gene (Mansky et al., 2003). 
In contrast to the well-studied HIV-1 RT, studies on the effects of NRTI resistance-associated 
mutations on the nucleotide specificity and fidelity of the HIV-2 polymerase are limited to a few 
single- and double-mutants with substitutions at positions 74, 89, 111 and 215 (i.e., L74V, E89G, 
V111I, S215Y, L74V/S215Y and E89G/S215Y), whose effects were evaluated for a small subset of 
misincorporations or mispairs using nucleotide discrimination assays (Taube et al., 1997; Deuzing 
et al., 2015). Unfortunately, those studies could not provide reliable mechanistic interpretations of 
the data because assays were performed under steady-state conditions. None of the studied residues 
was part of the complex conferring multi-NRTI resistance, although sometimes V111I appears as 
an accessory mutation that compensates for the lower fitness of classwide NRTI-resistant HIV-2 
(Deuzing et al., 2015). Furthermore, as for the WT HIV-2 RT, it has not been tested the intrinsic 
fidelity of mutant HIV-2 RTs carrying amino acid substitutions associated to multidrug resistance.  
 
1.4.3.3. RNA-dependent DNA synthesis fidelity of retroviral RTs  
Despite the large amount of research on the fidelity of retroviral RTs, most of the available 
studies have been devoted to the analysis of DNA-dependent DNA synthesis accuracy (reviewed in 
Menéndez-Arias, 2002, 2013a).  These studies have shown that oncoretroviral RTs are more faithful 
than lentiviral RTs.  Thus, the intrinsic error rates of HIV-1 RT were more than 10-fold higher than 
those obtained with AMV and MLV RTs (Roberts et al., 1988, 1989; Barrioluengo et al., 2012), 
determined with M13mp2 lacZα forward mutation assays (Bebenek and Kunkel, 1995). However, 
in HIV-1 RTs, antiretroviral drug resistance-associated mutations such as K65R or the combination 
of K65R and V75I were shown to increase fidelity of DNA-dependent DNA synthesis to levels 
similar to those obtained with oncoretroviral RTs (Shah et al., 2000; Barrioluengo et al., 2011). 
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The fidelity of RNA-dependent DNA synthesis of retroviral RTs has been evaluated in 
enzymatic assays by comparing kinetic parameters for misincorporation and mispair extension. 
Assays carried out under steady-state conditions with AMV, MLV and HIV-1 RTs did not reveal 
large differences when DNA templates were substituted by RNA templates (Yu and Goodman, 
1992; Bakhanashvili and Hizi, 1993). However, using pre-steady-state kinetics, Kerr and Anderson 
(1997) showed that misinsertion fidelity was 9-64 times (with duplex 45/25mer) and 14-23 times 
(with duplex 45/22mer) higher in RNA-templated than in DNA-templated reactions catalyzed by 
HIV-1 RT. These experiments were performed with synthetic duplexes bearing the same nucleotide 
sequences (except for having U instead of T in the RNA templates). However, nucleotide 
incorporation assays are restricted to a few template-primers and therefore provide limited 
information on the propensity of RTs to introduce base substitutions. 
Attempts to compare the fidelity of retroviral RTs in DNA polymerization reactions carried out 
with RNA or DNA templates using genetic assays did not provide consistent results. Studies 
performed with HIV-1 RT and the amber16 reversion assay using phage ФX174 showed that two 
out of the seven specific mismatches analyzed had 20- and 7-fold lower mutation frequencies with 
DNA templates than with RNA templates (Hübner et al., 1992). On the other hand, M13-based 
assays using lacZα or the HIV-1 env hypervariable region 1 (V1) as target genes showed little 
differences in fidelity between reactions carried out with HIV-1 RT using RNA or DNA templates.  
Thus, base substitution error rates determined with lacZα were 1.7×10−4 and 1.4×10−4 for DNA-
dependent and RNA-dependent reactions, respectively (Ji and Loeb, 1992). These small differences 
were also found for overall error rates in assays using a fragment of env as a target sequence (i.e., 
1.9×10−4 with DNA templates and 2.0×10−4 with RNA templates) (Ji and Loeb, 1994). In contrast, 
and using a modified version of the M13mp2 lacZα forward mutation assay, Boyer et al. (1992) 
showed that the overall fidelity of HIV-1 RT was about two to six-fold higher while copying RNA 
templates than DNA templates. In these experiments, authors suggested the contribution of errors 
made by the T7 RNAP while preparing the RNA used as template in the fidelity assays, 
acknowledging an undetermined impact on the calculated error rates.  
The discrepancies in the fidelity assessments could be explained in part by methodological 
differences in the assays, such as the use of distinct templates and RTs, or the different WT HIV-1 
group M/subtype B RT used for comparison in these experiments. For example, homodimers 
(p66/p66) versus heterodimers (p66/p51), or RT variants derived from different viral strains, such 
as NL4-3, HXB2, BH10 or NY5. Thus, the intrinsic fidelity of retroviral RTs during RNA-dependent 
DNA synthesis reactions should be properly measured under the same conditions, yielding a 
complete analysis of mutational spectra and estimates of base substitution and frameshift error rates.  
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 Objective 1. To determine the DNA-dependent DNA synthesis accuracy of WT HIV-2ROD 
RT, as well as that of mutant RTs carrying amino acids substitutions associated to 
multidrug-resistance such as K65R, and the combination K65R, Q151M and M184V by 
using M13mp2 forward mutation assays based on the expression of lacZα. 
 Objective 2. To characterize the RNA-dependent DNA synthesis fidelity of retroviral RTs, 
including those of WT MLV, AMV, HIV-1BH10, HIV-1ESP49, as well as mutant HIV-1ESP49 
RTs carrying the amino acid substitutions K65R/V75I, by using forward mutation assays. 
 Objective 3. To determine mutant frequencies, error rates for different type of mutations 
(e.g., base substitutions, frameshifts) and mutational spectra of retroviral RTs while reverse 
transcribing RNA templates, and to compare them with those obtained in DNA templates.  
 Objective 4. To study the impact of heterogeneity present in RNAs used as templates of 
reverse transcription in the estimates of RT’s fidelity.  
 Objective 5. To optimize deep sequencing experiments based on the use of Primer IDs to 
analyze the fidelity of RTs on RNA templates. 
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3.1. Enzymes and bacterial strains 
WT and mutant RTs belonging to different lentiviruses (i.e., HIV-1 and HIV-2) and 
oncoretroviruses (i.e., AMV and MLV) were used in this work (Table 2). Escherichia coli strains 
(Table 3) and plasmids (Table 4) used in this Thesis are indicated, together with their main features.  
Table 2. RTs and RNAPs used in this study 
Enzymes 
GenBank ID/ 
no. catalogue 
References and companies  
Recombinant   
RTs   
HIV-1BH10 AAA44198.1a Ratner et al. (1985) 
HIV-1ESP49 AAC64709.1b Quiñones-Mateu et al. (1998) 
     K65RESP49   
     K65R/V75IESP49    
HIV-2ROD X05291.1c Clavel et al. (1986); Guyader et al. (1987) 
     K65RROD   
     K65R/Q151M/M184VROD   
RNAPs   
Bacteriophage T7 AAA32569.1d Davanloo et al. (1984) 
Commercial   
RTs   
AMV #M170A Promega 
MLV #M5101 Promega 
RNAPs   
Bacteriophage T7 #P2075 Promega 
 #AM1312 Ambion  
HIV-1BH10, WT HIV-1 group M subtype B strain BH10; HIV-1ESP49, WT HIV-1 group O strain ESP49; 
K65RESP49 and K65R/V75IESP49, RTs of HIV-1ESP49 bearing amino acid substitutions K65R and K65R/V75I, 
respectively; HIV-2ROD, WT HIV-2 group A strain ROD; K65RROD and K65R/Q151M/M184VROD, RTs of 
HIV-2ROD bearing the change K65R or the combination K65R, Q151M and M184, respectively. 
a The amino acid sequence of HIV-1BH10 RT used in this Thesis has a 100% identity with the positions 
168−560 of the referred Pol polyprotein. b The amino acid sequence of HIV-1ESP49 RT presents changes 
V142I, S204L, V314M, and R398W in comparison with the given GenBank ID. c The amino acid sequence 
of HIV-2ROD RT is 100% identical to the translated nucleotides of the HIV-2ROD RNA genome from position 
2,381 to 4,057 of the GenBank ID reference. d The T7 RNAP contains changes R389K, H623Y, and P665L 
compared to the provided GenBank ID.    
 
Table 3. Bacterial strains and plasmids referred to in this study 
Designation Genotype or description 
E. coli strains  
XL1 Blue recA1, endA1, gyrA96 (nalR), thi-1, hsdR17 (rK- mK+), glnV44, relA1, lac, F' 
[Tn10 proA+B+ lacIq Δ(lacZ)M15]  
DH5α F– endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG phoA 
purB20 φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK–mK+), λ– 
BL21 B, F− ompT gal dcm lon hsdSB(rB- mB-) 
BL21(DE3)pLysS  BL21 strain, λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5]), with pLysS 
BL21(pREP4) BL21 strain, with plasmid pREP4 
NR9099 [Δ(pro-lac)], thi, ara, recA56/F' (proAB, lacIqZΔM15) 
MC1061 hsdR, hsdM+, araD, Δ(ara, leu), Δ(ara, leu), Δ(laclPOZY), galU, galK, strA 
CSH50 [Δ(pro-lac)], thi, ara, strA/F' (proAB, laclqZΔM15, traD36) 
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Table 4. Bacterial strains and plasmids referred to in this study 
Designation Genotype or description 
Plasmids  
pRT66BBH10 trcP vector, lacIq, AmpR, MscI-HindIII fragment, encodes the HIV-1BH10 p66 
subunit 
pRT66BESP49 trcP vector, lacIq, AmpR, MscI-HindIII fragment, encodes the HIV-1ESP49 p66 
subunit 
pATPR tacP vector, Tn3R, KanR, EcoRI-BamHI fragment, encodes the HIV-1817 PR   
pT5m T7P vector, AmpR, BamHI-HindIII fragment, encodes the HIV-2ROD p68 subunit  
pLysS [T7p20 orip15A] (CmR) ; encodes the T7 lysozyme 
pQE9T7 T5P vector, AmpR, CmR, BamHI-HindIII fragment, encodes the T7 RNAP 
pREP4 [orip15A] lacIq, KanR; encodes the lac represor 
 
3.2. RT purification 
3.2.1. HIV-1 RTs 
HIV-1 RT purification relies on the co-expression of the large subunit of the RT (p66) and the 
HIV-1 protease in E. coli XL1-Blue (Table 3), previously transformed with plasmids pRT66BBH10 
or pRT66BESP49, together with pATPR (Figure 9) (Boretto et al., 2001; Matamoros et al., 2005).  
 
Figure 9. Plasmids used in HIV-1 RTs purification. (A) Plasmid pRT66BBH10. This construction derives 
from plasmid pTrc99A (Amersham Biosciences) (Canard et al., 1999). The plasmid pRT66BBH10 encodes the 
major subunit (p66) of the RT from HIV-1 group M subtype B strain BH10, including a region with a tag of 
six histidines at the C-terminus of the enzyme. The insert was introduced using the restriction sites of MscI 
and HindIII endonucleases in the multicloning site (MCS) (Boretto et al., 2001). (B) Plasmid pRT66BESP49. 
Same as the plasmid represented in A, but codifying for the p66 subunit of the HIV-1 group O strain ESP49 
RT (Matamoros et al., 2005; Álvarez et al., 2009). (C) Plasmid pATPR. This plasmid contains the HIV-1 
protease coding sequence preceded by two ribosome binding sites (RBS), including that of T7g10 before the 
starting ATG codon of the viral protease. The insert was cloned into the EcoRI and BamHI sites of the plasmid 
pAT, from which pATPR proceeds (Boretto et al., 2001). The co-expression of pATPR together with either 
pRT66BBH10 or pRT66BESP49 produces p66/p51 heterodimers resulting from cleavage of p66 by the viral 
protease. AmpR and KanR indicate the regions codifying for the ampicillin and kanamycin resistance genes, 
respectively. His6 represents the sequence that encodes the six-histidine tag. Tn3R, Tn3 resolvase; ori, origin 
of replication. The gen lacI encodes the lac repressor protein that binds to the lac operator and allows to control 
the expression of HIV-1 p66 and protease polypeptides by addition of IPTG.  
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3.2.1.1. Site-directed mutagenesis  
Nucleotide sequences encoding for p66 subunits of HIV-1BH10 and HIV-1ESP49 RTs were cloned 
in plasmids pRT66BBH10 and pRT66BESP49, respectively (Figure 9). The vector pRT66BESP49 was 
used as template to introduce mutations K65R and K65R/V75I using the “QuickChangeTM Site-
Directed Mutagenesis Kit” of Stratagene according to the manufacturer’s instructions. Mutagenic 
primers are shown in Table 5. 
 Table 5. Primers used in mutagenesis reactions with pRT66BESP49 
Mutation Mutagenic primer sequence 
K65R 5′-CTTTGCTATAAAAAGGAAAGATAGTACTAAGTGG-3′ 
3′-GAAACGATATTTTTCCTTTCTATCATGATTCACC-5′ 
V75I 5′-CAGTACTAAATGGAGAAAATTAATAGATTTCAGAGA-3′  
3′-GTCATGATTTACCTCTTTTAATTATCTAAAGTCTCT-5′  
Left column indicates the mutation introduced in the RT. Mutagenized codons are underlined. 
 
Mutagenesis reactions were carried out in 50 µl of 20 mM Tris-HCl pH 8.8 buffer, containing 
10 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 0.1% (w/v) Triton X-100, 0.1 mg/ml bovine serum 
albumin (BSA), 125 ng of each of the corresponding mutagenic primers, around 50 ng of the 
template plasmid, 500 μM of each of the four dNTPs and 2.5 U of Pfu Turbo DNA polymerase 
(Stratagene). The PCR was started with an incubation of 2 min at 95 ºC followed by 20 cycles each 
one including incubations of 30 s at 95 ºC, 1 min at 55 ºC and 12 min at 68 ºC. After cooling the 
reaction at 4 ºC, the obtained product was treated with 10 U of DpnI (New England Biolabs) for 1 
hour at 37 ºC. DpnI is an endonuclease that specifically degrades the methylated or hemimethylated 
DNA. The template pRT66BESP49 used in the mutagenic reaction is methylated due to its 
amplification in an E. coli dam+ strain. After that treatment, the newly synthesized DNA with the 
desired mutations remains undigested, and was analyzed on a 1% agarose gel. 
E. coli DH5α competent cells (Table 3) were then transformed with 5 μg of the product of the 
mutagenesis reaction by thermal shock (20-30 min on ice, followed by 1 min at 42 ºC and 2 min on 
ice). Then, bacteria was grown on 1 ml of Luria-Bertani medium (LB, containing 10 g bactotriptone, 
5 g yeast extract and 10 g NaCl, per liter) during 1 hour at 37 ºC, and ampicillin-resistant colonies 
were selected. The integrity of the entire RT sequence, as well as the presence of the desired 
mutations, were confirmed by sequencing the DNA plasmid extracted with the “Wizard Plus SV 
Minipreps” kit (Promega). The sequencing reactions were carried out in Macrogen Korea (Seoul, 
South Korea), and sequences were subsequently analyzed using Seqman 4.0 (DNAstar Inc.) 
software. Once the presence of the mutation was confirmed, the plasmids were used to transform 
the E. coli XL1-Blue PR strain by thermal shock. This strain derives from E. coli XL1-Blue, 
previously transformed with the pATPR plasmid (Figure 9). This plasmid contains the nucleotide 
sequence encoding the HIV-1 protease from isolate 817 (GenBank ID: AF117566), except for a 
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V64I substitution (Boretto et al., 2001), together with the kanamycin resistance gene. Ampicillin- 
and kanamycin-resistant colonies were selected for the following steps.    
 
3.2.1.2. Expression of HIV-1 RT p66/p51 heterodimers 
Twenty ml of LB medium containing ampicillin (100 μg/ml) and kanamycin (50 μg/ml) were 
inoculated with 5-10 μl of a glycerol-containing stock of E. coli XL1-Blue strain cells previously 
transformed with pRT66B and pATPR plasmids (described above). This culture was grown 
overnight at 37 ºC under constant stirring (around 180 rpm). Then, the culture was added to 300 ml 
of the same antibiotics-containing media and grown for another 4 hours under the same conditions. 
After this step, three one-liter flasks with fresh LB medium containing ampicillin (100 μg/ml) and 
kanamycin (50 μg/ml) were prepared. Then, 100 ml of the bacterial culture obtained in the previous 
step were added to each flask. These cultures were maintained under constant agitation at 37 ºC until 
the optical density at 600 nm reached a value between 0.6 and 0.8. Then, IPTG was added to a final 
concentration of 0.6 mM in order to induce the expression of the p66 subunit of the RT and the PR 
encoded within the plasmids. After maintaining the culture at 37 ºC for another 24 hours, the cells 
were harvested by centrifugation at 3000 rpm at 4 ºC for 30 min using a rotor JLA 10.500 (Beckman) 
and an Avanti J-26 XP centrifuge (Beckman Coulter). 
 
3.2.1.3. Lysis of bacteria 
The obtained bacterial pellet was resuspended in 20 ml of 40 mM Tris-HCl pH 8.0 buffer, 
containing 25 mM ethylenediaminetetraacetic acid (EDTA), 10% (w/v) sucrose, 2 mM 
phenylmethylsulfonyl fluoride (PMSF), 2 mM benzamidine, and 1 mg/ml lysozyme. The mixture 
was stirred at 4 ºC for 15 min. Then, another 20 ml of a solution containing 0.8% (w/v) NP-40, 20 
mM dithiothreitol (DTT), 2 mM PMSF and 2 mM benzamidine were added and again mixed at 4 ºC 
for 15 min. Finally, we added NaCl to a final concentration of 0.5 M and the mixture was sonicated 
at a constant amplitude of 24 microns for 1 min using a Labsonic M sonifier (Sartorius). The 
sonicated sample was centrifuged at 15000 g at 4 ºC for 15 min using a rotor JA 25.50 and an Avanti 
J-26 XP centrifuge (Beckman Coulter). The resulting supernatant was diluted in 7 volumes of 50 
mM sodium phosphate pH 6.8 buffer (made of 25 mM Na2HPO4 and 25 mM NaH2PO4) and stored 
at 4 ºC. 
 
3.2.1.4. Cation-exchange chromatography 
First of all, a cellulose phosphate P11 (Whatman) column was prepared. For that purpose, 
around 1.5 g of resin were washed in 25 volumes of 0.5 M NaOH during 5 min in agitation. After 
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allowing the resin to settle, the supernatant was removed and the washing process was repeated once 
again with 0.5 M NaOH, then twice with sterile water, twice with 0.5 M HCl and finally twice more 
with sterile water. Subsequently, the cellulose phosphate resin was packed into the column and was 
equilibrated for about 2 hours with 50 mM sodium phosphate pH 6.8 buffer, leaving the column at 
the same pH. The sample obtained in the previous section was passed through the column and then 
washed with around 200 ml of the equilibrating buffer.  
The bound enzyme was eluted from the column using a cation concentration gradient prepared 
with 40 ml of 50 mM sodium phosphate pH 6.8 buffer, and 40 ml of the same buffer containing 2 
M NaCl. The formation of the gradient was facilitated by a HoeferTM SG100 gradient maker 
(Amersham Biosciences) containing a magnetic bar in the chamber used for the less concentrated 
dilution, and placed on a magnetic stirrer (ANS-001, BSB). Fractions of 30 drops per tube were 
collected in 2 ml tubes using a collector (FC205, Gilson). Afterwards, the presence of enzyme was 
checked by measuring the absorbance of all fractions at 280 nm using a Hitachi U-2000 
spectrophotometer (Hitachi Ltd). The enzyme-enriched fractions were pooled and subjected to 
affinity chromatography. 
 
3.2.1.5. Affinity chromatography 
The pooled sample collected after the cation-exchange chromatography step was loaded in a 2 
ml-column of Ni2+-nitriloacetic acid-agarose (ProBondTM, Invitrogen), previously equilibrated in 50 
mM sodium phosphate pH 6.8 buffer containing 0.3 M NaCl. After loading the sample, the column 
was washed with 100 ml of 50 mM sodium phosphate pH 6.0 buffer containing 0.5 M NaCl. The 
RT interacts with the Ni2+ ions bound to the agarose matrix of the column through the imidazole 
groups of the C-terminal hexahistidine tail. The enzyme was eluted with an imidazole gradient, 
prepared with 20 ml of 50 mM sodium phosphate pH 6.0 buffer containing 0.5 M NaCl, and another 
20 ml of the same buffer containing 0.5 M NaCl and 0.5 M imidazole. Fractions of 2 ml were 
collected and their absorbance at 280 nm was determined.  
 
3.2.1.6. Dialysis and concentration 
The RT-enriched fractions (around 20 ml) were pooled and subjected to dialysis using Visking® 
dialysis membranes of 16 mm and with a pore diameter of ~25 Å (Serva). Dialysis was performed 
in 250 ml of 50 mM Tris-HCl pH 7.0 buffer, containing 25 mM NaCl, 1 mM EDTA, 10% (w/v) 
glycerol, and 1 mM DTT added just before starting. Three changes of the dialysis solution were 
made, each one of at least 2 hours, maintaining one of them overnight. Finally, the dialyzed sample 
was concentrated to a final volume of 1-2 ml by ultracentrifugation at 3500 rpm and 4°C using 
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Centriprep® 30K (Merck Millipore Ltd) filter concentrators and a rotor JLA 16.250 in an Avanti J-
26 XP centrifuge (Beckman Coulter). Ultracentrifugation usually involved at least two rounds of 30 
min. Depending on the volume and RT concentration desired, the sample can also be concentrated 
by an Amicon® Ultra-4 Ultracel®-10K (Merck Millipore Ltd).  Then, the sample was subjected to 
a microcentrifugation of 1 min in a Hettich Mikro200 to eliminate possible pellets. The concentrated 
RT aliquots obtained were stored at -20 ºC. The purity of the obtained heterodimers was determined 
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Protein concentration 
was determined by using the RT molar extinction coefficient at 280 nm (ε280 = 260450 M-1 cm-1), 
while the concentration of active enzyme was analyzed as a measure of the amount of RT bound to 
the template-primer at time zero, as described in Kati et al. (1992).    
 
3.2.2. Purification of HIV-2 RTs 
The purification of HIV-2 RTs relies on the co-expression of the large subunit (p68) of the RT 
and the HIV-2 protease (strain D194) in E. coli BL21(DE3)pLysS (Table 3), previously transformed 
with the plasmid pT5m (Figure 10), which was kindly provided by Amnon Hizi (Tel Aviv 
University, Israel). As an expression strain, BL21 has the potential advantage of being deficient in 
various proteases (e.g. ompT and lon) that could degrade recombinant proteins during purification. 
DE3 is a λ prophage derivative carrying the T7 RNA polymerase (gene 1) under the control of the 
IPTG-inducible lacUV5 promoter. The plasmid pT5m carries the coding sequence of the p68 subunit 
of HIV-2 RT as well as that of the HIV-2D194 PR, controlled by the T7 promoter. Finally, the plasmid 
pLysS allows to block basal expression of T7 RNAP by encoding the gene of the T7 lysozyme 
inhibitor. The sequence of this gene is found in the antisense orientation relative to the tet promoter, 
so only small amounts of T7 lysozyme are produced (Figure 10). Altogether, under IPTG induction 
and in the absence of glucose (that inhibits the formation of CAP/cAMP activators), T7 RNAP is 
expressed from the λDE3 prophage and drives the transcription of HIV-2 p68 RT-subunit and PR in 
the plasmid pT5m.  
 
3.2.2.1. Site-directed mutagenesis  
The RT-coding region of the p68 subunit of HIV-2ROD, and the PR-coding region of HIV-2D194 
are found in the polycistronic plasmid pT5m under the control of a single T7 promoter (Figure 10). 
The resulting long polycistronic mRNA contains both genes, each one having its own ribosome-
binding-site (RBS) and stop codon. Six amino acids of histidine flank both, N- and C-termini of p68. 
It has been described that HIV-2 RTs with His6 tags only at the carboxyl terminus of p68 (like in 
HIV-1 RT) did not bind to NTA-agarose-columns, and then they could not be purified (Sevilya et 
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al., 2001). In our case, the N-terminal His6 tag is linked to the RT through an amino acid sequence 
that contains a thrombin cleavage site. The vector pT5m was used as template to introduce the amino 
acid substitution K65R and the combination of mutations K65R/Q151M/M184V using the 
“QuickChangeTM Site-Directed Mutagenesis Kit” of Stratagene according to the manufacturer’s 
instructions. Mutagenic primers are shown in Table 6.  
 
Figure 10. Plasmids and genes involved in HIV-2 RTs purification. (A) λDE3 prophage derivative. The 
prophage is found within BL21 bacteria and encodes the T7 RNAP (gene 1) under the control of an IPTG-
inducible promoter. Under activating conditions (absence of glucose, promoting the formation of CAP/cAMP 
stimulators) and in the presence of IPTG, the E. coli RNAP drives the transcription of T7 RNAP gene, thereby 
allowing its expression. (B) Plasmid pT5m. This plasmid leads the synthesis of a polycistronic messenger 
RNA, which has two ribosome-binding sites (RBS), one upstream of the p68 RT-subunit gene and the other 
upstream of the HIV-2D194 PR gene. Sequences coding six-histidine tags are present at the amino and carboxyl 
termini of p68 subunit (Sevilya et al., 2001). The asterisk represents a sequence that once translated acts as a 
recognition site for digestion with thrombin. BamHI and HindIII restriction sites delimit the whole insert 
within the pT5m plasmid. A T7 promoter drives the transcription of the whole construction. (C) Plasmid 
pLysS. This plasmid encodes the T7 lysozyme in an antisense orientation, blocking the basal expression of T7 
RNAP mediated by the λDE3 prophage. AmpR and CmR indicate the regions codifying for the ampicillin and 
chloramphenicol resistance genes, respectively. Ori, indicates the origin of replication. 
 Table 6. Primers used in HIV-2ROD RT mutagenesis reactions  
Mutation Mutagenic primer sequences 
K65R 3’-CAAAAACAGGAAAGAGAACTAACGTTTA-5’ 
5′-GTTTTTGTCCTTTCTCTTGATTGCAAAT-3′ 
Q151M 3’-AGGGAAGGTAGGGTAACCGTTCTGAAAT-5’ 
5′-TCCCTTCCATCCCATTGGCAAGACTTTA-3′  
M184V 3’-TCTATAGTAGGTGCATGACTTACTATTA-5’ 
5′-AGATATCATCCACGTACTGAATGATAAT-3′ 
Left column indicates the mutation(s) introduced in the RT. Mutagenized codons are 
underlined. 
 
Mutations found in the triple mutant K65R/Q151M/M184V were orderly added starting from 
mutant K65R, then introducing mutation Q151M, and finally M184V. The mutagenesis reaction 
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was performed as described in section 3.2.1.1, and the product was transformed in E. coli DH5α 
competent cells by thermal shock. As described above, ampicillin-resistant colonies were selected 
and the desired RT sequence confirmed by sequencing. After ratifying the presence of the mutation, 
the plasmid pT5m was used to transform the E. coli BL21(DE3)pLysS strain by thermal shock. 
Finally, ampicillin- and chloramphenicol-resistant colonies were selected for the following step. 
 
3.2.2.2. Expression of HIV-2 RT p68/p54 heterodimers 
Four flasks with 40 ml of LB medium containing 40 mM glucose, 100 μg/ml ampicillin and 34 
μg/ml chloramphenicol were inoculated with 5-10 μl of a glycerol-containing stock of E. coli 
BL21(DE3)pLysS cells previously transformed with the pT5mRODRT plasmid (described above). 
These cultures were grown overnight at 30 ºC under constant stirring (ca. 180 rpm). After this step, 
each 40 ml-flask of bacterial culture was added to a one-liter flask with fresh antibiotics-containing 
medium, supplemented with 2 mM glucose. The four cultures were maintained under constant 
agitation at 30 ºC, until the optical density at 600 nm reached a value of 0.7. Therefore, IPTG was 
added to a final concentration of 1 mM, in order to induce the expression of the p68 subunit of the 
RT and the PR encoded within the plasmid pT5m. After maintaining the cultures at 30 ºC for another 
3 hours, cells were harvested by centrifugation at 3500 rpm at 4 ºC for 30 min using a rotor JLA 
10.500 and an Avanti J-26 XP centrifuge (Beckman Coulter). 
 
3.2.2.3. Lysis of bacteria  
The pellets obtained in the four cultures were re-suspended together in 24 ml of 50 mM sodium 
phosphate pH 8.0 cold buffer, containing 50 mM NaCl, 0.75 mg/ml hen egg-white lysozyme and 
1.5 mM PMSF. After keeping the mixture on ice stirring for 25 min, 1.72 ml of 4 M NaCl were 
added. Then, the solution was subjected to brief periods of sonication at a constant amplitude of 24 
microns using a Labsonic M sonifier (Sartorius). Afterward, the sample was centrifuged at 23000 
rpm for 60 min at 4°C using a Beckman JA 25.50 rotor and an Avanti J-26 XP centrifuge (Beckman 
Coulter). The obtained supernatants were diluted with one volume of 66 mM sodium phosphate pH 
7.0 buffer, containing 0.3 M NaCl, and were stored at 4°C.  
 
3.2.2.4. Affinity chromatography  
A 3-ml Ni2+-nitriloacetic acid-agarose column (Invitrogen, Carlsbad, CA, USA), was prepared 
and equilibrated with 50 mM sodium phosphate pH 7.0 buffer containing 0.3 M NaCl. After 
applying the supernatant sample, the column was washed with 50 ml of the equilibrating buffer and 
with 90 ml of 50 mM sodium phosphate pH 6.0 buffer containing 0.3 M NaCl, 10% glycerol and 20 
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mM imidazole, in order to eliminate unspecific binding. Subsequently, the RT was eluted with a 20 
mM–0.5 M imidazole gradient, prepared with 30 ml of 50 mM sodium phosphate pH 6.0 buffer 
containing 0.3 M NaCl, and 10% glycerol. Absorbance at 280 nm was measured for every fraction 
and those showing the highest values were analyzed by SDS-PAGE. Fractions containing the 
heterodimer were pooled and dialyzed against 250 ml of 50 mM sodium phosphate pH 6.8 buffer, 
using Visking® dialysis membranes of 16 mm and with a pore diameter of ~25 Å (Serva). Three 
changes of the dialysis solution were made, maintaining each one for at least 2 hours.  
 
3.2.2.5. Cation-exchange chromatography 
The dialyzed sample was applied on a 5 ml P11 phosphocellulose column (Whatman, 
Maidstone, Kent, England), previously equilibrated with the dialysis buffer. After washing the 
column with 50 mM sodium phosphate pH 6.8 buffer containing 0.4 M NaCl, the RT was eluted 
with a total gradient of 60 ml from 0.4 to 1.2 M NaCl prepared in the washing buffer (i.e., 50 mM 
sodium phosphate pH 6.8 buffer containing 0.4 M NaCl). Fractions eluted from the salt gradient 
were analyzed by spectrophotometry at 280 nm and SDS-PAGE, and those containing the 
heterodimer were pooled and dialyzed against 50 mM Tris-HCl pH 7.0, containing 25 mM NaCl, 1 
mM EDTA pH 8, 1 mM DTT and 10% glycerol. Again, three changes of the dialysis solution were 
made, each one of at least 2 hours, and maintaining one of them overnight. Finally, the enzyme was 
concentrated in Centriprep® 30K and Amicon® Ultra-4 Ultracel®-10K (Merck Millipore Ltd) 
concentrators to <0.5 ml, and stored at −20 °C. Enzymes were quantified by active site titration 
before biochemical studies, as described in Kati et al. (1992). 
 
3.3.  Purification of T7 RNA polymerase 
The bacteriophage T7 RNAP was purified as an N-terminal 6-histidine tagged monomer after 
its expression in E. coli BL21(pREP4) strain (Table 3), previously transformed with plasmid 
pQE9T7 (Figure 11). The T7 RNAP-coding sequence was cloned in a pQE9 plasmid in sites 
generated by BamHI and HindIII endonucleases, leading to an in-frame translational fusion of the 
polymerase with the 6-histidine tag codified in the vector (Figure 11) (Ellinger and Ehricht, 1998). 
The resulting plasmid pQE9T7 was kindly provided by Ralf Ehricht (Alere Technologies Gmbh, 
Jena, Germany). The plasmid pREP4 found within BL21 bacteria constitutively expresses the lac 
repressor protein (encoded by the lacI gene) that trans-represses the bacteriophage T5 promoter 
found on the pQE9T7 expression vector. Under the addition of IPTG, the promoter T5 is induced 
and transcription catalyzed by the E. coli RNAP initiates.   
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Figure 11. Plasmids used in T7 RNAP purification. (A) Plasmid pQE9T7. This plasmid contains the T7 
RNAP-coding sequence cloned in the restriction sites of BamHI and HindIII endonucleases. The polymerase 
sequence is arranged in such a way that leads to an in-frame translational fusion of the T7 RNAP with the 6-
histidine tag codified in the vector (Ellinger and Ehricht, 1998). (B) Plasmid pREP4. It expresses constitutively 
the lac repressor protein (encoded by the lacI gene) that trans-represses the bacteriophage T5 promoter found 
on the pQE9T7 vector. Under the addition of IPTG, the promoter T5 is induced and transcription initiates via 
E. coli RNAP, allowing the expression of T7 RNAP. AmpR, CmR and KanR indicate regions codifying for the 
ampicillin, chloramphenicol and kanamycin resistance genes, respectively. Ori, indicates the origin of 
replication. 
 
3.3.1. Expression of T7 RNAP 
A fresh colony of E. coli BL21(pREP4) strain cells previously transformed with the plasmid 
pQE9T7 was inoculated in 20 ml of Tryptone Yeast medium (TY medium contains 6 g bactotriptone, 
3 g yeast extract and 0.38 g CaCl2 per liter). Antibiotics ampicillin and kanamycin were added at 
100 µg/ml and 25 µg/ml, respectively. This culture (20 ml) was incubated at 37 °C overnight under 
constant agitation. Then, the culture was added to a 1-liter flask of fresh medium containing 
ampicillin/kanamycin, and maintained again at 37 °C under constant agitation until an optical 
density at 600 nm of 1.0 was reached. Subsequently, the expression of T7 RNAP was induced with 
1 mM IPTG during three additional hours and the cells were harvested by centrifugation at 3600 g 
during 30 min at 4°C using a rotor JLA 10.500 and an Avanti J-26 XP centrifuge (Beckman Coulter).  
 
3.3.2. Lysis of bacteria 
The bacterial pellet was resuspended in 15 ml of 50 mM sodium phosphate pH 8.0, containing 
300 mM NaCl and 0.5 mM DTT. After adding lysozyme, PMSF and benzamidine to a final 
concentration of 6 mg/ml, 0.5 mg/ml and 2.5 mM, respectively, the mixture was stirred on ice for 
30 min and sonicated at a constant amplitude of 24 microns for 40 s using a Labsonic M sonifier 
(Sartorius). Then, the sample was centrifuged at 15000 g at 4 ºC for 30 min using a rotor JA 25.50 
and an Avanti J-26 XP centrifuge (Beckman Coulter). The resulting supernatant was collected for 
the following step and stored at 4°C.  
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 3.3.3. Affinity chromatography 
The supernatant containing His6-tagged T7 RNAP was applied twice on a 6-ml Ni2+-NTA 
Sepharose column previously equilibrated with 50 mM sodium phosphate buffer pH 8.0 containing 
300 mM NaCl and 0.5 mM DTT. Then, the column was washed with 100-150 ml of the same buffer, 
containing 10% glycerol, 20 mM imidazole and 20 µg/ml PMSF. The protein was eluted by a 60-
ml linear 0.02-0.5 M imidazole gradient in 50 mM sodium phosphate pH 8.0, containing 300 mM 
NaCl and 0.5 mM DTT. Fractions were measured spectrophotometrically at 280 nm and those 
showing a peak were examined by SDS-PAGE.   
 
3.3.4. Dialysis and concentration 
Fractions containing T7 RNAP were pooled and dialyzed against 250 ml of 20 mM sodium 
phosphate buffer pH 7.7, containing 100 mM NaCl, 1 mM EDTA, 10% glycerol, and 1 mM DTT 
added just before dialysis, using Visking® dialysis membranes of 16 mm and with a pore diameter 
of ~25 Å (Serva). Four dialysis of 2 hours each were carried out, including one maintained overnight. 
The volume (7 ml) was then reduced by centrifugation at 1100 g and 4°C twice during 15 min and 
once more during 5 min, using Centriprep® 30K filter concentrators. The protein concentration in 
the final preparation was determined by using the T7 RNAP molar extinction coefficient at 280 nm 
(ε280 = 1.4 × 105 M-1 cm-1) (King et al., 1986), as well as according to the method of Bradford 
(Bradford, 1976). The concentrated T7 RNAP aliquots obtained were stored at −20 ºC. 
 
3.4. M13mp2 forward mutation assays  
3.4.1. Determination of DNA-dependent DNA synthesis fidelity of RTs 
3.4.1.1. Preparation of “gapped DNA” 
Twelve ml of 2xYT medium (containing 16 g bactotriptone, 10 g yeast extract and 10 g NaCl, 
per liter) were inoculated with a fresh colony of E. coli NR9099 strain (Table 3), previously grown 
on M9 minimal plates. The culture was maintained at 37 °C under constant stirring for about 4 hours 
until the optical density at 600 nm reached a value of 0.6. Then, this initial culture was added to a 
1-liter of fresh medium and maintained for another two hours. After inoculating an isolated plaque 
of the WT M13mp2 phage, the culture was grown overnight at 37 °C under constant agitation. 
Afterwards, the sample was centrifuged at 4000 rpm during 30 min at 4 °C using a rotor JLA-
10.500 and an Avanti J-26 XP centrifuge (Beckman Coulter). Subsequently, the supernatant was 
separated from the pellet. The supernatant contains the cell-free M13mp2 filamentous phage, whose 
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genome consists of a circular positive-polarity ssDNA, while the pellet contains the replicative form 
(RF) of the phage as dsDNA within the bacteria. Thus, the supernatant was used for the purification 
of the M13mp2 ssDNA, while the dsDNA was extracted from the bacterial pellet (described below). 
An illustrative representation of the whole assay is shown in Figure 12.  
 
Figure 12. Measurement of DNA-dependent DNA synthesis fidelity based on M13mp2 forward 
mutation assays. (A) Gapped DNA formation. Gapped DNA was obtained by hybridizing the M13mp2 
ssDNA with a 6789-bp dsDNA fragment. This fragment lacking the lacZα sequence was obtained by 
polyethylene glycol purification after digestion of the M13mp2 dsDNA (or replicative form) with PvuII. (B) 
Gapped DNA serves as substrate for DNA-dependent DNA synthesis reactions mediated by RTs. The product 
of the “gapped filling” reaction was used to transform Escherichia coli MC1061 competent cells. The 
transformed cells were plated onto M9 medium-containing plates with X-Gal and IPTG with E. coli CSH50 
cells. Errors made by RTs while copying DNA templates result in a decrease in α-complementation and could 
be detected by the altered color phenotype (light blue or colorless) of the mutant plaques. After mutant 
selection and DNA purification, the error specificity was determined by sequencing.  
 
3.4.1.1.1. Purification of phage M13mp2 ssDNA 
The supernatant isolated in the previous step was centrifuged once more under the same 
conditions in order to ensure that bacteria were completely eliminated. Then, supernatant was 
divided into four 250 ml aliquots and each one was subjected to the following steps. Fifty ml of 15% 
polyethylene glycol (PEG) 8000 and 2.5 M NaCl were added. The mixture (300 ml) was inverted 
several times, maintained on ice during 10 min, and centrifuged at 4000 rpm for 30 min at 4 °C 
using a rotor JLA 10.500. The pellet containing the precipitated phage was resuspended in a mixture 
made of 2 ml of 1 M Tris-HCl buffer pH 8.0, 2 ml of 0.5 M EDTA and 14 ml of distilled water, and 
kept on ice for 30 min. Again, the sample was centrifuged at 2500 rpm for 15 min at 4 °C using a 
rotor JA-25.50 to eliminate residual PEG. This rotor was used in subsequent ultracentrifugations. 
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Afterwards, 100 µl of proteinase K (10 mg/ml) (New England Biolabs) were added to the 
supernatant in order to degrade the ~2700 copies of major coat protein (pVIII) that cover each 
genome particle (Stopar et al., 2003; Houbiers and Hemminga, 2004; Kehoe and Kay, 2005). The 
mixture was stirred and incubated at 37 °C for 30 min under constant agitation. Solutions were 
pooled two by two, and four ml of a cationic detergent [5% -(w/v)- cetyltrimethylammonium 
bromide and 0.5 M NaCl] were added to each tube containing two mixtures. After incubating 10 
min at room temperature, the samples were centrifuged at 12000 g for 30 min at 4 °C. The pellets 
were resuspended in 6 ml of 1.2 M NaCl, and 5 ml of 100% isopropanol were added, maintaining 
the mixture overnight at −20°C. Then, the samples were centrifuged at 12000 g for 30 min at 4 °C 
and the ssDNA-containing pellets were precipitated with ethanol. After resuspension in 500 µl of 
distilled water, the ssDNA was checked in 1% agarose gels and kept at −20°C.  
 
3.4.1.1.2. Purification of phage M13mp2 dsDNA and digestion 
The M13mp2 dsDNA was purified from the pellet (obtained as described in section 3.4.1.1), 
using the commercial kit “Pure YieldTM Plasmid Maxiprep System” (Promega) following the 
manufacturer’s instructions. Then, 100 µg of dsDNA were digested with the restriction enzyme 
PvuII (New England Biolabs) in 100-200 µl of 10 mM Tris-HCl buffer pH 7.9, containing 50 mM 
NaCl, 10 mM MgCl2 and 1 mM DTT, at 37 °C during 2 hours. One unit of PvuII per 1.5 µg of 
dsDNA was used. The RF contains three restriction sites for PvuII, providing four fragments of 
dsDNA of 6789, 268, 93 and 46 base pairs (bp) (Figure 12). After precipitation with ethanol, the 
digestion was analyzed in a 1% agarose gel.  
The digested DNA sample was then adjusted to 6% PEG 8000 and 0.55 M NaCl, leaving the 
DNA at a concentration ranging from 0.5 to 0.05 µg/µl. The mixture was incubated overnight at 4 
°C and later centrifuged at 14000 rpm for 20 min at 4 °C in a microcentrifuge (Mikro200, Hettich). 
6% PEG promotes the precipitation of fragments of more than 1650 bases (Lis, 1980), thereby 
allowing to pellet in the centrifugation exclusively the fragment of 6789 bp. The pellet was then 
resuspended in 20 μl of 0.2 M NaCl and later precipitated by ethanol, in order to remove residual 
PEG. After resuspension, the 6789-bp dsDNA fragment was checked in a 0.8% agarose gel.  
 
3.4.1.1.3. Hybridization of ssDNA and the 6789-bp dsDNA fragment 
Five µg of the 6789-bp dsDNA fragment were diluted in 50 μl (0.1 µg/µl) in order to reduce 
the ionic strength and facilitate the separation of the strands. After an incubation of 5 min at 70 °C, 
the ssDNA was added in a 1:1 proportion (taking into account the ssDNA co-purified with the 
dsDNA sample) and was maintained at 70 °C for 2 min. Then, the mixture was kept on ice for 5 min 
Alba Sebastián Martín 
 
 
48 
and saline-sodium citrate (SSC) 20X buffer (3 M NaCl and 300 mM sodium citrate adjusted to pH 
7.0) was added until a final concentration of 2X. Then, the sample was heated 5 min at 60 °C and 
kept on ice 10 min. The formation of the gapped DNA was analyzed in a 0.8% agarose gel (of 
dimensions 15 cm x 25 cm, or 250 ml) at 90 V during 3.5 h. Fractions containing properly annealed 
gapped DNA were pooled and precipitated with ethanol. After resuspension in water, the 
concentration of the product was measured in a NanoDrop ND-1000 (Thermo Scientific) apparatus 
and the proportion between gapped DNA and dsDNA was estimated in agarose (0.8%) gel 
electrophoresis to determined the genuine concentration of gapped DNA.  
 
3.4.1.2. Gap-filling synthesis reaction  
“Gap-filling” synthesis reactions were carried out at 37 ºC during 60 min, in 25 µl of 25 mM 
Tris-HCl buffer pH 8.0, containing 100 mM KCl, 2 mM DTT, 4 mM MgCl2, 250 µM of each dNTP 
and 100 nM RT. Each reaction contained 100-150 ng of gapped DNA, which was preincubated at 
55 ºC during 5 min to reduce secondary structure in the ssDNA and avoid undesirable hybridizations. 
Nine or ten gap filling reactions were performed for each tested RT (that from WT HIV-1ROD, and 
mutant RTs K65RROD and K65R/Q151M/M184VROD). The reactions were stopped by the addition 
of EDTA at a final concentration of 6 mM. In order to check if the synthesis had been completed, 
the obtained products were analysed on a 0.8% agarose gel (of dimensions 15 cm x 25 cm, or 250 
ml) at 65 V during 16-18 h. At least 22 μl of sample should be applied to assure a proper 
visualization. Gapped DNA was used as a control, in order to compare its electrophoretic mobility 
with that of the “gap-filling” product (difference of 407 nucleotides). Samples clearly filled were 
pooled together.  
 
3.4.1.3. Preparation of competent cells 
A fresh colony of E. coli MC1061 cells was inoculated in 10 ml of 2xYT medium and was 
grown at 37°C overnight under constant agitation. This initial culture was added to 500 ml of 2xYT, 
and one hour later, 2xYT medium was added to complete a total volume of 1 L. The culture was 
grown under the same conditions until the absorbance at 600 nm achieved a value between 0.5 and 
0.8. The volume was then kept on ice during 30 min and centrifuged at 4000 g and 4 °C for 30 min 
using a rotor JLA-10.500. The pellet was washed in one liter of sterile cold water and centrifuged at 
2200 g and 4 °C for 20 min. The process was repeated with 500 ml of sterile cold water. Then, the 
pellet was resuspended in 20 ml of 10% cold glycerol and the last centrifugation was carried out at 
3000 g and 4 °C for 15 min using a rotor JA 25.50. After resuspending the bacteria in 3 ml of 10% 
glycerol, 50 µl aliquots were prepared, and immediately frozen by using dry ice and ethanol. 
Competent bacteria were stored at −80 °C. 
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3.4.1.4. Electroporation and plating 
The product of the gap filling reaction (1 µl), obtained as described in section 3.4.1.2, was 
inoculated in 50 µl of MC1061 competent cells. This bacterial strain is preferred because it shows a 
very high electroporation efficiency (Bebenek and Kunkel, 1995). After keeping the sample on ice 
for 3 min, the mixture was transferred to an electroporation cuvette (0.2 cm, BioRad) and 
electroporated at 200 Ω resistance, 25 µF capacitance and 2.5 kV voltage using a “Gene Pulser” 
(BioRad). Immediately afterwards, 500 µl of SOC medium (20 g/l bactotriptone, 5 g/l yeast extract, 
0.5 g/l NaCl, 2.5 mM KCl, 20 mM MgCl2, 20 mM MgSO4, and 20 mM glucose) were added. 
Comparing the resulting time constant with that of bacteria without DNA (around 5 ms), the amount 
of sample to use in the plating can be estimated.  
The mixture of plating contains 2.5 ml of “soft-agar” (0.9% NaCl and 0.8% agar) preheated at 
49 °C, 50 μl of 5% (w/v) cold X-Gal, 25 μl of 0.1 M IPTG, 500 μl of a logarithmic culture of bacteria 
E. coli CSH50, and 25-75 μl of the electroporated sample (the exact amount is determined in initial 
trials). The whole mix is stirred and poured on M9 minimal plates. After solidifying, plates are 
incubated upside down overnight at 37 °C. During that time, M13mp2 phages are produced in 
MC1061 bacteria and infect the CSH50 lawn cells, which can grow in the minimum medium plates. 
Alpha-complementation takes place in CSH50 bacteria, between the α fragment of the β-
galactosidase enzyme carried by phages and their Ω fragment.   
 
3.4.1.5. Selection and analysis of mutant plaques  
The infection produces well-defined lysis plaques, including WT and different types of mutants. 
WT plaques were arbitrarily assigned a color value of 4+ (dark blue), while mutant plaques vary 
from almost WT (3+) to colorless (0+), going through medium blue (2+) and light blue (1+) (Figure 
13) (Bebenek and Kunkel, 1995). This color gradation in plaque phenotype is a consequence of the 
errors introduced by the RT while synthesizing the DNA during the “gap-filling” reaction. Thus, 
these errors provoke a partial or complete loss of β-galactosidase activity after the α-
complementation. It is essential to carefully examine the plates 24 h following plating, since the 3+ 
phenotype is more easily distinguished at this time; but also several days later when plaques have 
acquired more intensity. Mutants were collected and stored at 4 °C in 1 ml of 0.9% NaCl. After 
selecting mutants, every single plaque is counted because mutant frequencies were calculated as the 
ratio of mutant plaques to the total number of plaques screened. In case of doubt, the possible mutant 
plaque is plated together with a WT by using only 1 μl of a dilution 1/500 of this mix. Then, if all 
lysis plaques obtained in this verification plating have the same color (Figure 13E), the plaque was 
in fact a WT, whereas if two different colors can be clearly observed (Figure 13A-D), the lysis 
plaque under study was confirmed as a mutant.   
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Figure 13. WT and mutant lysis plaques obtained in M13mp2-based forward mutation assays. (A-D) 
Mutant plaques together with a WT, whose phenotypes vary within a shade of blue tonalities, with an 
arbitrarily assigned color value of 0+ (A, colorless), 1+ (B, light blue), 2+ (C, blue), 3+ (D, dark blue, almost 
WT). (E) WT lysis plaque. (F) Prototypic plating obtained in an assay.   
 
In order to purify the phage dsDNA, 100 μl of phage-containing NaCl in 2xYT medium were 
grown in agitation overnight at 37 °C and DNA was extracted from bacterial pellet by using the 
commercial kit “Wizard® Plus SV Minipreps DNA purification System” (Promega). As a 
verification procedure, 200 ng of mutant DNA were digested with 1.5 units of MscI and 10 units of 
BamHI (New England Biolabs), and only those mutants fitting the correct pattern of bands were sent 
for sequence analysis. M13mp2 DNA has one restriction site per each enzyme, resulting in two 
fragments of 2860 and 4336 bp. The digestion was carried out in 10 μl of 20 mM Tris-acetate buffer 
pH 7.9, containing 50 mM potassium acetate, 10 mM magnesium acetate, 1 mM DTT and 0.1 mg/ml 
BSA. The product was analyzed in a 1% agarose gel. Then, mutant phenotypes were confirmed by 
nucleotide sequencing of the phage dsDNA using primer 5′-GCTTGCTGCAACTCTCTCAG-3′ 
(Macrogen Inc.).  
Specific error rates were calculated as described by Bebenek and Kunkel (1995). Briefly, the 
number of a particular class of errors is divided by the total number of plaques observed in the assay, 
by the number of sites at which the error under consideration can be detected and by 0.6 (the 
probability that a polymerase error in the newly synthesized minus strand will be expressed in E. 
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coli). Errors were detected at 125 template positions for base substitutions and 148 for frameshifts 
(79 at runs, and 69 at non-runs). Overall error rates were determined by considering 237 template 
positions were any phenotypic change could be detected (Figure 14). It should be noted that silent 
mutations and mutations that do not affect the β-galactosidase activity may not be detected in these 
assays. It has been estimated that this limitation results in a 2- to 3-fold underestimation of the actual 
mutation rates (Abram et al., 2010).  
 
Figure 14. Base substitutions causing a phenotypically detectable change in lacZα target. Single-
nucleotide substitutions are indicated by the letter corresponding to the new base (in blue) above the wild-type 
template sequence of the lacZα target (Bebenek and Kunkel, 1995).    
 
3.4.2. Determination of RNA-dependent DNA synthesis fidelity of RTs 
3.4.2.1. Purification of RNA template 
A modified M13mp2 phage was used for the study of RT’s fidelity on RNA templates (the assay 
is depicted in Figure 15). In that phage, the promoter of the bacteriophage T7 RNAP was placed 
upstream the lacZα gene, between bases −112 and −113 (Boyer et al., 1992). The replicative form 
containing the T7 RNAP promoter (RF/T7) was obtained as described in sections 3.4.1.1 and 
3.4.1.1.2 for the RF. Around 40 μg of RF/T7 were digested with 1 unit of FspI per μg of DNA, in 
50 μl of 20 mM Tris-acetate buffer pH 7.9, containing 50 mM potassium acetate, 10 mM magnesium 
acetate and 1 mM DTT. The reaction was incubated at 37 °C during 2 h, followed by a standard 
extraction with phenol:chloroform:isoamyl alcohol (25:24:1, by volume) to eliminate the enzyme, 
and a precipitation with ethanol to remove salts. The linearized DNA was resuspended in 20 μl of 
RNase-free water. The simple restriction site for FspI is found at position +195 of the lacZα gene.  
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Five or six µg of linearized RF/T7 were used as template for transcription by T7 RNAP. 
Reactions were carried out in a total volume of 50 µl. Two different transcription conditions were 
used: (i) 40 mM Tris-HCl buffer (pH 7.9), containing 6 mM MgCl2 and 0.5 mM of each NTP 
(optimal conditions); and (ii) 40 mM Bis-Tris or PIPES buffer (pH 6.75), containing 1.5 mM MgCl2 
and 0.2 mM of each NTP. In both cases, reactions also contained 10 mM NaCl, 10 mM DTT, 2 mM 
spermidine and 50-60 units of RNasin® Plus RNase inhibitor (Promega). For these experiments, 40 
units of T7 RNAP (Promega) or 150 nM of recombinant T7 RNAP were used. Samples were 
incubated at 37 °C for 2 hours to obtain a 313-nucleotide RNA product (corresponding to positions 
-118/+195 in the lacZ gene). The dsDNA RF/T7 template was then digested with 5-6 units of RQ1 
RNase-free DNase (Promega) at 37 °C during 15 min, and the RNA product was purified by 
extraction with phenol:chloroform:isoamyl alcohol (25:24:1, by volume), followed by ethanol 
precipitation in the presence of sodium acetate. The size and integrity of the RNA was tested in a 
1% agarose gel, in comparison with RNA markers of 0.1-1.0 kb (Perfect RNA Novagen).  
 
3.4.2.2. Synthesis of complementary DNA 
The purified RNA was used as template in reverse transcription reactions carried out with WT 
AMV, MLV, HIV-1BH10 and HIV-1ESP49 RTs, and mutant RTs K65RESP49 and K65R/V75IESP49. The 
cDNA synthesis reactions were carried out at 37 °C for 2 hours in 50 μl of 25 mM Tris-HCl buffer 
pH 8.0, containing 100 mM KCl, 2 mM DTT, 4 mM MgCl2, 40 units of RNasin® Plus RNase 
inhibitor (Promega), 250 μM of each dNTP and 100 nM RT (active site concentration). Each reaction 
contained 2 pmol of RNA, previously heated to 65-70 °C for 5 min, and primed with a two-fold 
molar excess of the Rtr174/18 oligonucleotide (5’-CTGTTGGGAAGGGCGATC-3’). Six to ten 
reverse transcription reactions were performed for each enzyme. The reactions were stopped by 
adding EDTA at a final concentration of 15 mM, and incubated at 80 °C for 5 min to denature the 
hybrid cDNA-RNA.  
The RNA template used in reverse transcription was digested at 37 °C for 1 hour, after adding 
1 µl of RNase CocktailTM containing RNase A and RNase T1 (Ambion). Two tubes of the obtained 
cDNA products were pooled together. Subsequently, the sample was purified by phenol extraction, 
precipitated with ethanol and resuspended in 10 μl. Simultaneously, another cDNA synthesis 
reaction was performed with 1 μCi of α[32P]dCTP (Perkin Elmer) only as a control of the 
concentration and size of the product (309 bases). The labeled cDNA was applied on a 12% 
polyacrylamide gel with 8 M urea and subjected to electrophoresis at 70W 3000V 50-100 mA for 
about 4 hours. Then, the gel was revealed through exposition to phosphoroimaging plates (Fujifilm 
BAS-MP 2040S) and scanned with a BAS 1500 (Fujifilm).  
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3.4.2.3. Phosphorylation and hybridization of cDNA with “gapped DNA”  
Ten μl of cDNA were phosphorylated with 5 units of the bacteriophage T4 polynucleotide 
kinase (PNK) (New England Biolabs) and 1 mM of ATP in 12.7 μl of 70 mM Tris-HCl buffer pH 
7.6, containing 10 mM MgCl2 and 5 mM DTT. After 1-h incubation at 37 °C, the reaction was heat-
inactivated at 65 °C for 5 min. The cDNA was then hybridized with 8 μl of 2 nM gapped DNA, 
previously heated during 5 min at 55 °C. Two μl of SSC 20X were added to facilitate the process. 
The cDNA was in excess over gapped DNA and the mixture was heated to 70-75 °C for 5 min and 
slowly cooled at room temperature. Three μl of each hybridized product where separated and the 
rest was analyzed by electrophoresis in 0.8% agarose gels, as indicated in section 3.4.1.2. 
 
3.4.2.4. Plating, selection and analysis of mutant plaques  
Preparation of competent bacteria, plating, selection and analysis of mutant plaques, as well as 
calculation of mutant frequencies proceeded as for DNA-dependent assays (see sections 3.4.1.3., 
3.4.1.4., and 3.4.1.5.). Specific error rates were calculated as previously described, but taking into 
account that the primer used for reverse transcription hybridized at positions +174 to +191 of the 
lacZα nucleotide sequence. Then, errors were detected at 123 template positions for base 
substitutions and 178 for frameshifts (38 at runs, and 140 at non-runs). Despite the different target 
size for base substitutions and frameshifts, we determined overall error rates to facilitate the 
comparison of different retroviral RTs by considering 200 template positions where any phenotypic 
change could be detected (see Figure 14, except positions +174 to +191). Statistical analysis about 
the differences in the proportion of mutations at specific sites in the spectra of different RTs was 
determined by using a two-tailed Fisher’s exact test, using the GraphPad software. 
 
3.5. Promoter-dependent transcription assays 
The plasmid pTRI-β-actin-Mouse (included in the Ambion MAXIscript® T7 Transcription Kit) 
was used by T7 RNAP as the promoter-dependent template in transcription assays. These assays 
were used to assess nucleotide misincorporation efficiencies in the absence of one NTP or with 
unbalanced mixtures of NTPs, under different transcription conditions. First, the plasmid was 
digested for 90 min at 37 ºC with EcoRI (New England Biolabs) in 50 µl of 100 mM Tris-HCl buffer 
pH 7.5, containing 50 mM NaCl, 10 mM MgCl2, 0.025% Triton X-100 and 3 units of the enzyme 
per µg of plasmid. The resulting linearized plasmid was analyzed in 1% agarose gels and purified 
with the NucleoSpin® Gel and PCR Clean-up Kit (Macherey-Nagel) according to the 
manufacturer’s instructions. 
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Transcription assays were carried out at 37 ºC for 0-30 min in different buffers depending on 
the desired pH (i.e. MES, PIPES, Bis-Tris and Tris-HCl).  Reactions were done in 20 µl of 40 mM 
buffer (pH 5.5-7.5), containing 10 mM NaCl, 0.5-6 mM MgCl2, 2 mM spermidine, 10 mM 
dithiothreitol (DTT), 5 units of RNasin® Plus RNase inhibitor (Promega), 15 units of T7 RNAP 
(Ambion) and 0.5 µg of the linearized pTRI-β-actin-Mouse plasmid. Reactions were initiated by the 
addition of different combinations of NTPs at 100 µM each [e.g., * (ATP, GTP, CTP, UTP); −A 
(GTP, CTP, UTP); −G (ATP, CTP, UTP); and −U (ATP, GTP, CTP)], as well as with unbalanced 
mixtures of the four NTPs, including one that is added in a low concentration [e.g., −A↑ (GTP, CTP 
and UTP at 100 µM each, plus 1 µM ATP); or −G↑↑ (ATP, CTP and UTP at 100 µM each, plus 20 
µM GTP)], always in presence of 0.2 µCi of [α-32P]CTP (Perkin Elmer). Reactions were quenched 
at appropriate times by adding the stop solution [10 mM EDTA in 90% formamide, containing 3 
mg/ml xylene cyanol FF and 3 mg/ml bromophenol blue]. The RNA products were resolved on 
denaturing polyacrylamide gel electrophoresis (20% polyacrylamide and 8 M urea). Then, gels were 
exposed to a phosphor screen and scanned with a BAS1500 PhosphorImager instrument (Fuji).  
 
3.6. Promoter-independent single-nucleotide transcription assays 
The transcription (DNA-dependent RNA synthesis) fidelity of T7 RNAP was studied by single-
nucleotide incorporation assays with correct and incorrect nucleotides at pH 7.9 in the presence of 
6 mM MgCl2, and at pH 6.75 in the presence of 1.5 mM MgCl2. Due to the many constrains in 
studying transcription elongation starting from the promoter sequence, we chose to use a promoter-
free elongation substrate that allows to bypass the nonprocessive stages of initiation and study the 
fidelity of RNA synthesis only in the elongation phase. Promoter-free elongation substrates have 
already been used to dissect the kinetic pathway of T7 RNAP (Anand and Patel, 2006; Tang et al., 
2011). Thus, assays were carried out with the VSR10 template-primer (Anand and Patel, 2006), a 
hybrid containing double-stranded DNA and a short RNA oligonucleotide, lacking the T7 RNAP 
promoter (Table 7).  
  Table 7. Primers used in promoter-independent transcription assays with T7 RNAP 
Oligonucleotides Sequence  
Primer RNA 5′-GGGGGCUGGC-3′ 
Non-template DNA 5′-GACTACAGACAGGACCCACATAGGATC-3′ 
Template DNA 5′-CCCGACCGAGCTGATGTCTGTCCTGGGTGTATCCTAG-3′ 
 
Template DNA, non-template DNA and primer RNA were mixed at a 1:1.5:1 ratio, heated at 
95 °C for 20 min, and then progressively cooled at 75, 55, 45, 20 and 4 °C for 20 min each. The 10-
nt primer RNA (3 pmol) was previously labeled at its 5’ end with 10 μCi of [γ-32P]ATP (Perkin 
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Elmer) and 5 units of T4 PNK (New England Biolabs) in 20 μl of 70 mM Tris-HCl buffer pH 7.6, 
containing 10 mM MgCl2 and 5 mM DTT. The labeling was performed at 37 °C during 45 min, and 
the PNK was heat-inactivated by incubating the reaction at 90 °C for 10 min. Before annealing, 
labeled RNA primer was diluted until 100 μl to purify it with a Micro bio-SpinTM column (BioRad) 
loaded with Sephadex G-25 (GE Healthcare) in order to eliminate the excess of labeled ATP that 
could interfere with the transcription reaction.  
The sample was centrifuged 4 min at 4000 rpm. In order to determine the concentration of the 
RNA after its purification and to ensure the correct incorporation of the radioactive phosphorous, 
the samples before and after using the Micro bio-SpinTM columns were chromatographed in PEI-
cellulose plates (TLC, 20x20 cm, Merck) using 0.5 M disodium phosphate as mobile phase. The 
PEI-cellulose sheets were exposed to phosphoroimaging plates (Fujifilm BAS-MP 2040S) and the 
intensity of both RNA samples was determined with a BAS 1500 scanner (Fujifilm), and using the 
software TINA 2.09 (Raytest Isotopenmessgerate GmbH, Staubenhardt, Germany). This method 
was used to estimate the final RNA concentration.  
Kinetic parameters for UTP and CTP incorporation were determined at 37 °C using a rapid 
quench-flow instrument (model QFM-400, Bio-Logic Science Instruments), upgraded with a mixer 
cross and a special mixer (Bio-Logic). Assays were carried out in 24 µl of 40 mM Tris-HCl buffer 
pH 7.9, containing 6 mM MgCl2 (or Bis-Tris buffer pH 6.75 with 1.5 mM MgCl2), 10 mM NaCl, 2 
mM spermidine and 10 mM DTT, in the presence of increasing concentrations of NTP. All 
magnesium was loaded in the syringe of the instrument corresponding to the mixture of T7 RNAP 
and VSR10, facilitating its positioning in the active site before starting the reaction. Due to the short 
time reactions (ms), this strategy allowed to avoid dramatic reductions in the catalytic constants, 
especially when low magnesium concentration was used (1.5 mM). The concentration of VSR10 
was 240 nM and the recombinant T7 RNAP was added to a final concentration of 1 µM. Excess of 
enzyme ensured single turnover kinetic conditions for elongation rate measurements. Reactions 
were stopped with EDTA (0.3 M final concentration).  
Pre-steady-state kinetic data were fit to a burst equation: [P] = A × [1-exp(-kobs × t)] + kss × t, 
where [P] is the product concentration, A is the amplitude of the burst, kobs is the apparent kinetic 
constant of formation of the phosphodiester bond and kss is the kinetic constant of the steady-state 
linear phase. The dependence of kobs on the NTP concentration is described by the Michaelis-Menten 
equation: kobs = kpol × [dNTP]/(Kd + [dNTP]), where Kd is the equilibrium constant and kpol is the 
catalytic rate constant of the nucleotide incorporation reaction. Kinetic parameters were determined 
using curve-fitting tools provided by the SigmaPlot software (Systat Software Inc.).  
The incorporation of non-complementary nucleotides GTP and ATP was performed manually 
with template-primer VSR10 (240 nM). Reactions were carried out in 20 µl of 40 mM Tris-HCl 
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buffer pH 7.9 (or Bis-Tris buffer pH 6.75), containing 6 mM MgCl2 (or 1.5 mM MgCl2), 10 mM 
NaCl, 10 mM DTT, 2 mM spermidine and 24 units of RNasin® Plus RNase inhibitor. The T7 RNAP 
was supplied at 1 µM. Samples were preincubated at 37 °C for 10 min, and the reaction was then 
initiated by adding increasing concentrations of NTP. Reactions were stopped at different times (0-
30 s) by mixing an aliquot of 4 µl with an equal volume of stop solution. Samples were incubated at 
90 °C for 10 min before loading in polyacrylamide-urea gels. Results were analyzed by 
phosphorimaging and nucleotide incorporation data were fitted to the Michaelis-Menten equation, 
as described above.  
 
3.7. Binding affinity of T7 RNAP for template-primer VSR10 
The equilibrium dissociation constant (Kd) for T7 RNAP binding to the template-primer VSR10 
was determined after pre-incubating the enzyme with increasing concentrations of the 5’-32P-labeled 
VSR10 (60 nM-2.3 µM) at 37 °C for 10 min. Then, the incorporation reaction was initiated by 
adding UTP to a final concentration of 5 µM. Reactions were carried out in 20 µl of 40 mM Tris-
HCl buffer pH 7.9 containing 6 mM MgCl2 (or Bis-Tris buffer pH 6.75 containing 1.5 mM MgCl2), 
and 10 mM NaCl, 10 mM DTT, 2 mM spermidine and 24 units of RNasin® Plus RNase inhibitor. 
The T7 RNAP was supplied at 0.75-1 µM in reactions carried out at pH 7.9 with 6 mM MgCl2. At 
pH 6.75 and 1.5 mM MgCl2, the T7 RNAP concentration was 120-250 nM. Aliquots of 4 µl were 
taken at 10, 20, 30 and 40 s, quenched with stop solution and analyzed by denaturing polyacrylamide 
gel electrophoresis and phosphorimaging, as described above. The burst amplitudes (RT bound to 
template-primer at time zero) were plotted as a function of the template-primer concentration, and 
the data were fitted to the following quadratic equation:   
[E • T/P] = 0.5 × [(𝐾𝑑 + ET + T/P) − √(𝐾𝑑 + ET + T/P)2 − 4 × ET × T/P ] 
Where ET and T/P are the total active enzyme and template-primer concentration used in the 
assay, respectively, and Kd is the equilibrium dissociation constant for T7 RNAP binding to the 
template-primer. 
 
3.8. Deep sequencing assays 
3.8.1. Reverse transcription 
RNA-dependent DNA synthesis accuracy of RTs was determined following the approach of 
Primer IDs (described in Jabara et al., 2011; Zhou et al., 2015). Reverse transcription reactions were 
carried out in 20 μl of 50 mM Tris-HCl buffer pH 8.3, containing 75 mM KCl, 3 mM MgCl2, 100 
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mM DTT, 1 unit of RNasin® Plus RNase inhibitor (Promega), 500 μM of each dNTP, and 150 nM 
RT. HIV-1BH10 and K65R/V75IESP49 RTs were used in these experiments. Each reaction contained 
200,000 RNA template molecules, corresponding to the HIV-1 (LAV) RNA genome. This RNA 
was purified from supernatants of 8E5 cells (NIH AIDS Reagent Program, Division of AIDS, 
catalogue number 95) (Folks et al., 1986), which contain a single integrated copy of proviral DNA 
and lacks unintegrated DNA. These cells do not produce RT.  
The RNA sample was kindly provided by Drs. Rafael Delgado Vázquez and Mónica García 
Álvarez (Hospital Doce de Octubre, Madrid, Spain). The primer used to initiate the synthesis of 
cDNA contained a nucleotide sequence complementary to the PR-coding region of the viral RNA 
genome (see primer PR-cDNA in Table 8). This primer also contained a degenerated twelve-
nucleotide sequence, yielding ~16.8×106 different barcoded combinations (i.e., 412). Primers were 
added to the reaction in excess (62.5 pM), compared to RNA templates. Thus, each cDNA molecule 
was tagged with an individual and unique barcoded primer.  
Table 8. Primers used in deep sequencing experiments to determine the RT’s RNA-dependent 
DNA synthesis fidelity. The HIV-1 (LAV) RNA genome was used as template. 
Primersa Sequence (5’-3’) ntb 
PR-cDNA GTGACTGGAGTTCAGACGTGTGCTCTTCNNNNNNNNNNNNCAGTTTAACT
TTTGGGCCATCCATTCC 
67 
R-PCR1 GTGACTGGAGTTCAGACGTGTGCTC 25 
F-PCR1 CTTCCTACAAGGGAAGGCCAGG 22 
R-PCR2 TACGGTAGCAGAGACTTGGTCTGTGACTGGAGTTCAGACGTGTGCTC 47 
F-PCR2 ACACTGACGACATGGTTCTACATATAAGAGACAGNNNNCAGGAGCCGAT
AGACAAGGAAC 
60 
R-PCR3 CAAGCAGAAGACGGCATACGAGAT-[BC]-TACGGTAGCAGAGACTTGGTC 
T 
56 
F-PCR3 AATGATACGGCGACCACCGAGATCTACACTGACGACATGGTTCTACA 47 
a F/R, forward/reverse. b nt, no. of nucleotides. Sequence in purple indicates the 5’ end of the cDNA.  The 
underlined sequences correspond with protease gene sequences. Nucleotide sequences in green and blue 
correspond to CS2 and CS1 sequences, respectively. Finally, red sequences relate to the Illumina sequencer 
adaptors.  
 
3.8.2. Amplification and sequencing  
The obtained cDNA samples were sent to Fundación Parque Científico de Madrid (FPCM), for 
further analysis. There, amplicons were generated after three successive PCRs (Figure 16), in order 
to incorporate indexes necessary for sequencing at the termini of the amplicon. Twelve μl of cDNA 
were amplified in a first PCR with the Q5® Hot Start High-Fidelity DNA Polymerase (New England 
Biolabs). The reaction was performed in a total volume of 25 μl of 1X Q5 reaction buffer (New 
England Biolabs), in the presence of 200 μM of each dNTP, and 500 nM of each primer (R-PCR1 
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and F-PCR1, see Table 8). Samples were heated 2 min at 95 °C, subjected to 30 cycles of 30 s at 95 
°C, 1 min at 55 °C and 1 min at 72 °C, and finally incubated for 10 min at 72 °C.  
 
Figure 16. Adaptation of the Primer ID approach to the MiSeq platform. MiSeq library contruction 
resulting from the reverse transcription of HIV-1 (LAV) RNA genome was used for sequencing. The synthesis 
of cDNA was initiated with degenerate primers (Primer IDs) containing twelve positions with random 
nucleotides, providing a barcode for each cDNA molecule synthesized. PR-cDNA primers represent the 
Primer IDs. First PCR synthesized the second strand of cDNA and amplified the available DNA. Following 
PCRs introduced indexes needed for the Illumina platform: CS1 (blue) and CS2 (green) during second PCR, 
and p5 and p7 sequences (red) in the third PCR.  
 
Subsequently, 1 μl of the first PCR product was used as input in the second PCR, which was 
equivalent to the previous one, except for the primers used in the reaction (R-PCR2 and F-PCR2, 
see Table 8). These primers contain the sequences CS1 and CS2, needed to introduce the sequencer 
indexes. Then, a third PCR was performed in a total volume of 20 μl of 1X Q5 reaction buffer (New 
England Biolabs), with the enzyme Q5® Hot Start High-Fidelity DNA Polymerase (New England 
Biolabs), and in the presence of 400 nM of primers (R-PCR3 and F-PCR3, from the Access Array 
Barcode Library for Illumina Sequencers –Fluidigm−, see Table 8). One μl of the second PCR 
product was used for the third amplification. This PCR was programmed to carry out the reaction 
for 30 s at 95 °C, then 14 cycles of 10 s at 98 °C, 20 s at 60 °C, and 20 s at 72 °C, and a final 
elongation phase of 2 min at 72 °C. This PCR provided the final amplicon containing the indexes 
required for the Illumina sequencer. 
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The obtained amplicons were validated and quantified by an Agilent 2100 Bioanalyzer using 
DNA7500 chips. Equimolecular pools of these amplicons were purified by using agarose gel 
electrophoresis in order to eliminate primers and dimers found in excess. The purified pools were 
titrated by quantitative PCR using the “Kapa-SYBR FAST qPCR kit for LightCycler®480”, and a 
reference standard for quantification. Finally, the pool of amplicons at a concentration of 10 pM was 
denatured prior to be seeded on a flowcell, where clusters were formed and sequenced using a 
“MiSeq Reagent Kit v3”, in a 2×300 pair-end sequencing run on a MiSeq sequencer.  
 
3.8.3. Analysis of sequences 
Raw reads were originally provided as FASTQ files, and were analyzed at the Genomics and 
NGS core facility of the Centro de Biología Molecular Severo Ochoa, which is part of the CEI 
UAM+CSIC (Madrid, Spain). After performing a quality analysis over reads using FastQC software 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/), paired reads were joined to obtain one 
single sequence. This process was performed with a fast and accurate paired-end read merger called 
PEAR, which evaluates all possible paired-end overlaps without requiring the target fragment size 
as input. PEAR also implements a statistical test for minimizing false-positive results.  
Then, a cutoff value for the minimum number of cDNA molecules required to generate a 
consensus was established, taking into account the number of maximum reads obtained for the most 
represented barcode in the sample. Thus, it would be possible to eliminate those consensus made of 
barcodes generated as a consequence of a mutation (offspring) in the most represented barcodes, 
also refers to as birthday problem. The cutoff value was calculated by using the following formula, 
generated by Zhou and colleagues (2015): 𝒄𝒗 = 𝑵𝟎 + 𝟏. 𝟗𝟔𝑺𝑵𝟎, where cv indicates the cutoff value; 
N0, the maximum frequency of offspring barcodes for a barcode with an abundance of N sequences; 
SNo, the standard deviation of N0. A cutoff value of around 76 was obtained (with N0≈69, and 
SNo≈3.5), by setting the maximum limit at N=10,000 sequences per barcode.  
Afterwards, consensus sequences were calculated by using an in-house Python (v2.7) script to 
resolve PCR and sequencing errors. Consensus were created by selecting at each position the base 
found with maximum frequency between all the cDNA molecules with the same barcode. Only 
consensus made from the alignment of a number of cDNA molecules comprised in the range 76-
10,000 were considered. Then, consensus were subjected to a multiple alignment using MAFFT 
software (https://mafft.cbrc.jp/alignment/software/), and later a BLAST analysis was performed for 
the consensus sequences against the LAV reference sequence, obtained from the NCBI database. 
Variants indicate errors made by eukaryotic RNAP II while synthesizing the RNA molecule used as 
template, together with those generated by the RT during reverse transcription.  
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3.8.4. Calculation of error rates  
Error rates for HIV-1BH10 and K65R/V75IESP49 RTs were calculated by dividing the number of 
mutations found for a specific type of error (e.g., base substitutions, frameshifts) by the number of 
consensus sequences analyzed and the number of positions where this type of error can be found. 
Base substitutions and frameshifts could be detected at 355 template positions, as well as the overall 
mutations. Frameshifts may occur at 83 homopolymeric sites and 272 heteropolymeric positions 
(Figure 17).    
 
Figure 17. HIV-1 (LAV) RNA sequence targeted in deep sequencing experiments. The primer used to 
initiate the cDNA synthesis hybridize at positions +356/+380 (sequence underlined in black). Base 
substitutions and frameshifts are detected at any position between +1 and +355. Sequences underlined in green 
correspond to heteropolymeric sites, whereas bases colored in red indicate the homopolymeric positions.    
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4.1. Determination of DNA-dependent DNA synthesis fidelity of WT 
HIV-2ROD RT in comparison with drug-resistant mutants K65RROD 
and K65R/Q151M/M184VROD RTs, and WT HIV-1BH10 RT  
Nucleoside RT inhibitors (NRTIs) constitute the backbone of current treatments against HIV-
1 and HIV-2. Mutational pathways leading to the development of nucleoside analogue resistance 
are different in both types of HIV. In HIV-2, NRTI-resistance is developed exclusively through the 
discrimination pathway (i.e., capacity of RT to distinguish between analogue and natural dNTPs), 
in contrast to HIV-1 that relies either on the exclusion or the excision pathway (Boyer et al., 2012). 
Resistance to all approved NRTIs is conferred in HIV-2 RT by the combination of amino acid 
substitutions K65R, Q151M and M184V (Smith et al., 2009). On the other hand, several amino acid 
changes in HIV-1 RT leading to drug resistance have been associated with increased fidelity (e.g., 
M184V) (reviewed in Menéndez-Arias, 2009).  
Based on these findings, we analyzed the DNA-dependent DNA synthesis fidelity of resistant 
RTs K65RROD and K65R/Q151M/M184VROD, in comparison with WT HIV-2ROD and HIV-1BH10 
RTs. In order to determine overall error rates and mutant frequencies for these four RTs, and to 
analyze rates of specific types of errors (base substitutions and frameshifts), M13mp2 forward 
mutation assays were carried out. M13-based assays using lacZα as a reporter gene provide a broad 
fidelity assessment, based on a relatively large number of mutational sites and sequence contexts, in 
contrast to single-nucleotide incorporation assays restricted to a reduced number of substrates, and 
sequence positions.  
By using this method, a dsDNA derived from phage M13mp2, and lacking the lacZα gene 
sequence in one of the two DNA chains (gapped DNA) was used as substrate. Mutations introduced 
when the RT copied the gapped region (corresponding to the lacZα gene) produced a partial or 
complete loss of activity in the β-galactosidase enzyme. After α-complementation on an appropriate 
indicator strain, these changes were detected by the altered color phenotype of mutant plaques, when 
phages were grown in the presence of IPTG and X-Gal. By using this method, silent mutations could 
not be detected. The method is outlined in Figure 12.  
Mutant frequencies were calculated as the ratio of mutant (pale blue or colorless) to total 
plaques.  In these assays we found that the WT RT of the HIV-1BH10 strain had lower accuracy than 
the WT HIV-2ROD RT, although differences were relatively small with mutant frequencies of 1.99% 
and 1.24%, respectively (Table 9). Mutations K65R and K65R/Q151M/M184V had almost no effect 
on the intrinsic accuracy of the HIV-2ROD RT, with mutant frequencies being only slightly lower in 
comparison with that of the WT enzyme.   
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Table 9. Accuracy of WT and mutant HIV RTs in M13mp2 lacZα forward mutation assays 
RTs Total plaques Mutant plaques Mutant frequencya 
WT HIV-2ROD 9,660 120 0.01242 
K65RROD  4,750 56 0.01179 (1.1) 
K65R/Q151M/M184VROD 5,142 53 0.01031 (1.2) 
WT HIV-1BH10 2,915 58 0.01990 (0.6) 
aBackground frequencies in these assays were estimated to be less than one in 20,000 plaques (Barrioluengo 
et al., 2011). Numbers between parentheses indicate the fold-increase in fidelity relative to the WT HIV-2 RT.  
 
The mutational specificity of the studied RTs was determined after sequencing the lacZα 
mutants generated in the forward mutation assays. Analysis of the obtained mutational spectra 
revealed a few general trends common to WT and mutant HIV-2 RTs (Figures 18-21). For example, 
more than one third of all errors introduced by HIV-2 RT variants (mutant and WT enzymes) were 
frameshifts, and in most cases consisted of deletions of one nucleotide.  
Two-nucleotide deletions were also present in the spectra of all HIV-2 RTs, representing the 
20% of all frameshifts in the case of the WT HIV-2 enzyme. Deletions occurred predominantly at 
heteropolymeric sequences in the spectra of both HIV-2 and HIV-1 RTs. However, HIV-1BH10 RT 
showed less than 15% of frameshifts in the whole spectrum. Base substitutions were frequently 
observed in all spectra, with transversions appearing at least three times more frequently than 
transitions in the analyzed lacZα sequence. A predominance of G-to-T substitutions was detected in 
all mutational spectra, although their frequency was smaller in the case of the 
K65R/Q151M/M184VROD RT. 
Despite the similarities among the spectra, there were also remarkable differences in the hotspot 
distribution between WT and mutant HIV-2 RTs (Table 10). In our analyses, a hotspot was defined 
as a position where at least four mutations were observed. The statistical differences in hotspots 
distribution shown by different RTs were determined by using a two-tailed Fisher’s exact test, and 
are given in Table 10. Interestingly, the mutational spectrum of the K65RROD RT showed one 
hotspot at position −49, characterized by the presence of one-nucleotide deletions, and another 
hotspot in which G-to-T transversions accumulate at position +102.  
On the other hand, mutations induced by the triple mutant of HIV-2ROD RT clustered at position 
+82, including various deletions and base substitutions (G-to-T transversions, and G-to-C 
transitions); and at position +123, where one-nucleotide deletions were detected. All mentioned 
hotspots were absent in the spectrum of WT HIV-2ROD RT (P < 0.01, for comparisons with K65RROD 
RT; and P < 0.03 for those with the triple mutant RT). It is remarkable that none of the frameshift 
hotspots described occurred at homopolymeric sequences (or at runs, i.e., those sequences were a 
base is repeated at least three times).   
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The analysis of error rates (Table 11) demonstrated that all HIV-2 RTs introduced frameshifts 
with a similar frequency, while differences in fidelity were observed when looking at base 
substitution error rates.  Thus, the frequency of this type of mutations was reduced by less than two-
fold in the case of classwide-resistant K65R/Q151M/M184VROD RT relative to the WT enzyme, 
while K65R alone produced a mere 1.5-fold increase in nucleotide substitution fidelity. 
The comparison of WT HIV-2ROD and HIV-1BH10 RTs demonstrated that both enzymes 
introduced similar types of errors (i.e., frequent one-nucleotide deletions, and more transversions 
than transitions). However, frameshifts were more abundant in the mutational spectrum of the HIV-
2ROD RT (compare spectra shown in Figures 18 and 21). In comparison with the WT HIV-1BH10 RT, 
the HIV-2 enzymes were less prone to introduce single nucleotide substitutions, but showed higher 
overall frameshift error rates due to their strong tendency to introduce deletions at heteropolymeric 
sequences. 
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4.2. Determination of RNA-dependent DNA synthesis fidelity of six 
retroviral RTs  
4.2.1. Analysis of mutant frequencies and error rates of WT MLV, AMV, HIV-1BH10 
and HIV-1ESP49 RTs, as well as mutant RTs K65RESP49 and K65R/V75IESP49 using RNA 
templates  
A modified version of M13mp2 lacZα forward mutation assays was used to determine mutant 
frequencies, and error rates of RNA-dependent DNA synthesis for WT MLV, AMV, HIV-1BH10 and 
HIV-1ESP49 RTs, as well as mutant RTs K65RESP49 and K65R/V75IESP49. For this purpose, a 
commercial T7 RNAP was used to synthesize a lacZα RNA template that was then reverse 
transcribed by retroviral RTs (the method is represented in Figure 15). The cDNA product was 
hybridized with a gapped dsDNA lacking the lacZα gene in one of the two DNA strands. Errors 
made by RTs during reverse transcription result in a decrease in α-complementation, and could be 
detected under appropriate conditions. Mutant frequencies obtained with the six studied RTs, and 
calculated as the ratio of mutant to total plaques, are given in Table 12. These assays showed less 
than two-fold differences in fidelity between the most accurate and the least faithful RTs.  
Table 12. RNA-dependent DNA synthesis fidelity of WT and mutant RTs in M13mp2 
lacZα forward mutation assays 
RTs Mutant plaquesa Total plaques Mutant frequencyb 
WT HIV-1BH10 52 12,836 0.00405  
WT HIV-1ESP49 46 13,347 0.00345 (1.18) 
K65RESP49 c 54 18,284 0.00295 (1.37) 
K65R/V75IESP49 69 23,512 0.00293 (1.38) 
WT MLV 36 13,569 0.00265 (1.53) 
WT AMV 28 11,250 0.00249 (1.63) 
a For each enzyme, mutant plaques were obtained after transfection of gapped DNA hybridized with the 
cDNA product of ten synthesis reactions. The RNA used as template in the reverse transcription reaction 
was synthesized by the T7 RNAP (Promega) in a transcription buffer containing 40 mM Tris-HCl pH 
7.9, and 6 mM MgCl2 (full composition given in Materials and Methods). b Background frequencies in 
these assays were estimated to be less than one in 20,000 plaques (Barrioluengo et al., 2011). Numbers 
between parentheses indicate the fold-increase in fidelity relative to the WT HIV-1BH10 RT. c Results 
obtained for mutant K65RESP49 and K65R/V75IESP49 RTs, as well as for WT MLV and AMV are based 
in part on data collected by Verónica Barrioluengo (Barrioluengo, 2013). 
 
The mutational specificity of the studied RTs was determined after sequencing the lacZα gene 
of the mutant plaques generated with the M13mp2-based mutation assays (Figures 22-27). All 
mutational spectra showed a hotspot of one-thymidine insertions at the homopolymeric sequence 
located at positions +137/+139. As in previous analysis, a hotspot was defined as a position 
containing at least four clustered mutations, and statistical differences in hotspot distribution 
between all RTs were determined by using a two-tailed Fisher’s exact test (Table 13).  
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It is important to highlight that differences in the number of insertions found in the hotspot at 
positions +137/+139 between the six RTs did not show statistical significance. In addition, U-to-C 
transitions at positions −36/−35 and U-to-A transversions at position +73 were observed in the 
spectra of five RTs.  On the other hand, we also found large deletions in all mutational spectra, 
except in the one generated with the AMV RT.  In the case of HIV-1BH10, HIV-1ESP49 and the 
K65RESP49 RTs, the large deletions clustered at positions +172/+173 (Figures 22-24), corresponding 
to the first two nucleotides incorporated during reverse transcription.  These deletions could derive 
from misalignment errors occurring while extending the DNA primer.   
Despite the similarities found among the mutational spectra, there were also remarkable 
differences. Thus, for example, AMV RT generated one-nucleotide insertions of adenine in the 
homopolymeric region located at positions +91/+94 (Figure 27), whereas MLV RT showed one 
hotspot at position +144, including various deletions, and transversions (A-to-C and A-to-T) (Figure 
26). Interestingly, the spectrum of the K65R/V75IESP49 RT showed an important hotspot at position 
+147 (U-to-C substitutions) (Figure 25). This hotspot is absent in the mutational spectra of the other 
analyzed RTs (P<0.005, for all five comparisons) (Table 13).  On the other hand, mutations induced 
by HIV-1ESP49 RT seemed to be scattered throughout the whole lacZα sequence (Figure 23). The 
spectrum induced by the single-mutant K65RESP49 had one hotspot at position +109 (Figure 24), 
while in the one obtained with HIV-1BH10 RT, G-to-T changes accumulated at position +149 (Figure 
22). 
Error rates for all RTs are summarized in Table 14. The highest error rates were obtained with 
WT HIV-1BH10 RT, while one of the most faithful enzymes was the double-mutant K65R/V75IESP49 
that showed 1.4-fold increased accuracy relative to the HIV-1BH10 RT. Mutant K65R/V75IESP49 RT 
had a low tendency to introduce frameshifts, although it had a relatively high base substitution error 
rate. This enzyme was prone to generate transitions (81%), which accumulated at two major hotspots 
(at positions −36 and +147), and three minor hotspots (located at nucleotides −35, −7 and +87). 
Unlike in the case of K65R/V75IESP49, this strong bias towards the generation of transitions was not 
observed with the other RTs studied.  On the other hand, compared with the other RTs, the HIV-
1BH10 polymerase was prone to introduce frameshift errors, which were predominantly one-
nucleotide deletions. 
By using the forward mutation assay we cannot determine whether the errors were made by the 
T7 RNAP during the synthesis of the RNA template (transcription) or by RTs during cDNA 
synthesis (reverse transcription). The overall error rates obtained with the RTs used in this study 
were in the range of 2.5×10−5 to 3.5×10−5.  These values are relatively close to reported estimates of 
transcription error rates obtained in different organisms (Imashimizu et al., 2013; Traverse and 
Ochman, 2016; Reid-Bayliss and Loeb, 2017; reviewed in Ninio, 1991; Magnuson et al., 2016) (see 
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Discussion), and suggest the existence of an inaccuracy threshold imposed by the T7 RNAP while 
synthesizing the RNA template.  
 
4.2.2. Analysis of bacteriophage T7 RNA polymerase transcription fidelity  
4.2.2.1. Fidelity of promoter-dependent transcription under different conditions  
In order to reduce the possible inaccuracy threshold imposed by T7 RNAP in M13mp2-based 
assays, we analyzed its fidelity under different reaction conditions. An EcoRI-linearized pTRI-β-
actin-Mouse plasmid containing a T7 promoter sequence was used as template (Figure 28). In vitro 
transcription by T7 RNAP (Ambion) was performed in the presence of [α-32P]CTP. The +1 base (G, 
in bold at the top of Figure 28) is the first base incorporated into RNA, as the polymerase transcribes 
using the opposite strand (3’→ 5’) as a template. Reactions were carried out at different pH and 
Mg2+ concentrations, either in the presence of all four NTPs or with biased NTP pools (i.e., lacking 
or with a very low concentration of one ribonucleotide) (Figure 28, A-D).  In this assay, when all 
NTPs were present, the polymerase synthesized an RNA of 53 nucleotides (lanes marked with an 
asterisk, in Figure 28).  When using biased pools, the amount of full-length RNA was reduced, since 
the insertion of incorrect nucleotides would be needed to complete the synthesis reaction. Thus, the 
full-length RNAs obtained with unbiased NTP pools reflected the inaccuracy of T7 RNAP.   
Comparison of relative amounts of full-length products in reactions carried out with biased 
NTP mixtures and in the presence of all NTPs provided a rough estimate of the accuracy of T7 
RNAP in different assay conditions. It should be noted that G is required to initiate transcription, 
and therefore T7 RNAP cannot synthesize RNA in the absence of this nucleotide (lanes 3 in Figure 
28). The same happened in the absence of A (lanes 1 in Figure 28), except for the reaction carried 
out in the presence of 6 mM MgCl2, that favoured the incorporation of incorrect nucleotides allowing 
the visualization of a slight full-length RNA.  It is important to indicate that [α-32P]CTP incorporates 
for the first time in the RNA at position +7. For that reason, reactions performed in the absence of 
G or A, that were required for initial transcription, did not show intermediate stops.  In the case of 
these two nucleotides, it was essential to perform additional reactions in which G or A were added 
in a low concentration.   
When ATP was supplied at 1 µM while maintaining the three other NTPs at 100 µM (lanes 2), 
a small but significant amount of full-length RNA was observed at higher magnesium 
concentrations, as well as above pH 7.0.  Similar findings were obtained in reactions with NTP 
mixtures having low concentrations of GTP (10-20 µM) (lanes 4 and 5 in Figure 28).  The amount 
of full-length products in biased reactions was greater at 6 mM MgCl2 and at pH 7.5, suggesting a 
lower accuracy in those conditions. Inefficient RNA synthesis was also observed in the absence of 
Results 
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Figure 28. Promoter-dependent transcription by T7 RNAP in different reaction conditions. Part of the 
nucleotide sequence of plasmid pTRI-β-actin-Mouse (included in the MAXIscript® T7 Transcription Kit 
(Ambion)) including the T7 RNAP promoter (in red) and the EcoRI restriction site are shown above. After 
digestion with EcoRI, the plasmid was used as template for in vitro transcription by T7 RNAP in the presence 
of [α-32P]CTP. The +1 base (G, in bold) is the first base incorporated into RNA during transcription. Then, 
the polymerase transcribes using the opposite strand (3’→5’) as a template. (A-D) Panels show transcriptions 
performed at different concentrations of Mg2+ (A and B) and at various pH (C and D). In control reactions 
(marked *), the four NTPs were supplied at 100 µM, except for reactions shown in panel A (6 mM Mg2+) 
where their concentrations were increased to 500 µM each. Reactions carried out in the absence of A, G and 
U are shown in lanes 1, 3 and 6, respectively.  Lanes 2, 4 and 5 show primer extensions carried out with 
limiting amounts of ATP and GTP (indicated in the tables below), and high concentrations of the three other 
NTPs. M stands for nucleic acid markers. 
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U (lanes 6 in Figure 28), although again more intense bands could be detected with 6 mM MgCl2, 
like in the absence of A. At pH 5.5-6.0 we did not detect any transcription products even in the 
presence of all NTPs, indicating that this range of pH is not optimal for T7 RNAP-mediated 
transcription. In addition, the efficiency of the reaction was very low in the presence of 0.5 mM 
MgCl2.  Taken together, our data indicate that T7 RNAP showed good activity, and improved 
accuracy at pH 6.5-7.0, and in the presence of Mg2+ at 1-3 mM.  
 
4.2.2.2. Nucleotide incorporation kinetics under different conditions  
RNA templates used in forward mutation assays were synthesized under optimal conditions for 
transcription by T7 RNAP (Tunitskaya and Kochetkov, 2002). These reactions were carried out in 
40 mM Tris-HCl buffer pH 7.9, containing 6 mM MgCl2 (for further details see Materials and 
Methods, section 3.4.2.1).  However, promoter-dependent transcription assays revealed qualitative 
differences in fidelity when RNA was synthesized at lower pH, and in the presence of reduced 
amounts of magnesium. These observations indicated that transcriptions could be more accurate 
when carried out in buffers at pH 6.75, containing 1.5 mM MgCl2.  
The efficiency and nucleotide specificity of T7 RNAP was determined in single-nucleotide 
incorporation assays using a VSR10 hybrid containing dsDNA and a 10-nucleotide RNA primer, 
labeled with γ[32P]ATP (Figure 29). These assays were carried out with purified recombinant T7 
RNAP due to the requirement of relatively large amounts of enzyme.  Nucleotide incorporation rates 
were determined at different concentrations of correct (UTP) or incorrect ribonucleotides (ATP, 
CTP and GTP) in standard buffer conditions (40 mM Tris-HCl pH 7.9, containing 6 mM MgCl2), 
as well as in conditions enhancing T7 RNAP fidelity (40 mM Bis-Tris buffer pH 6.75 and 1.5 mM 
MgCl2).  Kinetic constants for UTP incorporation could not be obtained due to the high efficiency 
of the polymerization reaction.  Thus, at nucleotide concentrations above 300 µM, T7 RNAP showed 
UTP incorporation rates (kobs) above 150 s−1 in both assay conditions.  Nevertheless, this is probably 
an underestimate as the reaction becomes immeasurably fast at increasing nucleotide concentrations.  
At low concentrations of UTP, the polymerase showed different kinetic behaviours at pH 7.9/6 mM 
Mg2+, and pH 6.75/1.5 mM Mg2+ (Figure 29A).  The relationship between kobs and [UTP] was linear 
at pH 7.9/6 mM Mg2+ but hyperbolic at pH 6.75/1.5 mM Mg2+.  
Similar patterns were observed with the incorporation of CTP.  In reactions carried out in 40 
mM Tris-HCl buffer pH 7.9, containing 6 mM MgCl2, a linear relationship between kobs and [CTP] 
was shown while increasing from 0.5 to 4 mM the concentration of nucleotide. In contrast, 
nucleotide incorporation efficiencies were much lower at pH 6.75/1.5 mM Mg2+ and fitted a 
hyperbola. These data revealed that relative incorporation rates of CTP (incorrect) versus UTP 
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(correct) were lower at pH 6.75/1.5 mM Mg2+ than at pH 7.9/6 mM Mg2+. However, reliable 
estimates of kinetic constants were obtained only for the misincorporation of C at pH 6.75/1.5 mM 
Mg2+ (Figure 29B). 
 
Figure 29. Nucleotide incorporation kinetics for UTP and CTP into VSR10 template-primer by 
recombinant T7 RNA polymerase. Nucleotide sequences of the VSR10 complex (Anand and Patel, 2006) 
are shown above. VSR10 is made of a double-stranded DNA (black) annealed to a 10-nt RNA primer (red). 
The RNA is labeled at its 5’ end with [γ-32P]ATP. The arrow indicates the nucleotide incorporation site. (A) 
UTP and CTP incorporation rates at different nucleotide concentrations, obtained at pH 7.9 and 6 mM MgCl2 
(black circles), and at pH 6.75 and 1.5 mM MgCl2 (grey circles). (B) Pre-steady-state kinetics of CTP 
incorporation on VSR10 by T7 RNAP, at pH 6.75 (Bis-Tris buffer) and 1.5 mM MgCl2. In the left panel, 
continuous lines represent the best fit of the data to the single-exponential equation, obtained at different 
nucleotide concentrations. The right panel shows the nucleotide concentration dependence of CTP 
incorporation. The continuous line represents the best fit of the kobs data to the Michaelis-Menten equation. 
The obtained polymerization rates (kpol) and apparent equilibrium dissociation constant (Kd) of CTP were 4.98 
± 0.71 s−1 and 2.23 ± 0.61 mM, respectively. Results were obtained from three independent experiments. 
 
Unlike in the case of pyrimidines, the efficiencies of ATP and GTP misincorporation by T7 
RNAP were much lower, which allowed their manual determination. This is consistent with the poor 
incorporation observed in the qualitative assays in the absence of ATP and GTP. Kinetic parameters, 
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given in Table 15, showed that T7 RNAP incorporated non-complementary purines with 2.6- to 3.0-
fold higher efficiencies at pH 7.9/6 mM Mg2+ than at pH 6.75/1.5 mM Mg2+.  ATP was incorporated 
more efficiently than GTP in both reaction conditions.  The catalytic efficiency of ATP incorporation 
was 29.15 ± 15.17 M−1 s−1 at pH 7.9/6 mM Mg2+ and 11.05 ± 1.53 M−1 s−1 at pH 6.75/1.5 mM Mg2+. 
Similar differences were obtained for GTP, although at pH 6.75/1.5 mM Mg2+ the kpol/Kd of T7 
RNAP was only 6.60 ± 1.16 M−1 s−1, while at pH 7.9/6 mM Mg2+ was 19.77 ± 10.53 M−1 s−1. Taken 
together, these data provide further support to the notion that at pH 6.75 and 1.5 mM Mg2+ the T7 
RNAP showed a modest but consistent improvement in its fidelity of RNA synthesis.   
Table 15. Nucleotide incorporation kinetics for GTP and ATP into VSR10 template-primer for 
recombinant T7 RNA polymerase 
NTP 
pH 7.9 and 6 mM MgCl2 pH 6.75 and 1.5 mM MgCl2 
kpol  
(×10−2 s−1) 
Kd  
(µM) 
kpol/Kd  
(M−1 s−1) 
kpol  
(×10−2 s−1) 
Kd  
(µM) 
kpol/Kd  
(M−1 s−1) 
GTP 1.8 ± 0.6  901.2 ± 334.9 19.77 ± 10.15 4.3 ± 0.7 652.5 ± 50.9 6.60 ± 1.16 
ATP 1.7 ± 0.2 583.0 ± 296.6 29.15 ± 15.17 4.1 ± 0.5 367.8 ± 20.5 11.05 ± 1.53 
Incorporation rates (kpol) were determined by assuming the concentration of catalytically competent T7 RNAP 
in the assay (i.e., polymerase bound to template-primer at time zero) determined by using the dissociation 
equilibrium constants given in Figure 30. Data shown are the mean values ± standard deviations obtained 
from at least three experiments. 
 
4.2.2.3. Template-primer binding affinity of T7 RNAP under different conditions 
In addition to its effects on fidelity, we also measured the impact of transcription conditions on 
the affinity of T7 RNAP for the template-primer. For that purpose, the enzyme was incubated with 
increasing concentrations of VSR10 complex and the reaction initiated by adding the correct 
nucleotide (UTP). Interestingly, the assay conditions had a strong influence on template-primer 
binding.  At pH 7.9 and 6 mM Mg2+, the dissociation equilibrium constant (Kd) for T7 RNAP and 
the VSR10 heteroduplex was about 30 times higher than at pH 6.75 and 1.5 mM MgCl2 (Figure 30).  
The higher affinity for VSR10 of the T7 RNAP at lower pH and Mg2+ concentration could represent 
an additional advantage towards increasing the efficiency of RNA synthesis in the presence of 
limiting amounts of template.  
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Figure 30. Dissociation equilibrium constants (Kd) for T7 RNA polymerase and the VSR10 dsDNA/RNA 
heteroduplex. (A-B) Data shown were obtained from representative assays carried out at pH 7.9 and 6 mM 
MgCl2 (panel A) and at pH 6.75 and 1.5 mM MgCl2 (panel B). The solid line represents the best fit of the data 
to the quadratic equation relating the template-primer bound to the T7 RNAP and the total concentration of 
the VSR10 heteroduplex. Reported Kd values represent averages ± standard deviations obtained from at least 
three independent experiments.   
 
4.2.3. Estimates of RNA-dependent DNA synthesis fidelity of HIV-1 RTs using more 
faithful RNA templates 
Although the biochemical studies revealed that it is possible to increase transcription fidelity 
by reducing the pH and magnesium concentration of the reaction, it is not clear whether this would 
affect estimates of fidelity of RNA-dependent DNA synthesis of retroviral RTs.  As shown in Tables 
12 and 14, the highest mutant frequency and overall error rate obtained with RNA templates 
synthesized at pH 7.9 and in the presence of 6 mM MgCl2 were found in assays carried out with the 
HIV-1BH10 RT.   
We used this enzyme to test the impact of the RNA template on mutation frequencies obtained 
with M13mp2 lacZα forward mutation assays. Theoretically, more faithful RNAs (i.e., those 
carrying less transcription errors) would reduce the mutational threshold of the assay.  RNAs 
containing the lacZα sequence were synthesized using recombinant T7 RNAP in the two different 
conditions (i.e., pH 7.9/6 mM Mg2+, and pH 6.75/1.5 mM Mg2+).  Lower mutation frequencies were 
obtained with HIV-1BH10 RT using RNA templates synthesized at lower pH and Mg2+ concentrations, 
although the differences were not large (Table 16).  
The analysis of the mutational spectra showed similar distributions of transitions, and 
transversions using both RNAs (Figures 31 and 32). The mutational spectra of HIV-1BH10 obtained 
with RNA synthesized at pH 7.9 and in the presence of 6 mM Mg2+ accumulate U-to-C transitions 
at position +121. This hotspot is not present in the spectra obtained with RNA made at pH 6.75/1.5 
mM Mg2+ (P < 0.03 in a two-tailed Fisher’s exact test). At the lower pH and Mg2+ concentration, we 
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observed an increased tendency to introduce frameshift errors in homopolymeric versus 
heteropolymeric sequences, but in both cases at a lower rate compared to the spectra obtained at pH 
7.9/6 mM Mg2+ (Table 17).  In any case, base substitution and frameshift error rates were about 49-
58% lower in assays carried out with RNA obtained using the pH 6.75/1.5 mM Mg2+ conditions. 
Table 16. RNA-dependent DNA synthesis fidelity of HIV-1 RTs in M13mp2 lacZα forward 
mutation assays 
RTs 
T7 RNAP 
source 
Transcription 
conditions Mutant 
plaques 
Total 
plaques 
Mutant 
frequency 
pH 
[Mg2+] 
(mM) 
WT HIV-1BH10 Recombinant 7.9  6 45 4,650 0.00968 
WT HIV-1BH10 Recombinant 6.75  1.5 70 11,226 0.00624 
K65R/V75IESP49 Recombinant 6.75  1.5 56 14,735 0.00380 
K65R/V75IESP49 Commercial 6.75a 1.5 51 19,466 0.00262 
Template RNA used in these assays was obtained in T7 RNAP-catalyzed reactions carried out at different pH 
and [Mg2+], as indicated. 
a This assay was carried out with the T7 RNAP from Promega in PIPES buffer (pH 6.75), and results were 
obtained after pooling the products of six reverse transcription reactions.  
 
In previous studies carried out in the laboratory, we found that the mutant K65R/V75IESP49 RT 
was >15-fold more accurate than the HIV-1BH10 RT in forward mutation assays measuring fidelity 
of DNA-dependent DNA synthesis (Barrioluengo et al., 2011).  We compared the difference in 
fidelity of both RTs using M13-based assays with RNA obtained at lower pH and MgCl2 
concentration.  Although mutant frequencies obtained with the double-mutant RT were lower than 
those obtained with HIV-1BH10 RT using RNAs synthesized at pH 6.75/1.5 mM Mg2+ (Table 14), 
the effects were not large. An overall error rate of 3.3×10−5 was estimated for the K65R/V75IESP49 
RT under those conditions (Table 17). 
Interestingly, the analysis of mutational spectra revealed that major hotspots obtained with 
K65R/V75IESP49 RT while reverse transcribing an RNA template synthesized at pH 7.9/6 mM Mg2+ 
(Figure 25) were absent from the spectra obtained with the RNA made at pH 6.75/1.5 mM Mg2+ 
(Figure 33).  Examples of hotspots that were lost with RNAs obtained at lower pH and Mg2+ 
concentration included clusters of U-to-C transitions found at positions −36/−35 and +147 (P < 
0.002, for both comparisons), as well as accumulations of U-to-A transversions found at position 
+73, together with one-nucleotide frameshifts (P < 0.02). It should be pointed out that for the same 
RT (K65R/V75IESP49), the number of one-thymidine insertions located in the homopolymeric region 
+137/+139 was statistically different comparing assays in which RNA was obtained under different 
transcription conditions (low/high pH and magnesium concentration, and commercial/recombinant 
T7 RNAP) (P < 0.05). 
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The analysis of data shown in Tables 12, 14, 16 and 17 also revealed that RNA synthesized by 
recombinant T7 RNAP had lower quality than the RNA made with commercial preparations of the 
enzyme that rendered lower mutant frequencies in M13mp2-based assays, for both HIV-1BH10 and 
K65R/V75IESP49 RTs. This difference in the quality of the RNA is observed even when recombinant 
T7 RNAP transcribes at pH 6.75/1.5 mM Mg2+ and the commercial enzyme at pH 7.9 and high Mg2+ 
concentration.  Thus, error rates obtained with the HIV-1BH10 RT using RNA synthesized at pH 7.9/6 
mM Mg2+ were estimated to be 8.4×10−5 with the recombinant T7 RNAP, and 3.5×10−5 with the 
commercial enzyme, a difference of 2.4-fold. Similar experiments with K65R/V75IESP49 RT and 
RNAs transcribed at pH 6.75/1.5 mM Mg2+ showed error rates of 3.3×10−5 and 2.3×10−5 for 
recombinant and commercial T7 RNAPs, respectively.  
The smaller differences observed with the K65R/V75IESP49 RT relative to the HIV-1BH10 RT can 
be attributed to the existence of a transcriptional threshold that has a bigger influence on more 
faithful RTs.  This limit seems to be achieved with RNAs obtained at pH 6.75/1.5 mM Mg2+ with 
the commercial T7 RNAP. However, when the commercial enzyme is used, the pH and Mg2+ 
concentration had a relatively small influence in the error rate (2.5×10−5, with RNAs obtained at pH 
7.9/6 mM Mg2+) while differences may not be significant.  Interestingly, and in agreement with our 
proposal, the error rate of HIV-1BH10 RT was reduced by 1.6-fold when the RNAs were synthesized 
by recombinant T7 RNAP at pH 6.75/1.5 mM Mg2+, as compared with those obtained at pH 7.9/6 
mM Mg2+. Meanwhile, the smaller reduction in the error rate (1.1-fold) observed with 
K65R/V75IESP49 RT when changing transcription conditions might be attributed to the use of 
commercial T7 RNAP to synthesize the RNA templates. 
The origin of the T7 RNAP had a minor effect on hotspot distribution in the K65R/V75IESP49 
spectra when the template RNA was synthesized at lower pH and magnesium concentration 
(Figures 33 and 34). Thus, major hotspots at positions +87 and +139 were found with RNAs 
synthesized at pH 6.75/1.5 mM Mg2+, with recombinant or commercial T7 RNAP. Differences in 
hotspot distribution along the lacZα sequence between both assays were not significant statistically. 
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4.3. Determination of RNA-dependent DNA synthesis fidelity of RTs 
by deep sequencing experiments based on the use of Primer IDs 
Although M13mp2-based forward mutation assays provide a broad assessment of RT’s fidelity, 
allowing to compare data obtained from RNA- versus DNA-templated reactions, they are restricted 
to the detection of changes leading to a phenotypic effect. Thus, synonymous mutations and errors 
that do not affect the activity of the reporter gene (e.g., β-galactosidase activity in the case of lacZα 
assays) are not considered. In contrast, next-generation sequencing (NGS) technologies yield 
millions of read bases, providing depth in the analysis and allowing to detect all errors at any 
position.  
In this Thesis, RNA-dependent DNA synthesis fidelity of RTs has been measured by using NGS 
platforms and protocols adapted for the use of Primer IDs, which are degenerated oligonucleotides 
used to initiate the synthesis of cDNA. This method provides a strategy to tag each cDNA molecule, 
and eliminates the bias generated by PCR amplification and sequencing errors, by creating a 
consensus between all cDNA molecules with the same barcode. Barcoded primers with twelve 
random nucleotides were used in reverse transcription reactions performed by HIV-1BH10 and 
K65R/V75IESP49 RTs. Amplicon libraries were constructed from the cDNA samples, and sequenced 
by using MiSeq Illumina 300 system in paired-end (2×300). About 2×106 raw reads were obtained 
for each RT (Table 18), being the length of reads between 35 and 301 nucleotides.  
 Table 18. Raw reads and joined sequences by paired-end read merger (PEAR) 
RTs Original paired reads Joined sequences Joined sequences (%) 
HIV-1BH10 1,921,903 1,910,996 99.43 
K65R/V75IESP49 1,743,634 1,733,270 99.40 
 
Similar quality patterns of the samples were obtained for both enzymes (Figure 35). These 
patterns revealed a reduction in the quality of bases while advancing in the positions of the amplicon, 
following a general tendency in this kind of analysis. However, the lower quality of the distant bases 
is compensated by the joining of sequences read in paired-end during MiSeq sequencing. This 
process was performed with a fast and accurate paired-end read merger called PEAR.  
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Figure 35. Representative quality per base boxplot of reads. HIV-1BH10 (above) and K65R/V75IESP49 
(below) RTs.   
 
After joining paired-end sequences, >99% of the reads were recovered (Table 18). Consensus 
were determined from cDNA molecules with the same barcode, assuming the maximum limit of 
10,000 reads and the lower limit established by the cutoff value (76 reads). This threshold yields 
few valid consensus (Table 19), since we obtained only 149 and 146 consensus for HIV-1BH10 and 
K65R/V75IESP49 RTs, respectively. The high number of discarded consensus is mainly due to the 
high number of barcodes with very few reads. This biased distribution of reads per barcode may 
reflect the offspring barcodes generated by PCR and sequencing errors. 
  Table 19. Summary of obtained barcodes and the resulting consensus 
RTs Total barcodes 
Maximum number of 
sequences per barcode 
Consensus Discarded 
HIV-1BH10 8,642 820,752 149 8,493 
K65R/V75IESP49 8,289 530,475 146 8,143 
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Once the consensus sequences were generated, they were subjected to multiple alignment and 
compared to a reference sequence taken from LAV genome at the NCBI database. Variants found 
in the samples with respect to the reference sequence are indicated in Table 20, and show mutations 
that were introduced either by the eukaryotic RNAP II while synthesizing the RNA used as template, 
or by the RT during reverse transcription.  
Table 20. Summary of mutations found in the consensus sequences for HIV-1BH10 and 
K65R/V75IESP49 RTs 
Enzyme Position 
Reference 
sequence 
Mutated 
sequence  
No. of 
errors 
Frequency 
HIV-1BH10 RT 
(146 consensus 
sequences) 
61 AGGGGGGC AGGGGGGGC 5 0.03425 
72 UAAAGG TAAAAGG 2 0.01370 
114 UAG TAAG 2 0.01370 
147 CAAAAAUG CAAAAAATG 4 0.02740 
157 AGGGGGAAU AGGGGGGAAT 2 0.01370 
241 AUUAG ATTTAG 2 0.01370 
322 U C 1 0.00685 
K65R/V75IESP49 RT 
(149 consensus 
sequences) 
23 A G 1 0.00671 
67 GCA GCCA 2 0.01342 
122 AUG ATTG 2 0.01342 
147 CAAAAAUG CAAAAAATG 3 0.02013 
354 C T 6 0.04027 
 
Both mutational summaries showed the accumulation of one-adenine insertions at the 
homopolymeric sequence located around position +147, as well as the presence of C-to-T changes 
as unique base substitutions. Interestingly, all frameshifts observed for both RTs were one-
nucleotide insertions. Different remarkable hotspots can be observed in the spectra of both enzymes. 
For example, one-nucleotide insertions of guanidine around position +61 in the case of HIV-1BH10 
RT, or C-to-T transitions at position +354 in the case of K65R/V75IESP49 RT.  
Error rates were calculated for each type of error (Table 21), based on the number of consensus 
analyzed for each enzyme, and the number of positions were each mutation can be detected (355 
sites for base substitutions and frameshifts, 83 for insertions at homopolymeric sequences, and 272 
for insertions at heteropolymeric regions). NGS experiments revealed a 1.3-fold difference in 
fidelity between K65R/V75IESP49 and HIV-1BH10 RTs in reactions carried out with RNA templates, 
in agreement with the results of M13mp2 forward mutation assays. These results confirm the lower 
accuracy of the HIV-1BH10 enzyme. HIV-1BH10 RT showed a higher overall error rate than the 
K65R/V75IESP49 RT, mainly due to the high rate of frameshifts at homopolymeric sites. In contrast, 
the double mutant enzyme showed a higher tendency to introduce insertions at heteropolymeric 
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sites. In addition, K65R/V75IESP49 RT did not show a bias between the introduction of base 
substitutions and frameshifts.  
Table 21. Summary of error rates for HIV-1BH10 and K65R/V75IESP49 RTs for various 
classes of mutations, based on the use of Primer IDs in next-generation sequencing 
assays  
Mutation type 
HIV-1BH10 RT K65R/V75IESP49 RT 
No. of errors Error rate No. of errors Error rate 
All classes 18 1/2,879 14 1/3,778 
Base substitutions 1  1/51,830 7 1/7,556 
   Transitions 1 (100%)  7 (100%)  
   Transversions 0 (0%)  0 (0%)  
Frameshifts 17 1/3,049 7  1/7,556 
      Insertions 17 (100%)  7 (100%)  
      Deletions 0 (0%)  0 (0%)  
   At runsa 13 1/932 3  1/4,122 
   At non-runs 4  1/9,928 4  1/10,132 
a A run is considered when there is a row of three or more identical nucleotides. 
  
Taken together, these results were in good agreement with those obtained from forward 
mutation assays (Table 14), supporting the validity and potential of this methodology. However, 
these error rates proceed from a low number of mutations, and it would be desirable to increase the 
number of consensus sequences to obtain a sufficiently robust analysis.   
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5.1. Fidelity of WT and drug-resistant HIV-2ROD RTs 
Lentiviral RTs (e.g., those of HIV-1, SIV or feline immunodeficiency virus) are known to be 
less accurate than oncoretroviral RTs, such as those of MLV or AMV (reviewed in Menéndez-Arias, 
2009, 2013a). The study presented in this Thesis shows that WT HIV-2ROD RT is only 1.6 times 
more faithful than the reference HIV-1BH10 RT. These differences in fidelity are similar to those 
reported for other primate lentiviral RTs when compared with HIV-1 group M subtype B 
polymerases, such as the RTs of strains BH10 or HXB2, using M13-based forward mutation assays. 
Thus, the HIV-1BH10 RT showed about two-fold decreased fidelity in comparison with a prototypic 
WT HIV-1 group O RT (Álvarez et al., 2009, 2013), while SIVmne and SIVagm RTs were only 1.3 
and 1.8 times more accurate, respectively, than subtype B RTs (Stuke et al., 1997; Diamond et al., 
2003).  
Despite the relatively small differences in mutation rates, HIV-1 group M subtype B RTs 
emerge as the less faithful polymerases among those of primate lentiviruses while synthesizing DNA 
using DNA as template,. The higher intrinsic fidelity of HIV-2ROD RT in comparison with HIV-1BH10 
RT resulted from its lower nucleotide substitution error rate, a trend that was also observed with the 
SIVagm RT (Stuke et al., 1997). In contrast, our analysis showed that WT HIV-2ROD RT has a 
relatively high frameshift error rate (5.7×10−5), ranking among the highest reported for RTs of 
primate lentiviruses. 
HIV-1 and HIV-2 RTs are important targets in the fight against AIDS. However, HIV-2 
infected patients have fewer treatment options, since all antirretroviral drugs approved to treat HIV 
infections have been specifically designed to inhibit HIV-1 replication. Despite the inefficacy of 
NNRTIs, as well as the fusion inhibitor enfuvirtide and several protease inhibitors against HIV-2 
(reviewed in Menéndez-Arias and Tözsér, 2008; Menéndez-Arias and Álvarez, 2014), both HIV-1 
and HIV-2 strains display similar susceptibility to NRTIs. NRTIs constitute the backbone of current 
therapies against infections caused by all HIV isolates (Menéndez-Arias, 2013b). Challenging HIV 
with antiretroviral drugs facilitates the selection of strains containing mutations associated to drug 
resistance.  
NRTI resistance is conferred by mutations that can act through two different mechanisms: (i) 
the exclusion pathway, that affects discrimination between canonical dNTPs and NRTIs, by 
reducing the incorporation efficiency of the latter; and (ii) the excision pathway, that promotes the 
removal of the already incorporated 3’-chain-terminating NRTI from the end of the blocked primer 
(Figure 36). Excision acts in a process similar to polymerization run in reverse and is mediated by 
a pyrophosphate donor, usually ATP. Unlike HIV-1, HIV-2 does not develop resistance to NRTIs 
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through the excision pathway, but relies exclusively on the nucleotide discrimination pathway 
towards the acquisition of resistance.  
 
Figure 36. Mechanisms of NRTI resistance. (A) Excision pathway. AZT monophosphate (AZT-MP, purple) 
blocks polymerization once incorporated in the growing DNA chain, due to the absence of a 3’–OH end. The 
ATP-mediated removal of the already incorporated AZT-MP yields an AZTppppA excision byproduct and a 
3’–OH end, facilitating the resumption of polymerization. (B) Exclusion pathway. Discrimination between 
natural dNTPs (yellow) and analogues, such as lamivudine (3TC, dark green) avoid certain drugs to enter in 
the growing DNA chain allowing the polymerization to continue. Both mechanisms yield a complex 
competent for polymerization. P, phosphate group; yellow circles with three phosphates, dNTPs. RNA is 
depicted with red circles, and DNA with yellow circles. Adapted from Delviks-Frankenberry et al. (2010).  
 
In HIV-1, amino acid substitutions conferring resistance to NRTIs via the excision pathway are 
widely known as thymidine analogue resistance mutations (TAMs) (Larder, 1994). In patients 
receiving long-term therapy, TAMs appear in two clusters: TAM1 (M41L, L210W, and T215Y) and 
TAM2 (D67N, K70R, K219E/Q, and sometimes T215F) (Yahi et al., 1999). In contrast, TAMs are 
rarely observed in cell culture after HIV-2 passage in the presence of AZT (Reid et al., 2005), and 
are found with a very low prevalence in HIV-2 obtained from patients treated with AZT and other 
nucleoside analogues (Brandin et al., 2003; Gottlieb et al., 2009; Ntemgwa et al., 2009).  
In HIV-2, Met73 and to a lesser extent Ile75 play a critical role in the suppression of the excision 
pathway when TAMs are present in the RT (Álvarez et al., 2018) (Figure 37A). The equivalent 
residues of the HIV-1 RT are Lys73 and Val75. All HIV-2 mutants having the substitution M73K 
in their RT were excision-proficient in biochemical assays. However, mutations selected under drug 
pressure frequently cause a loss of viral fitness. Thus, development of resistance through the excision 
pathway and involving the acquisition of M73K is highly unlikely, because HIV-2 variants carrying 
this substitution in the RT showed impaired viral replication (Álvarez et al., 2018).  
On the other hand, HIV-1 RT develops resistance to NRTIs via the exclusion pathway through 
the acquisition of amino acid changes found at the dNTP-binding site of the DNA polymerase 
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domain (e.g., K65R, L74V, V75I, and M184V). These changes antagonize the effects of TAMs 
while interfering with the RT’s ability to discriminate between natural dNTPs and the triphosphate 
forms of NRTIs (reviewed in Menéndez-Arias, 2013b). In HIV-1 RT, K65R is selected in the 
presence of tenofovir, while Q151M was originally found in patients treated with AZT in 
combination with ddI or ddC. M184V appears under treatment with lamivudine (3TC) (reviewed in 
Menéndez-Arias, 2008). In the HIV-1 RT, the “Q151M complex” consists of a combination of five 
mutations (A62V, V75I, F77L, F116Y, and Q151M) (Figure 37B) that confers resistance to all 
approved NRTIs except tenofovir (Shirasaka et al., 1995; Hachiya et al., 2011). In contrast, in HIV-
2 the “Q151M complex” is almost restricted to the unique presence of Q151M due to the different 
structure of the nucleotide binding site of the RT (reviewed in Boyer et al., 2006).  
 
Figure 37. Structure of HIV-1 resistant RT. (A) Ribbon representation of the polypeptide backbone around 
the nucleotide-binding site of the mutant HIV-1 RT D67N/K70R/K73M. The side chains of Val60, Arg70, 
and Met73 (pink), and the incoming dNTP (yellow) are shown with stick and sphere representations. In this 
mutant RT, distance between the amido group of Arg70 and the hydroxyl group of the incoming dTTP reaches 
values up to 6.2 Å. This long distance is not observed in the double mutant D67N/K70R RT, where molecular 
dynamics simulations predict that those groups form a hydrogen bond. Adapted from Álvarez et al. (2018). 
(B) Structural superposition of WT HIV-1 RT (grey) and mutant HIV-1 RT (yellow) bearing the Q151M 
complex (A62V, V75I, F77L, F116Y, and Q151M) (cyan for mutated side chains). Adapted from Das et al. 
(2017).  
 
The major mutations conferring resistance to NRTIs in HIV-2 are K65R, Q151M (sometimes 
accompanied by V111I), and M184V (Damond et al., 2005; Deuzing et al., 2015). Although K65R, 
Q151M and M184V might be selected under NRTI pressure in HIV-1 as well as in HIV-2, the triple 
mutant is characteristic of the HIV-2 RT since Q151M is the preferred mutation selected during 
treatment with AZT (Descamps et al., 2004; for reviews see Menéndez-Arias, 2013b; Menéndez-
Arias and Álvarez, 2014). The combination of the three amino acid substitutions (K65R, Q151M, 
and M184V) confers classwide-nucleoside analogue resistance in HIV-2 RT (Smith et al., 2009). 
The study presented in this Thesis shows that effects on fidelity obtained with K65R (alone or in the 
context of a multidrug-resistant RT) were different in the HIV-2ROD RT as compared with the HIV-
1BH10 enzyme. 
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Interestingly, our studies revealed that there were relatively small differences in fidelity 
between the classwide NRTI-resistant K65R/Q151M/M184VROD RT and the WT HIV-2ROD enzyme, 
despite the presence of K65R in the mutational complex. These effects were unexpected considering 
that K65R alone produced large increases in fidelity (>8-fold) in forward mutation assays carried 
out with HIV-1 RTs from phylogenetically distant strains such as HXB2 (group M subtype B) (Shah 
et al., 2000) or ESP49 (group O) (Barrioluengo et al., 2011). Furthermore, estimates of HIV-1 
mutant frequencies obtained in cell culture after one round of replication were consistent with the 
enzymatic data and showed a 3.3-fold reduction for virus containing the K65R mutation in their RT, 
as compared with the virus carrying a WT RT (Mansky et al., 2003).  
The results obtained with the triple mutant K65R/Q151M/M184V in the HIV-2ROD RT were in 
agreement with those obtained with the single mutant RT K65RROD. Thus, our results showed that 
K65R alone had almost no effect on the overall fidelity of the HIV-2ROD polymerase, although it 
produced a modest decrease in the base substitution error rates. Our data on the role of K65R in 
HIV-2 are in agreement with published misinsertion ratios obtained with WT HIV-2ROD RT and 
mutants K65RROD and K65R/Q151M/M184VROD, performed in our laboratory using gel-based 
assays (Álvarez et al., 2017). Differences in misinsertion ratios between WT and mutant RTs bearing 
K65R were small and non-significant, except for the case of A opposite A, which was about 4 times 
less efficient for the single mutant K65R than for the WT HIV-2ROD RT. However, dATP 
incorporation was very inefficient in the sequence context used in the study, suggesting that this 
type of errors would be rare during reverse transcription.  
Moreover, classwide NRTI-resistant K65R/Q151M/M184VROD RT and the WT HIV-2ROD RT 
did not show significant differences in their mispair extension ratios, when the kinetic parameters 
could be reliably determined (Álvarez et al., 2017). The K65RROD mutant RT showed increased 
fidelity in comparison with the WT HIV-2ROD RT only in extension reactions with template-primers 
having a G:G mismatch at their 3’ ends. However, in this case the catalytic efficiency of nucleotide 
incorporation was very low (in the order of 10−6 μM−1 s−1). 
On the other hand, the effects of K65R on the evolutionary rate of HIV-2 have not been assessed 
in previous studies. However, a recent work has shown the quick reversion of the mutation when 
present in SIVmac239 infecting pigtailed macaques (Lloyd et al., 2016). Interestingly, WT and 
mutant SIVmac239 showed similar mutation rates in cell-based assays although K65R-containing 
viruses showed slightly reduced variability. The differences in mutation rates were estimated to be 
less than 1.3-fold, but considered statistically significant (Lloyd et al., 2016). It is noteworthy to 
mention that mutant MLV carrying the equivalent substitution in its RT (i.e., K103R) was found to 
be less infectious than the WT. However, no differences were found in assays measuring the 
frequency of lacZ inactivation after one round of replication in cells infected with WT and mutant 
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viruses (Halvas et al., 2000), thereby suggesting that K103R had no effect on the intrinsic fidelity 
of the MLV RT.  
Although several studies carried out with HIV-1 RT variants have shown that K65R and other 
mutations conferring resistance to nucleoside analogues (e.g., M184V) increase their DNA 
polymerase fidelity, there are examples of NRTI resistance mutations having little effect on the 
accuracy of HIV-1 RT (e.g., L74V, Q151M) (reviewed in Menéndez-Arias, 2009, 2013a). Our 
results show that in HIV-2, classwide NRTI resistance may not be associated with significant 
changes in the intrinsic fidelity of the RT, although a lower fitness is expected for drug-resistant 
viruses as a result of the lower catalytic efficiency of their RT. Therefore, the relationship between 
drug resistance and increased fidelity cannot be established, particularly for the major mutations 
found in HIV-2 strains resistant to NRTIs. 
The increased intrinsic fidelity conferred by K65R appears to be a specific characteristic of 
HIV-1 RT and not shared by RTs of the HIV-2/SIV lineage. A structural justification of these 
differences is very difficult due to the lack of structural information for HIV-2 RT. However, a 
number of amino acid sequence differences found in the β3-β4 hairpin loops (residues 63–75) of 
HIV-1 and HIV-2 RTs (Figure 38) could have a significant impact on its conformation and mobility, 
thereby affecting neighbouring contacts between the side-chains of Lys or Arg65. In support of this 
proposal, crystal structures of ternary complexes composed of mutant K65R HIV-1BH10 RT, dsDNA, 
and incoming nucleotides (i.e., dATP or tenofovir-diphosphate) have shown stacking interactions 
between guanidinium groups of Arg65 and Arg72 that restrict the conformational adaptability of 
both residues (Das et al., 2009).  
 
Figure 38. Alignment of β3-β4 hairpin loop (residues 63-75) amino acid sequences of HIV-1BH10 and 
HIV-2ROD-SIV RTs. Conservative and non-conservative changes are indicated in green and red boxes, 
respectively. 
 
The amino acid sequences of the β3-β4 hairpin loops of HIV-1 group M subtype B and group 
O RTs are identical (IKKKDSTKWRKLV), but different from those found in HIV-2ROD and 
SIVmac239 RTs (IKKKDKNKWRMLI) (Figure 38). The distribution of charged residues along 
the hairpin loop sequence is rather different in both pairs of RTs and it is tempting to speculate that 
substitutions of basic residues in these structures could have an impact on fidelity. Nevertheless, 
how interactions between hairpin loop residues may influence the intrinsic fidelity of the enzyme is 
a question open for future research.  
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5.2. RNA-dependent DNA synthesis fidelity of retroviral RTs 
5.2.1. Fidelity of retroviral RTs in reactions carried out with RNA templates 
Previous studies on the accuracy of different retroviral RTs, such as those of WT HIV-1BH10, 
HIV-1ESP49, MLV and AMV, as well as mutant RTs K65RESP49 and K65R/V75IESP49, while 
synthesizing DNA using DNA templates revealed that there were large differences in fidelity 
between all of them (reviewed in Menéndez-Arias, 2009, 2013a). In contrast, the results obtained 
for these RTs in the present study show that the intrinsic fidelity of RNA-dependent DNA synthesis 
varies within the small range of 2.5×10−5 to 3.5×10−5, in assays carried out with RNA transcribed by 
a commercial T7 RNAP at pH 7.9 and in the presence of 6 mM Mg2+. The comparison of mutant 
frequencies obtained with M13mp2 lacZα forward mutation assays illustrates the large variation in 
fidelity observed between different RTs depending on the template used in the reaction (DNA or 
RNA) (Figure 39).   
 
Figure 39. Comparison of RNA- and DNA-dependent DNA synthesis fidelities of retroviral RTs.  
Estimates of fidelity of RNA-dependent DNA synthesis are based on mutant frequencies obtained with the 
adapted M13mp2 lacZα forward mutation assay, reported in this Thesis (orange bars). Blue bars represent 
previously reported values, obtained using M13mp2-based assays measuring the accuracy of DNA-dependent 
DNA synthesis of HIV-1BH10 (Álvarez et al., 2017), HIV-1ESP49 (Álvarez et al., 2009), AMV (Roberts et al., 
1988), and MLV, as well as mutant K65RESP49 and K65R/V75IESP49 RTs (Barrioluengo et al., 2011).   
 
While HIV-1BH10 RT is >15-fold less accurate than mutant HIV-1ESP49 RTs K65R and 
K65R/V75I in DNA-dependent DNA synthesis reactions (Barrioluengo et al., 2011), differences 
between the most and least faithful RTs in assays carried out with RNA templates fall within less 
than two-fold (Table 14). Nonetheless, HIV-1BH10 RT remains as the least faithful enzyme in both 
types of assays.  
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All results reported in Figure 39 were obtained in our laboratory under the same experimental 
conditions, except in the case of mutation frequencies determined for AMV RT with DNA-
dependent DNA synthesis fidelity assays (Roberts et al., 1988). Our previous studies measuring the 
fidelity of DNA synthesis on DNA templates had shown that for the same RT, the variability in 
mutant frequencies obtained in forward mutation assays was under 30% for HIV-1BH10 and HIV-
1ESP49 RTs (Álvarez et al., 2009, 2013, 2017).  
The narrow window of variation in mutant frequencies or overall error rates (around two-fold) 
observed for retroviral RTs on RNA templates was also found when changing transcription 
conditions. Thus, in assays performed with RNA templates synthesized by a recombinant T7 RNAP 
using reaction conditions that favoured the accuracy of the transcription (i.e., pH 6.75/1.5 mM 
Mg2+), overall error rates were in the range of 3.3×10−5 to 5.5×10−5. The lower value of error rate 
obtained on RNA templates was 2.3×10−5, and it was obtained with the K65R/V75IESP49 RT using 
RNA templates synthesized by a commercial T7 RNAP at pH 6.75/1.5 mM Mg2+. In contrast, 
intrinsic error rates of RTs in DNA-dependent DNA synthesis can be as low as 6.3×10−6 (e.g., for 
K65RESP49 and K65R/V75IESP49 RTs) (Barrioluengo et al., 2011). Thus, in RNA-templated assays 
error rates were more than three-fold higher than the lowest values obtained with DNA templates. 
Structural studies with HIV-1 RT bound to RNA/DNA template-primers (Sarafianos et al., 
2001; Lapkouski et al., 2013; Das et al., 2014; Tian et al., 2018) have shown that the RT adopts a 
similar conformation than in complexes containing DNA/DNA hybrids. However, in the structures 
containing RNA/DNA complexes, there are additional contacts involving residues of the p51 subunit 
and 2’ −OH groups of the RNA template. These interactions contribute to the higher affinity of HIV-
1 RT for RNA/DNA hybrids obtained in biochemical studies (Bohlayer and DeStefano, 2006). 
Differences in the interaction between RTs and RNA/DNA complexes versus DNA/DNA template-
primers could be potentially responsible for the different types of errors obtained in assays 
measuring fidelity of RNA- versus DNA-dependent DNA synthesis.  
 
5.2.2. Mechanistic insights of RT-catalyzed DNA polymerization reaction with RNA 
or DNA templates    
The mutational specificity of the studied RTs was determined after sequencing the lacZα gene 
of mutants generated in M13-based assays. By analysing the mutational spectra induced by the 
different RTs we also obtained relevant information on preferred hotspots and types of errors on 
different templates (i.e., RNA versus DNA), and the contribution of specific errors likely made by 
T7 RNAP and found in RNA templates used in the assays.  
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Figure 40. Comparison of mutational spectra induced by retroviral RTs during RNA- and DNA-dependent 
DNA synthesis. (Up) Combined mutational spectra derived from RNA-dependent DNA synthesis reactions 
including all RTs analyzed in this Thesis (Figures 22 to 27). RTs included are those of HIV-1BH10 (pink), HIV-
1ESP49 (purple), AMV (red), and MLV (green), and mutants K65R/V75IESP49 (light blue) and K65RESP49 (brown). 
(Bottom) Combined mutational spectra induced during DNA-dependent DNA synthesis reactions, and taken from 
previously published reports (Roberts et al., 1989; Álvarez et al., 2009; Barrioluengo et al., 2011). RT color codes 
are the same as above. For all RTs and mutational spectra, single-nucleotide substitutions are indicated by the letter 
corresponding to the new base above the template sequence of the lacZα target. Open upright triangles represent 
insertions and inverted triangles indicate deletions. Indels are represented by triangles which are positioned at the 
3’ end of the frameshift with the number of inserted/deleted nucleotides indicated between parentheses. One-
nucleotide insertions correspond to the duplication of the base where the triangle is positioned, if not specified. 
 
The mutational spectra of the six RTs studied (collected in Figure 40) show that RTs are prone 
to introduce errors when copying RNA or DNA templates at positions −36/−34 (mostly, U-to-C or 
T-to-C transitions), +139/+149, and within nucleotides +165 and +171. In the latter case, 
transversions are largely predominant with the DNA template, while transitions, frameshift errors 
and large deletions dominated the RNA-dependent mutational spectra. In addition, we observed a 
different distribution of hotspots when comparing spectra obtained with RNA or DNA templates. 
The DNA-dependent mutational spectra showed scattered hotpots at positions −66, +108, +118, 
+136, and clustered at nucleotides +87 to +92. In contrast, the RNA-dependent spectra contained 
hotspots at positions −7, +73, +87, +109, and +121. Among them, the hotspot at position +73 was 
represented mainly by U-to-A transversions and one-nucleotide frameshifts.  
The mutational spectra induced by RTs during RNA-dependent DNA synthesis contain a 
prominent hotspot at the homopolymeric region located at +137/+139.  Errors at this position consist 
of insertions of one T in a run of three thymidines.  These errors were previously detected by Boyer 
et al. (1992) in spectra obtained with HIV-1 and AMV RTs, and attributed to errors made by the T7 
RNAP. Therefore, those errors would be already found in the RNA template used by retroviral RTs 
in the cDNA synthesis reaction. Our results are consistent with that proposal, since we also found 
one-nucleotide insertions at this site in all of the analysed mutational spectra, without statistically 
significant differences between them (Table 13).  Interestingly, the insertions were not detected at 
positions +137/+139 in the mutational spectrum induced by HIV-1 RT using lacZα RNA templates 
synthesized with the T3 RNAP (Ji and Loeb, 1992), supporting the notion that this particular error 
is specifically made by the bacteriophage T7 RNAP. In general, it appears that monotonous runs of 
adenines in DNA are universal hotspots for RNAP slippage events during transcription. Adenine 
runs have been found to be slippery in vitro, in model systems in Escherichia coli and yeast, and in 
genome-wide transcriptome analysis of epimutations in Caenorhabditis elegans (reviewed in 
Gordon et al., 2015).  
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Another important hotspot represented by many large deletions occurs at positions +167/+173, 
at the 3’ end of the primer used for cDNA synthesis by the retroviral RTs. Deletions were more 
frequent at positions that correspond to the incorporation of the first and second nucleotides (i.e., 
+172 and +173), and probably result from either inefficient extension of the primer during DNA 
synthesis or aberrant RT/template-primer interactions. Remarkably, frameshift errors near the 3’ end 
of the primer used in cDNA synthesis had been previously reported by Boyer et al. (1992), although 
in that study the hotspot induced by HIV-1 RT appeared at position +158. Interestingly, the authors 
also noted that this hotspot was absent from the mutational spectra generated with AMV RT. In our 
experiments, the large deletions at the 3’ end of the primer were found only in the mutational spectra 
induced by HIV-1BH10, HIV-1ESP49 and the K65RESP49 RT, but not with oncoretroviral RTs such as 
MLV or AMV RTs and the HIV-1ESP49 mutant K65R/V75I. The presence of this particular hotspot 
could be partly explained by the relatively high template-primer dissociation rate of HIV-1 RT 
during the first nucleotide incorporation events (Majumdar et al., 1988). 
 
5.2.3. Influence of transcription inaccuracy in forward mutation assays 
Our results show that M13mp2 assays yield values of overall error rates for six retroviral RTs 
in the range of 10−5, measured in the presence of RNA templates synthesized by the T7 RNAP. 
Differences in fidelity between the enzymes (i.e., WT HIV-1BH10, HIV-1ESP49, MLV and AMV, and 
mutant RTs K65RESP49 and K65R/V75IESP49) were around two-fold. This similarity in accuracy 
observed between different RTs while reverse transcribing RNA molecules is likely due to 
transcription errors affecting the quality of the RNA template used in the reactions. Transcription 
errors or epimutations (i.e., RNA mutations resulting from inaccuracy during transcription) are very 
difficult to quantify and large differences in error rates have been reported by several groups. The 
absence of a standardized method hampers the comparison of data coming from experiments that 
vary enormously depending on the studied RNAP (e.g., single- or multi-subunit, from unicellular or 
pluricellular, prokaryotic or eukaryotic organisms) and on the used technical approach (i.e., in vitro 
or in vivo, with methodologies that differ in drawbacks and advantages) (Table 22).   
Even with these disparities, studies with multiple RNAPs rendered rough estimates of 
transcriptional mutagenesis in the order of 10−5 transcription errors per nucleotide (Remington et al., 
1998; Huang et al., 2000; Imashimizu et al., 2013; Traverse and Ochman, 2016; Reid-Bayliss and 
Loeb, 2017; reviewed in Ninio, 1991; Magnuson et al., 2016), in agreement with the threshold 
observed for the synthesis of DNA on RNA templates with different RTs.  
Gel-based assays showed that T7 RNAP exhibited an average error frequency of 5×10−5 
obtained from measurements of nucleotide misincorporation ratios (Huang et al., 2000), in good 
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agreement with the average base substitution error rate of 3×10−5 determined by Remington et al. 
(1998) with a codon reversion assay. In contrast, Sultana et al. (2017) obtained a transcription error 
rate of 2×10−6, determined as an average of 11 of the 12 possible nucleotide misinsertion efficiencies 
(fins) at a given position (i.e., 4 nucleotides can occupy a specific template position, each one yielding 
1 correct and 3 incorrect incorporations).  
However, in both reports the comparison between incorrect and correct nucleotides was limited 
to a relatively small number of sequences. In addition, Huang et al. (2000) compared all the 
misincorporation rates, by using a normal transcript extension rate for the T7 RNAP of 60 bases/s, 
taken from Ikeda and Richardson (1987). On the other hand, Sultana et al. (2017) compared the 11 
catalytic efficiencies for the incorporation of incorrect nucleotides taking as a reference the catalytic 
efficiency (kpol/Kd) of the incorporation of U opposite a template dA (i.e., 2 ± 0.5×10−6), instead of 
comparing the catalytic efficiency of each incorrect nucleotide with that of the corresponding correct 
one.  
Table 22. Summary of transcription and reverse transcription error rates 
Technique Error rate a Enzyme analyzed b Reference 
Screening by electrophoretic mobility 
SSCP 2.5−5.6×10−5 (O) RNAP II + RT [RNA] O’Neil et al., 2002 
 2.4−6.7×10−5 (O) RT [DNA] O’Neil et al., 2002 
Kinetics analysis 
Nucleotide 
incorporation 
2×10−6 (BS) T7 RNAP Sultana et al., 2017 
Deep sequencing methods 
Rep-Seq 2.2×10−6 (BS) C. elegans transcripts  Gout et al., 2013 
 1.2×10−6 (F) C. elegans transcripts  Gout et al., 2013 
Primer ID 2.7×10−4  (O) T7 RNAP + HIV-1 RT [RNA] Yasukawa et al., 2017 
 1.3×10−4 (O) 
1.1×10−4 (BS) 
RNAP II + MLV RT [RNA] Zhou et al., 2015 
HiRes-Seq 10−4−10−5 (BS) E. coli RNAP  
in vitro and in vivo 
Imashimizu et al., 2013 
Cir-Seq 2.4−3.3×10−4 (BS) Poliovirus population Acevedo et al., 2014 
 3.3−8.2×10−5 (BS) RNAPs of E. coli, B. 
aphidicola, and C. ruddii 
Traverse and Ochman, 
2016 
 3.9×10−6−1.7×10−5 
(BS) 
S. cerevisiae transcripts Gout et al., 2017 
ARC-Seq 2.0×10−5 T7 RNAP in vitro Reid-Bayliss et al., 2017 
SMRT-Seq 5.6−7.5×10−5 (O) AMV and MLV RT [RNA] + 
T7 RNAP 
Potapov et al., 2018 
 5.2−8.4×10−5 (O) AMV and MLV RT [DNA]   
SSCP, single-stranded conformation polymorphism; Rep-Seq, replicated sequencing; HiRes-Seq, high-
resolution RNA sequencing; Cir-Seq, circular resequencing; ARC-Seq, accurate RNA consensus sequencing; 
and SMRT-Seq, single molecule real-time sequencing. 
a Error rates for base substitutions (BS), frameshifts (F) or overall (O) error rate. b In brackets, DNA and RNA 
indicates the template used in the reaction, related to the corresponding error rate.   
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Based on deep sequencing technologies, Traverse and Ochman (2016) found conserved 
transcription error rates (ranging from 3.3×10−5 to 8.2×10−5 per nucleotide) across different species 
of bacteria. These error rates were determined by circular resequencing (Cir-Seq) under different 
growth conditions (minimal and complex medium), and by considering either messenger or 
ribosomal RNA sequences. A scheme of the Cir-Seq method is depicted in Figure 41, and compared 
with other deep-sequencing protocols applied to the determination of transcription error rates. 
 
Figure 41. Summary of techniques used for the study of transcription and reverse transcription error 
rates. (A) Circular resequencing (Cir-Seq) (Acevedo and Andino, 2014). Rolling-circle reverse transcription 
of circularized RNA templates yields tandem-repeated copies of cDNA, which are cloned to generate a library 
of dsDNA molecules containing sequencing platform adapters. The tandemly linked reads are aligned, and 
consensus are obtained after computational processing, excluding sequencing and RT errors. (B) Accurate 
RNA consensus sequencing (ARC-Seq) (Reid-Bayliss and Loeb, 2017). Barcoded RNAs are circularized and 
subjected to rolling-circle reverse transcription, generating a multimeric cDNA from each RNA molecule. 
Then, they are restricted into monomers and tagged with a unique index, amplified and sequenced. Consensus 
of cDNA molecules with the same barcode, and then of cDNA consensus with the same RNA barcode allows 
to genuinely identify transcription and reverse transcription errors. (C) Single Molecule Real-Time sequencing 
(SMRT-Seq) (Potapov et al., 2018). DNA templates are transcribed by T7 RNAP. The obtained RNA is used 
as template of reverse transcription by RT that also synthesizes the 2nd strand. Adaptors circularize the 
amplicons before amplification. Transcription and reverse transcription errors are observed in both strands, 
while errors made by RT during 2nd strand synthesis are uniquely found in one strand producing a mismatch, 
as amplification and sequencing errors. Only errors found in both strands of DNA are counted. Errors of 
transcription (red), reverse transcription (light blue), 2nd strand synthesis (dark blue), and amplification and 
sequencing (green, and pink) are shown as stars.   
 
Recently, Reid-Bayliss and Loeb (2017) developed an outbreaking method called accurate 
RNA consensus sequencing (ARC-seq) that allowed to distinguish between transcription errors and 
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those made by the RT during first-strand (cDNA) synthesis (Figure 41). This technique is based on 
a new protocol for library preparation, and allowed the authors to set the value of transcription 
mutagenesis at 2×10−5 for T7 RNAP. This value was consistent with the error rates obtained in our 
study, suggesting that T7 RNAP might be responsible for the inaccuracy threshold observed in our 
assays.  Despite the scope of the technique and the broad specific information that could be obtained 
with this approach, authors restricted the study to transcription mutagenesis, and reverse 
transcription error rates were not provided. 
According to these studies, we reasoned that T7 RNAP was imposing a level of transcriptional 
mutagenesis that for all the RTs was reflected in a threshold of around 10−5 errors per nucleotide 
(Tables 14 and 17). This inaccuracy in the synthesis of the RNA used as template hampered the 
evaluation of the fidelity of RTs during reverse transcription. We modified the conditions of the 
transcription reaction in order to alter the fidelity of T7 RNAP. Our results showed that indeed the 
accuracy of the T7 RNAP can be manipulated to some extent by changing transcription conditions, 
although reductions of the inaccuracy threshold were modest.   
T7 RNAP synthesizes more faithful RNA at lower pH (6.75 vs. 7.9) and Mg2+ concentration 
(1.5 mM vs. 6 mM).  This increase in fidelity using the lower pH conditions has also been previously 
reported for several DNA polymerases (e.g., Taq DNA polymerase, exonuclease-deficient Klenow 
fragment of E. coli DNA polymerase I, human DNA polymerase α and HIV-1 RT) (Eckert and 
Kunkel, 1990, 1993a, 1993b).  Thus, increases of fidelity of up to 50-fold have been reported at pH 
6.2 compared to pH 9.8 for base substitutions using the Klenow fragment of E. coli DNA polymerase 
I (Eckert and Kunkel, 1993a).  Authors attributed these effects to altered template binding properties 
of the enzyme at a lower pH. In the case of T7 RNAP, nucleotide incorporation studies with nonpolar 
thymidine analogues have shown that hydrogen bonds are important for polymerization efficiency 
due to their role in stabilizing the closed ternary complex of the polymerase, but electrostatic 
interactions with the minor groove of the substrate were critical for fidelity (Ulrich and Kool, 2011).   
On the other hand, it has been shown that HIV-1 RT and Taq DNA polymerase display higher 
fidelity at low concentrations of Mg2+ (e.g., 0.25 mM), although this property was controversial in 
experiments carried out with the MLV RT (Eckert and Kunkel, 1990; Achuthan et al., 2014; Okano 
et al., 2018).  Despite improvements in fidelity obtained by reducing pH and Mg2+ concentrations, 
there are obvious limitations to this approach due to the loss of catalytic activity of the enzymes 
when departing from the optimal conditions for their polymerization activity.  
High-fidelity transcription conditions (pH 6.75 and 1.5 mM Mg2+) were used to transcribe the 
RNA that serves as template in M13mp2 forward mutation assays, achieving a slight reduction in 
the error rates of HIV-1BH10 and K65R/V75IESP49 RTs. Although modest, the changes in fidelity 
observed for the same RT under different conditions of transcription could be attributed to the 
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accuracy of the bacteriophage T7 RNAP. For example, the error rate calculated for HIV-1BH10 RT 
increased 2.4-fold (from 3.5×10−5 to 8.4×10−5) only by changing the commercial T7 RNAP for the 
recombinant enzyme.  
In this Thesis, we also measured the RNA-dependent DNA synthesis fidelity based on the use 
of Primer IDs (i.e., degenerate oligonucleotides) for the synthesis of cDNA. This technique allows 
to discard amplification and sequencing errors, and provides a broad assessment of fidelity 
determined from multiple template sequences. Overall error rates of 3.5×10−4 and 2.6×10−4 
mutations per nucleotide were obtained for HIV-1BH10 and K65R/V75IESP49 RTs. This result was in 
agreement with previous data that focused on the study of RTs accuracy using the HIV-1 protease 
coding region as a target (Zhou et al., 2015), which rendered an overall error rate of 1.3×10−4 for a 
commercial RT from MLV.  
In our experiments, as well as in the study of Zhou et al. (2015), HIV-1 (LAV) RNA genome 
was used as template. These templates are expected to be more accurate than those made by T7 
RNAP, because they have been extracted from 8E5 cells, which constitute a cell line derived from 
human T cells. 8E5 cells contain only one integrated copy of an HIV-1 provirus, whose transcription 
is controlled by a eukaryotic RNAP (i.e., RNAP II). It has been reported that prokaryotic and 
eukaryotic RNAPs show several proofreading mechanisms, associated to intrinsic capacities and 
extrinsic assistant factors (Knippa and Peterson, 2013; Bubunenko et al., 2017; Mellenius and 
Ehrenberg, 2017; Mishanina et al., 2017; reviewed in Gamba and Zenkin, 2018). However, the high 
number of homopolymeric sites found in the target region of the protease used in our experiments 
(Figure 17) is expected to contribute to increase its overall error rate. In addition, the low number 
of consensus and mutations obtained (Table 20) limit the significance of these data. A more 
extensive analysis with a greater number of consensus sequences is necessary to obtain robust data 
on transcription and reverse transcription accuracy in vitro.  
 The transcriptional threshold can be modestly reduced, but it is clear that it has a measurable 
influence on the assessment of genuine errors made by RTs while copying RNA. Nevertheless, very 
often, studies have assumed that transcriptional mutagenesis has a relatively small effect in 
measuring the RNA-dependent DNA polymerase fidelity of RTs, suggesting that errors made by 
RNAPs are negligible, and do not significantly affect estimates of error rates induced by RTs. This 
widespread idea does not rely on conclusive results and is mainly based on studies that assume the 
equality of RNA- and DNA-dependent fidelities of RTs, or derived from misinterpretations of data 
provided by several studies, for example those of O’Neil et al. (2002).   
The mutation rate for HIV-1 replication, which represents the combined error rate for RT and 
the human RNAP II, is approximately 2×10−5 per nucleotide per replication cycle, a rate that is 
similar to other retroviruses (Hu and Hughes, 2012; and references therein). The relative 
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contribution between the human RNAP II and the RT in the diversity of HIV-1 was determined by 
analysing the mutations produced in the HIV-1 long terminal repeats (LTRs) (O’Neil et al., 2002).  
Similar number of mutations were found in both LTRs (caused either by RNAP II during 
transcription or by RT during minus strand synthesis) and in one LTR (owing to the activity of RT 
while synthesizing the plus strand). Authors reported error rates of mutations found at both LTRs 
(made by both enzymes) of 2.5×10−5 for HIV-gpt viral vector and 5.6×10−5 for NL4-3gpt, similar to 
our results in forward mutation assays. In addition, 6.7×10−5 and 2.4×10−5 error rates were obtained 
during the synthesis of the plus strand for both viral vectors, respectively, associated exclusively to 
the RT. 
More recently, a next-generation sequencing approach was conducted to measure the fidelity 
of transcription and reverse transcription, by using a Single-Molecule Real-Time sequencing 
(SMRT-Seq) method (Figure 41) (Potapov et al., 2018).  The RNA template was synthesized by 
the T7 RNAP and reverse transcribed by three different commercial RTs related to those of MLV 
and AMV. All tested samples showed first-strand error rates ranging from 5.6×10−5 to 7.5×10−5 
(cumulatively made by T7 RNAP and RTs on an RNA template), whereas the second-strand error 
rates ranged between 5.2×10−5 and 8.4×10−5 (produced by RTs on DNA template). First strand error 
rates were similar to ours (Table 14), and despite the presence of transcriptional mutations, we 
demonstrated that the accuracy of RTs belonging to diverse retroviruses such as HIV-1, MLV or 
AMV was not the same using DNA or RNA templates. These differences in the fidelity of RTs 
depending on the nature of the template (i.e., RNA or DNA) should be taken into account when 
comparing error rates obtained in DNA-templated reactions with those obtained in RNA-templated 
reactions that include transcription errors.  
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 Conclusion 1. WT HIV-2ROD RT showed 1.6-fold lower mutant frequency than HIV-1BH10 
RT in forward mutation assays based on DNA-dependent DNA synthesis reactions. 
Meanwhile, K65R in HIV-2ROD RT had almost no effect on the overall fidelity of the 
enzyme, contrary to the increased intrinsic fidelity observed with this amino acid change in 
highly divergent HIV-1 RT contexts (group M and O).  
 Conclusion 2. In HIV-1 RT, drug resistance mutations have been previously associated with 
an increased fidelity. In contrast, our data revealed that in HIV-2 this relationship cannot be 
established, particularly for the major mutations found in HIV-2 strains resistant to NRTIs 
(K65R, Q151M, M184V). 
 Conclusion 3. Retroviral RTs such as HIV-1BH10 (group M subtype B) and HIV-1ESP49 
(group O) are more faithful when copying RNA than DNA templates. On the other hand, 
for WT AMV and MLV RTs, and mutant polymerases K65RESP49 and K65R/V75IESP49, 
differences between DNA- and RNA-dependent accuracy cannot be determined in a reliable 
manner due to the sequence heterogeneity of the RNA template. 
 Conclusion 4. The heterogeneity of RNA templates (generated as a consequence of errors 
made by T7 RNAP during transcription) limit the correct assessment of fidelity in RNA-
dependent DNA synthesis reactions, even after changing the reaction conditions to improve 
the quality of the RNA template. T7 RNAP synthesizes produced less epimutations in the 
presence of lower pH and higher magnesium concentrations (i.e., pH 6.75/1.5 mM Mg2+ 
versus pH 7.9/6 mM Mg2+). Despite limitations, HIV-1BH10 RT remains as the least accurate 
RT, and the mutant K65R/V75IESP49 is one of the most faithful RTs. 
 Conclusion 5. Mutational spectra of retroviral RTs on RNA compared to DNA templates 
showed differences in hotspot distribution and specificity. Based on the spectra, reverse 
transcription initiation is revealed as an error-prone process, due to the accumulation of 
deletion mutations observed in the first two positions following the primer. The hotspot of 
one-thymidine insertions at position +139 is likely produced by T7 RNAP.  
 Conclusion 6. Deep sequencing experiments based on the use of Primer IDs allow a broader 
measurement of RNA-dependent DNA synthesis fidelity of HIV-1 RTs, showing slight 
differences in fidelity between HIV-1BH10 and K65R/V75IESP49 RTs. Although a more 
detailed analysis of these data is still needed, similar results were obtained with next-
generation sequencing experiments in comparison with M13mp2 forward mutation assays. 
A better assessment of reverse transcription fidelity is expected to be helpful to improve 
next-generation sequence platforms that require retroviral RTs for RNA sequencing. 
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 Conclusión 1. La RT de tipo salvaje (WT) del VIH-2ROD mostró una frecuencia de mutantes 
1,6 veces menor que la del VIH-1BH10 en ensayos genéticos basados en reacciones de síntesis 
de ADN dependientes de ADN. Por otro lado, la RT del VIH-2ROD con el cambio K65R no 
tuvo prácticamente ningún efecto sobre la fidelidad global de la enzima. Por el contrario, 
publicaciones previas mostraron una mayor fidelidad intrínseca de K65R, en el contexto de 
aminoácidos de las RTs de grupos del VIH-1 altamente divergentes (grupos M y O). 
 Conclusión 2. En la RT del VIH-1, las mutaciones de resistencia a fármacos 
antirretrovirales se han asociado con una mayor fidelidad (por ejemplo, K65R o M184V). 
Sin embargo, nuestros datos revelaron que en el VIH-2 no se puede establecer dicha 
relación, particularmente para las principales mutaciones encontradas en cepas del VIH-
2ROD resistentes a análogos de nucleósido (K65R, Q151M, M184V). 
 Conclusión 3. Las RTs de retrovirus, como las del VIH-1BH10 (grupo M subtipo B) y del 
VIH-1ESP49 (grupo O), son más fieles al sintetizar ADN en moldes de ARN que de ADN. 
Por otro lado, no se pudieron determinar de manera fiable las diferencias de fidelidad de 
síntesis de ADN en función del molde (ARN o ADN) para las RTs WT del AMV y el MLV, 
así como para las polimerasas mutantes K65RESP49 y K65R/V75IESP49, debido a la 
heterogeneidad de la secuencia del molde de ARN, utilizado en las reacciones de 
retrotranscripción.  
 Conclusión 4. La heterogeneidad de los moldes de ARN (generada como consecuencia de 
los errores cometidos por la ARN polimerasa del fago T7 durante la transcripción) limita la 
determinación correcta de la fidelidad de las RTs en reacciones de síntesis de ADN 
dependientes de ARN. Esta limitación persiste incluso después de cambiar las condiciones 
de transcripción para mejorar la calidad del molde de ARN. La ARN polimerasa T7 produce 
menos errores al sintetizar el ARN en condiciones de menor pH y mayor concentración de 
magnesio (es decir, pH 6,75/1,5 mM Mg2+ frente a pH 7,9/6 mM Mg2+). A pesar de las 
limitaciones, la RT del VIH-1BH10 permanece como la RT menos precisa, y el mutante 
K65R/V75IESP49 es una de las RTs más fieles. 
 Conclusión 5. Los espectros de mutación generados por diversas RTs de retrovirus al copiar 
moldes de ARN, en comparación con aquellos producidos al copiar ADN, mostraron 
diferencias en la especificidad y distribución de errores. En base a los espectros, el comienzo 
de la retrotranscripción se revela como una etapa propensa a la introducción de errores, 
observándose una acumulación de deleciones en las dos primeras posiciones después del 
iniciador. La acumulación de inserciones de una base de timidina en la posición +139 
probablemente sea producida por la ARN polimerasa del fago T7. 
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 Conclusión 6. Los experimentos de secuenciación masiva basados en el uso de iniciadores 
degenerados permiten una determinación más precisa de la fidelidad de síntesis de ADN 
dependiente de ARN de las RTs del VIH-1, aunque muestran pequeñas diferencias de 
fidelidad entre las RTs del VIH-1BH10 y del doble mutante K65R/V75IESP49. Los 
experimentos basados en tecnologías de secuenciación de nueva generación (NGS) 
arrojaron resultados similares a los ensayos genéticos basados en el uso del fago M13mp2, 
si bien es necesario hacer un análisis más detallado de estos datos. Una evaluación más 
precisa de la fidelidad de la retrotranscripción permitirá mejorar las plataformas de NGS 
que requieren el uso de RTs de retrovirus para la secuenciación del ARN. 
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